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ABSTRACT 
 
The thymus is organised into functionally distinct microenvironments that facilitates 
development of a diverse and self-tolerant T cell repertoire. Following positive selection, 
thymocytes undergo chemotactic migration from the cortex to the medulla, a site that mediates 
negative selection of potentially autoreactive CD4
+
 and CD8
+
 single positive (SP) thymocytes. 
Importantly, current models suggest that the medulla also fosters the continued maturation of 
SP thymocytes, post-selection. However, the mechanisms of thymic medulla function remain 
unclear. 
Using a novel approach based on chemokine receptor expression, we have mapped stages in 
the positive selection process, and developed a model to study αβT cell development in the 
absence of medullary thymic epithelial cells (mTEC), but in the presence of an otherwise 
intact immune system. We show that mTEC are dispensible for the continued development of 
newly selected CD4
+
CD69
+
 SP thymocytes, yet are essential for the generation of FoxP3
+
 
regulatory T cells and their FoxP3
-
CD25
+ 
progenitors. In addition, although CCR4 represents 
a marker of early stage CD4
+
 SP positive selection, it is dispensable for SP medullary 
accumulation and intrathymic development. 
Collectively these findings highlight differences in the developmental requirements of 
conventional and regulatory CD4
+
 T cells, and rule out a role for CCR4 in cortex to medulla 
migration.  
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CHAPTER ONE: GENERAL INTRODUCTION 
  
 2 
1.1 AN OVERVIEW OF THE IMMUNE SYSTEM 
1.1.1 The Role Of The Immune System 
The fundamental role of the immune system is to protect its host against invading pathogens 
to prevent infectious disease. The immune system is comprised of an interactive network of 
diverse cell types, each with specialized roles in defending against infection. It has evolved to 
protect the host against infection through its ability to recognize foreign pathogens by self –
non-self discrimination. The environment exposes the host to a vast array of pathogenic 
organisms that challenge the defense system using a broad spectrum of mechanisms. It is, 
therefore, pivotal the immune system operates an extensive range of protective strategies via a 
complexity of cellular interactions, to facilitate successful detection and elimination of 
pathogens, whilst avoiding destruction of its own tissues as a consequence (Chaplin, 2010). 
 The defense system operates at two levels; innate immunity and adaptive immunity, 
determined by the speed and specificity of the reaction. Innate immunity is an evolutionarily 
ancient defense system present to some degree within all multicellular organisms (Boehm, 
2012). It provides a relatively non-specific, initial immune defense for immediate 
responsiveness to pathogenic exposure. In comparison, the adaptive immune system is more 
recent in its evolutionary status and is found only in vertebrates. Adaptive immunity is 
sophisticated, providing a delayed, but specific response to a target pathogen. Both branches 
of the immune response must function concurrently to effectively eradicate the threat and 
prevent the establishment of infection (Boehm, 2012; Janeway and Medzhitov, 2002; Turvey 
and Broide, 2010). 
  
 3 
1.1.2 The Innate Immune Response 
The innate immune system uses a broad range of recognition molecules for rapid detection of 
foreign pathogens to supply an initial defense against infection. The innate response lacks 
immunological memory, so will remain unchanged regardless of re-exposure to the same 
pathogen (Delves and Roitt, 2000a). The innate immune system has three principle 
components; mechanical, chemical and cellular. The mechanical elements of the innate 
system comprise of the host protective barriers. These barriers consist of cells from a non-
hematopoietic origin such as the cellular components of the skin and the epithelial cell linings 
of the respiratory, gastrointestinal and genitourinary tracts (Basset et al., 2003; Turvey and 
Broide, 2010). If invading pathogens should successfully infiltrate the protective barriers of 
the host and inflict tissue damage, a series of danger signals are trigged. This results in 
secretion of many of the soluble components of the innate system, which include chemokines 
and cytokines (Kumar et al., 2009). Chemokines orchestrate cell migration and attract cells of 
both the innate and adaptive response to the site of infection. Cytokines regulate the function 
of neighboring cells and have both pro-inflammatory and anti-inflammatory properties to 
provide an appropriate response to enhance the clearance of pathogens (Basset et al., 2003; 
Chaplin, 2010). The cellular components involved in the innate defense system consist of 
cells from a hematopoietic origin including: mast cells, dendritic cells (DC), macrophages, 
neutrophils, eosinophils and natural killer (NK) cells (Janeway and Medzhitov, 2002).  
The recognition strategy of the innate immune system is not to detect each foreign pathogen 
specifically, but to identify a small number of commonly expressed, highly conserved 
structures on entire classes of micro-organisms. These structures are known as pathogen-
associated molecular patterns (PAMPs) and the innate immune system has evolved to 
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recognize them via pattern- recognition receptors (PRRs), expressed by many of the cellular 
components of the innate system (Medzhitov and Janeway, 1997). The specificities of these 
innate receptors are genetically predetermined, therefore variation is limited to the number of 
genes encoded within the host genome (Turvey and Broide, 2010). Each receptor has defined 
specificities to the most highly conserved structures expressed by infectious pathogens. They 
can be broadly categorized into three classes: secreted, transmembrane or cytosolic (Iwasaki 
and Medzhitov, 2010). Secreted PRRs can bind the invading pathogen cell surface and flag 
them for destruction, either via the compliment system or by phagocytosis by macrophages 
and neutrophils (Medzhitov and Janeway, 2002). Transmembrane bound PRRs are found on 
many of the cellular components of the innate system including DC, NK and marcrophages. 
This catorgy includes Toll-like receptors, scavenger receptors and complement receptors. 
Upon pathogen binding these transmembrane PRRs cells secrete high levels of cytokines and 
chemokines, which aids the recruitment of additional cells types to the site of infection 
(Basset et al., 2003; Dempsey et al., 2003). Several PRRs are expressed within the cytosol and 
detect intracellular pathogens. These receptor are particularly important during viral and 
bacterial infection (Janeway and Medzhitov, 2002). In addition to recognizing PAMPs, PRRs 
can also recognize self-molecules, released after cell death or damage, known as danger 
associated molecular patterns (DAMPs). These immunological danger signals are released as 
a consequence of infection or inflammation and are an additional surveillance mechanism 
utilized by the innate system to detect any possible invasions of the host system (Modlin, 
2012). 
Upon pathogen recognition through PRRs engagement, a series of intracellular signaling 
events occurs to activate the innate cell to perform its effector functions immediately 
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(Dempsey et al., 2003). Thus, facilitating short-lived effector cells to provide the 
characteristic rapid responses of the innate system (Basset et al., 2003; Medzhitov and 
Janeway, 2000). Such responses frequently succeed in removing the majority of pathogenic 
threats without the requirement of backup from the adaptive system. However, the innate 
immune response alone is not always sufficient and activation of adaptive immunity is 
necessary for additional aid to clear the infection (Janeway and Medzhitov, 2002). 
As the adaptive immune system evolved in the presence of innate immunity the two do not 
operate in isolation. Many of the adaptive immune responses build on the foundations set by 
innate immunity (Dempsey et al., 2003). Various components of the innate system play a role 
in initiating and instructing the development of an adaptive immune response, which in turn 
can lead to recruitment and activation of additional innate cells to the site of infection. This 
synergy between the two arms of the immune system amplifies the responsiveness of both 
divisions and is essential to assure a fully efficient immune response (Chaplin, 2010; 
Dempsey et al., 2003; Medzhitov and Janeway, 1997). 
1.1.3 The Adaptive Immune Response 
In contrast to the limited number of pathogen recognition receptors of the innate response, the 
adaptive immune system possesses an exceptionally diverse and randomly generated receptor 
repertoire. The adaptive immune system uses antigen- specific receptors expressed by T and 
B lymphocytes to drive targeted responses against specific pathogens (Medzhitov and 
Janeway, 1997). Upon recognition of a specific pathogen, lymphocytes must undergo clonal 
expansion to greatly increase the numbers of antigen-specific cells to generate an efficient 
response. The antigen detection and expansion of cell numbers can take several days, during 
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which time the innate system has to work alone to control the invasion and prevent damage to 
the host (Delves and Roitt, 2000b).  Once a specific response has been raised and the threat 
has been successfully eradicated, long-lived effector cells can persist in a dormant like state, 
ready to rapidly re-express their effector function if they ever should re-encounter the same 
antigen.  This allows the adaptive response to have immunological memory and enables a 
rapid and enhanced response on re-exposure to the same pathogens, even decades after the 
primary encounter (Chaplin, 2010; Medzhitov and Janeway, 2000; Parkin and Cohen, 2001). 
T and B lymphocytes represent essential cellular components of the adaptive immune system. 
Both cell types express unique T cell receptors (TCR) and B cell receptors (BCR) for 
recognition of a vast diversity of antigens, generated by somatic gene rearrangement (Hedrick 
et al., 1984). BCR can be secreted as immunoglobulin (Ig), which recognizes antigen in its 
native form, whilst membrane bound TCR require pathogens to be processed and presented 
via major histocompatibility complex (MHC) molecules (Parkin and Cohen, 2001).  The 
major focus of this thesis is the developmental biology of T cells, therefore, an overview of T 
cell function is provided. 
1.1.4 T lymphocytes  
There are two functionally distinct subsets of T cells dependent upon their TCR, those that 
express a αβTCR and those that express a γδTCR. Both αβ and γδT cells develop from the 
same common progenitor within the thymus, yet what drives αβ versus γδ TCR commitment 
remains unresolved (Kreslavsky et al., 2010). The conventional αβT cells can be further 
classified into two populations, depending upon their surface expression of co-receptor 
molecules CD4 or CD8. Each subset binds antigen presented by a different class of MHC 
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molecule and upon activation each population differentiates into functionally distinct effector 
cells. CD4
+ 
T cells have a helper role, whilst CD8
+ 
T cells have cytotoxic functions. The co-
receptors are not just phenotypic markers, but also have a functional role to stabilize the 
interactions between the TCR and the peptide-MHC complexes on the surface of antigen 
presenting cells (APC) (Chaplin, 2010; Parkin and Cohen, 2001). The lineage commitment of 
the αβT cell is decided during their multi-stage developmental program in the thymus. Thus 
on exit into the periphery T cells have committed to γδT cell fate, or a CD4+ helper or CD8+ 
cytotoxic αβT cell lineage (Allison and Havran, 1991). 
γδT cell functions are less well characterized compared to their αβ T cell counterparts, 
constituting about 1-5% of the total lymphocyte population within the blood and peripheral 
organs (Carding and Egan, 2002). This specialized subset of lymphocytes possesses several 
innate-cell like features that enables their rapid activation upon stimulation by stress-induced 
ligands (Bonneville et al., 2010). The γδTCR recognize highly conserved antigens, which are 
released by stressed cells within the surrounding environment.  Upon activation, γδT cells 
promptly produce cytokines to regulate pathogenic clearance and tissue homeostasis.  This T 
cell subset is commonly homed to and resides within the epithelial layers of internal and 
external surfaces of the body, such as the skin, lung, tongue and intestinal epithelium(Allison 
and Havran, 1991). Within these areas this specialized lymphocyte cohort provides a first line 
of defense against invading pathogens (Bonneville et al., 2010; Xiong and Raulet, 2007). 
All data and discussion of T cells and TCR from this point will refer to conventional αβT 
cells only, unless stated. 
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1.1.4.1 Cytotoxic CD8
+ 
T Cells 
CD8
+
 T lymphocytes recognize endogenous peptides generated from antigens that are 
synthesized from within the host cell and present within the groove of MHC Class I 
molecules. This T cell subset acts to kill viral infected cells, but also participates in the 
defense response against bacterial and protozal infections. On binding specific antigen on its 
target cell, CD8
+
 T cells insert perforins into the infected cell membrane, which in turn results 
in DNA fragmentation and cell apoptosis. Cytotoxic CD8
+
 T cells can also recognize death-
inducing signals on the surface of infected host cells, known as Fas molecules. CD8
+ 
T cells 
express Fas ligands on their surface to detect these molecules, which upon binding induce cell 
apoptosis of the target cell (Harty et al., 2000). 
1.1.4.2 Helper CD4
+ 
T Cells 
CD4
+
 T cells recognize exogenous antigens, which have been ingested, processed and 
presented by MHC class II molecules on the cell surface of APC. CD4
+
 T cells have a helper 
function, regulating cellular and humoral immune responses (Chaplin, 2010). CD4
+
 T cells 
are traditionally believed to differentiate into two additional subsets upon their activation. The 
effector function pathway chosen is dependent upon the specific signals received from the 
surrounding environment and the APC cell from which they were primed. Those naive CD4
+
 
T cells primed by APC that produce the cytokine interleukin (IL)-12 differentiate into effector 
cells that secrete high levels of IL-2 along with Interferon-γ (IFNγ) (Bottomly, 1988; 
Mosmann and Coffman, 1989; Parkin and Cohen, 2001). These cells are classified as T helper 
1 (TH1) cells and commonly help activate a cell-mediated inflammatory response to clear 
intracellular pathogens. IL-2 can stimulate T cell proliferation of most T cell lineages 
(Mosmann and Coffman, 1989), whilst IFNγ induces natural killer (NK) cells and activates 
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macrophages to kill intracellular pathogens, such as fungi and protozoa (Parkin and Cohen, 
2001). Those naive CD4
+ 
T cells activated by IL-4 stimulated dendritic cells (DC) develop 
with a different effector function cell fate. These cells are known as T helper 2 (TH2) cells and 
are generally important in the clearance of extracellular pathogens. Upon activation TH2 cells 
produce cyokines: IL-4 IL-5, IL-9 and IL-13. These cytokines act to stimulate antibody 
production by B cells, whilst influencing the behavior of some cells of the innate response. 
(Bottomly, 1988; Chaplin, 2006; Mosmann and Coffman, 1989). 
There are additional alternative developmental pathways induced during the activation of 
naive CD4
+
 T cells. These different lineages include pro-inflammatory T helper 17 cells 
(TH17) and anti-inflammatory T regulatory (Treg) effector cells (Zhou et al., 2009). Both 
effector lineages can be induced by the cytokine transforming growth factor- β (TGF-β), 
however, the effector fate of the differentiating naive T cells is dependent on the presence of 
IL-6, an acute phase protein released during inflammation (Bettelli et al., 2006; Kimura and 
Kishimoto, 2010). Activation in the presence of both TGF-β and IL-6 results in the 
differentiation of naive T lymphocytes into TH17 cells and the suppression of TGF-β induced 
Treg generation (Bettelli et al., 2006). TH17 are characterized by their IL-17 producing 
capabilities. The combination of IL-6 and TGF-β induces retinoid- related orphan receptor 
(ROR)γt and RORα, key transcription factors in the differentiation of the TH17 lineage. TH17 
effector cells regulate defenses against extracellular pathogens and fungi, via their IL-17 
secretions. However, cells of this lineage have also been identified to contribute considerably 
to the development of autoimmune conditions, due to their pro-inflammatory nature 
(Harrington et al., 2005; Kimura and Kishimoto, 2010). 
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Stimulation by TGF-β and IL-2, in the absence of IL-6, induces activated naive T cells to 
convert into T regulatory (Treg) effector cell (Bettelli et al., 2006; Curotto de Lafaille and 
Lafaille, 2009). This differentiation process is under the control of transcription factor 
forkhead box P3 (Foxp3), which is essential for the maintenance and function of this 
specialized CD4
+
 T cell subset (Fontenot et al., 2003). These regulatory cells act to maintain 
immune homeostasis, prevent autoimmunity and modulate inflammatory responses to 
environmental and pathogenic insult (Sakaguchi et al., 1995). Foxp3
+
 CD4
+ 
Treg achieve their 
objectives via several sophisticated suppressive mechanisms, targeted towards many cell 
types involved in immune response. The regulatory mechanisms used by this cell type include 
the secretion of inhibitory cytokines such as IL-10. IL-35 and TGF-β. In addition Treg can 
stimulate perforin dependent killing methods and cause metabolic disruptions to other effector 
T cell targets, including alterations to the maturation and function of DC (Vignali et al., 2008). 
Treg are not exclusively induced within the periphery, but can also be generated 
intrathymically during the CD4
+
 T cell development program. Treg that develop within the 
thymus are known as natural (n)Treg and are believed to be generated through high avidity 
MHC Class II dependent TCR engagement (Bensinger et al., 2001; Jordan et al., 2001). 
1.1.5 Antigen Processing And T Cell Presentation 
MHC molecules are cell surface glycoproteins. MHC class I molecules display endogenous 
peptides synthesized within the host cell. MHC class I complexes are expressed on the cell 
surface of all nucleated cells and present peptide fragments that have been degraded from 
cellular proteins under the control of proteasomes (Neefjes et al., 2011). If cells are activated 
by IFNγ stimulation, proteasomes degrade antigens into peptide fragments for presentation on 
their surface. The generated peptides are translocated into the endoplasmic reticulum (ER) 
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where they are loaded into the class I protein-binding groove. This loading process is under 
the control of the ER protein tapasin, with the aid of various chaperone proteins (Hughes et al., 
1997) The peptide loaded class I molecules are then transported via the golgi complex into 
exocytic vesicles and released onto the cell surface for detection by CD8
+ 
T cells or NK cells 
(Raposo et al., 1995). This system is well adapted for the presentation of viral peptides 
produced within virally infected cells (Van Bleek and Nathenson, 1990), but can also be used 
to display tumor specific proteins (Neefjes et al., 2011). This antigen presentation technique, 
therefore, provides both antiviral and antitumor immunity, by enabling infected host cells to 
identify themselves as targets to CD8
+ 
T cells. The CD8
+ 
T cells can then provided a highly 
targeted response and remove the threat by cytotoxic attack (Wong and Pamer, 2003). 
Peptides derived from extracellular proteins may also be loaded onto MHC class I molecules 
by a process of cross presentation. This method is used during some viral infections to 
overcome the ability of various viruses to suppress antigen presentation within the host and 
thus prevent the display of peptide via the typical MHC Class I endogenous route (Delamarre 
et al., 2003; Nopora et al., 2012).  
MHC class II molecules are exclusively displayed on the cell surface of professional APC 
including DC, B cells and macrophages. This class of MHC complexes displays exogenous 
antigen to CD4
+
 T cells, which upon activation affect the behavior of a wide range of cells 
within their surrounding environment. It is critical that T cell activation is tightly regulated. 
Thus, MHC class II molecules are only displayed on a small fraction of cells, in comparison 
to MHC class I complexes that are ubiquitously expressed (Neefjes et al., 2011). The 
exogenous antigens presented by MHC class II proteins are taken up by the environment and 
primarily consist of proteins from extracellular pathogens such as bacteria, parasites and 
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viruses (Delamarre et al., 2003).  These antigens are ingested by APC though phagocytosis 
and processed into linear peptide fragments via proteolysis. The processed fragments then 
accumulate within the MHC class II loading compartments. MHC class II molecules are 
assembled within the ER before their transportation to the Class II loading areas, where they 
encounter the processed peptide fragments, which are loaded onto their peptide-binding 
groove. The antigen-MHC structures are then delivered to the cell surface for recognition by 
the TCRs of CD4
+ 
T cells (Landsverk et al., 2009). 
1.1.6 TCR Structure And Generation 
The αβTCR structure is comprised of two chains: the α chain and the β chain, held together 
by disulphide bonds to form a heterodimer. Each chain consists of a variable domain and a 
constant domain; with the variable regions determining the receptor antigen specificity. (Saito 
et al., 1984) The α and β variable domains encode for hypervariable complementarity-
determining regions (CDRs) of the receptor, which are the binding sites to complimentary 
peptide-MHC complexes. The variable region of the β-chains is encoded by variable (V), 
diversity (D) and joining (J) gene segments, whilst only V and J gene fragments encode the 
variable region of the α-chain (Nikolich-Zugich et al., 2004; Parkin and Cohen, 2001). 
Diversification of the TCR occurs through the random process of V(D)J recombination during 
the early developmental stages of intrathymic T cells generation. There is diversity in each 
V,D and J gene region and the recombination process joins only one gene segment per region 
to form a V(D)J complex consisting of randomly arranged fragments. This process involves 
nucleases to cut DNA fragments and ligases to bind gene fractions together, under the control 
of recombination activation genes (RAG-1) and RAG-2 (Mombaerts et al., 1992b; Shinkai et 
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al., 1992). The V(D)J gene segments are then joined to the constant gene regions, resulting in 
the formation of a final gene sequence from which proteins will be transcribed to generate 
either the α-chain or β-chain of the TCR. Using this system, each T lymphocyte has a 
different combination of gene segments to form a unique genetic code for antigen receptor 
synthesis. Diversity is further enhanced during the assembly of TCRs by imprecise splicing 
and frame shifts in base pairs, leading to synthesis of different amino acids (Delves and Roitt, 
2000a; Nikolich-Zugich et al., 2004). The enzyme terminal deoxyribonucleotidyl transferase 
(TdT) can also act to additionally alter the gene sequence of the V domains via insertion of 
extra nucleotides, with disruption to its expression resulting in a reduction to TCR diversity 
(Gilfillan et al., 1993). On successful α and β segment generation, different α and β-chains are 
paired, in the last attempt to enhance variation in the final TCR structure (Nikolich-Zugich et 
al., 2004). 
Although the production of a diverse TCR repertoire offers a huge benefit to the host in terms 
of defense against a vast range of invading pathogens, it also carries a great risk. The random 
nature of the generation of the repertoire bears the potential to generate lymphocytes with 
TCR specificity to self. Multiple complex tolerance mechanisms are in place to eliminate any 
potential self-reactive cells, which will be discussed in greater detail in Sections 1.2 and 1.3. 
1.1.7 TCR Signaling 
T cell receptors are associated with CD3 complexes on the surface that transmit activation 
signals into the cell upon T cell priming by antigen binding. The αβTCR subunits have short 
cytoplasmic tails, which makes it impossible for them to transduce down stream signals to the 
nucleus without the assistance of the accessory chains that make up the CD3 complex. The 
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CD3 complex comprises of transmembrane chains of CD3γ, CD3δ, CD3δε and CD3ζ. Each 
αβ TCR pair is non-covalently associated with a CD3γ heterodimer, a CD3ε heterodimer and 
a homodimer of two CD3ζ chains. All CD3 subunits contain immunoreceptor tyrosine-based 
activation motifs (ITAMs) within their cytoplasmic tails (van der Merwe and Dushek, 2011). 
TCR binding to peptide-MHC complexes results in biochemical changes to the CD3 complex. 
These changes include the phosphorylation of the tyrosines within the ITAMs by the receptor 
associate kinases: Lck and Fyn of the Src family. The phosphorylation of tyrosines within the 
cytoplasmic tails initiates ITAMs to interact with linker proteins; ζ-chain-associated protein 
kinase 70 (ZAP- 70), linker for activation of T cells (LAT) and SH2 domain containing 
leukocyte protein of 76kDa (SLP-76). Activation of these proteins leads to the stimulation of 
phospholipase C, G proteins Ras and Rac, along with protein tyrosine kinase (PTK) and 
mitogen-associated protein (MAP) kinase. Collectively the activation of these pathways 
results in down stream signaling cascades, which activate genes to control cell proliferation 
and differentiation (Smith-Garvin et al., 2009). 
The interactions between peptide- MHC molecules and TCR/CD3 complexes only provide 
partial signals for T cell activation. Along with TCR antigen binding, T cells also need to 
receive a second signal mediated through co-stimulatory molecules. Co-stimulatory signals 
play an essential role in both positive and negative regulation of a variety of T cell effector 
functions (Yokosuka and Saito, 2009). The most well characterized example of a co-
stimulatory molecule is CD28, expressed on the cell surface of T cells. CD28 can bind CD80/ 
CD86 complexes displayed on the surface of APC and particularly highly expressed on the 
cell surface of activated DC. Upon CD28 binding to CD80/86, in conjugtion with TCR 
antigen-MHC engagement, T cells become activated and induce their effector functions 
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(Sharpe and Freeman, 2002). Activated T cells can also express the co-stimulatory molecule 
cytotoxic T-lymphocyte antigen 4 (CTLA-4) on their surface, which additionally binds 
CD80/86. In contrast to CD28 activation signals via CD80/86 engagement, once bound 
CTLA-4 provides inhibitory signals to the T cells (Rudd and Schneider, 2003). The 
complicated costimulatory network for T cell activation enables the adaptive system to 
control signaling and ensure the most appropriate immune response is delivered for successful 
clearance of the immunological threat, without provoking unnecessary damaging to the host 
(Delves and Roitt, 2000b). 
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1.2 T CELL DEVELOPMENT 
1.2.1 Structure And Function Of The Thymus 
The thymus is a primary lymphoid organ that supports the differentiation of T cells. It is an 
evolutionary conserved organ that is a component of the adaptive immune response in all 
vertebrates (Boehm et al., 2012). The immunological role of the thymus was discovered over 
50 years ago. It was observed that the thymectomy of mice in their immediate neonatal period 
of life resulted in an absence of the T cell population (Miller, 1961). It has since been well 
characterized for its ability to provide a specialized microenvironment to support the 
establishment and maintenance of a highly diverse, self-tolerant T cell repertoire (Rodewald, 
2008). With increasing age, the thymus undergoes a gradual process of involution or atrophy, 
with the replacement of epithelial thymic tissue with a fibrofatty alternative. This disruption 
to the thymic architecture results in less efficient T cell development and the reduced 
emergence of naive T lymphocytes into the periphery. The role of the organ, therefore, is 
considered pivotal during early development, establishing and educating the T cell repertoire 
to protect the host from pathogenic threats for the remainder of its life (Lynch et al., 2009; 
Miller, 2002).  
The thymic microenvironment is anatomically divided into two key regions, the outer cortex 
and the inner medulla. Each area is comprised of unique stromal cells, which provide the 
essential signals needed for the stringent T cell developmental program (Rodewald, 2008). 
The thymic stroma is organized into a three-dimensional cellular network, comprised of DC, 
macrophages, endothelium cells, fibroblasts and thymic epithelial cells (TEC). The most 
abundant cellular component of the stroma are the TEC populations, which can be sub-
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divided into two distinct groups: cortical (cTEC) and medullary (mTEC), dependent upon 
their anatomical position within the two major thymic regions. These two thymic epithelium 
populations differ in their cellular morphology and their functional properties, but both are 
fundamental for successful T cell development. The cTEC subset has a vital role in the earlier 
stages of T cell development, in contrast to mTEC, which regulate later maturational periods 
of thymocyte differentiation. (Alves et al., 2009) 
The key developmental stages of intrathymic T cell generation and the migratory pathway of 
differentiating cell through the thymic microenvironment are summarized within Figure 1.1 
and 1.2. 
1.2.2 Thymic Colonization And T Cell Precursors 
T cell progenitors are derived from self-renewing multipotent hematopoietic stem cells (HSC) 
that have lineage potential to differentiate into all cellular components of the immune system. 
The site of development of HSC changes during ontogeny, with cells derived from the fetal 
liver during embryogensis and postnatally from the bone marrow. Fetal and postnatal T cell 
progenitors not only differ in their sites of development, but also in their methods of thymic 
colonization (Anderson et al., 2006). The initial colonization of a fetal thymus occurs 
approximately 11 days after gestation in mice (Owen and Ritter, 1969). At this stage in 
development the thymus lacks vascularization, resulting in precursors having to exit from 
adjacent blood vessels and migrate to the thymus through surrounding connective tissue. The 
immigration pathway to the fetal thymus occurs in a two step process. Firstly the T cell 
precursors must migrate to the mesenchymal layer, before travelling across an epithelial  
 
  
 18 
 
 
 
 
 
Figure 1. 1 The Stages Of Intrathymic T Cell Development 
The stages of the intrathymic T cell developmental program are defined by changes in 
surface expression patterns of co-receptors CD4 and CD8. Thymocyte differentiate 
from CD4- CD8- double negative (DN) to CD4
+
 CD8
+
 double positive (DP), before 
the final CD4
+ 
CD8
-
 or CD4
-
 CD8
+
 single positive (SP) stage in development.  
Alternative lineage potentials of populations are displayed in black boxes. The red 
arrows/text display essential checkpoints in the intrathymic T cell developmental 
program.  
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Figure 1. 2 The Migratory Pathway Of Developing Thymocytes 
During T cell development thymocytes undergo directed migration through distinct 
regions of the thymic microenvironment, where they receive essential signals from 
specialised stromal cell populations. Arrows indicate the direction of migration. Early 
thymic progenitors (ETP) enter via blood vessels (BV) at the corticomedullary 
junction (CMJ), where they migrate out through the cortex as DN cells (DN1 to DN3) 
before accumulating at the subcapsular zone at the DN3 stage in development. 
Thymocytes then differentiate into DP cells and migrate back through the cortex in the 
direction of the medulla. DP cells that successfully undergo positive selection 
commitment to a CD4
+
 SP or CD8
+ 
SP lineage fate and migrate across the CMJ into 
the medulla as a SP thymocyte.  
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basement membrane to gain entry into the thymic environment (Itoi et al., 2001). In contrast, 
postnatal T cell precursors that reside within the bone marrow migrate out into the blood 
circulation system, from where they can directly enter the organ at the corticomedullary 
junction (CMJ) (Lind et al., 2001). 
The differential pathway linking the multipotent HSC to the intrathymic T lineage committed 
cell is poorly understood. The developmental stages of T cell progenitors are commonly 
simplified into a multistep differentiation program. HSC within the bone marrow differentiate 
into short-lived, non-renewing multipotent progenitors (MPPs) (Morrison et al., 1997). These 
progenitors then undergo a series of irreversible lineage commitment events, resulting in the 
generation of downstream intermediate populations that are biased towards either a lymphoid 
lineage or a myeloid lineage.  MPPs give rise to either common lymphoid progenitors (CLPs) 
that generate downstream precursors with T and B lineage potential, or common myeloid 
progenitor (CMP) that differentiate into cell types such as macrophages and granulocytes 
(Kondo, 2010). Some cell types cannot be clearly grouped into a CLP or CMP lineage, 
however, such as DC, which have the potential to arise from both progenitors (Manz et al., 
2001).  
It is unknown if thymic colonizing progenitors prethymically commit to a T cell fate or if 
lineage commitment can occur intrathymically (Bhandoola et al., 2007; Schlenner and 
Rodewald, 2010). Regardless of their lineage potential the earliest intrathymic progenitors 
have long been thought to have no self-renewing properties. Short-lived thymocytes are 
believed to have no long lasting thymic residency and therefore need steady recruitment from 
the bone marrow to the thymus throughout life to maintain constant T cell generation. This 
recruitment is not continuous, but an intermittent and gated event that occurs in episodic 
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waves into both fetal thymic tissue and the steady-state adult thymus (Foss et al., 2001; Petrie, 
2003).  Fetal thymic grafting experiments have demonstrated that under steady state 
conditions the thymocyte pool is replenished within a four week time period (Berzins et al., 
1998). Thymic survival has more recently, however, been identified to be not only dependent 
on the short life span of thymocytes, but also reliant on competition between the incoming 
progenitors and the older residents. When placed under conditions of precursor deprivation 
thymocytes can persist and remain productive intrathymically for extended periods of time, 
demonstrating differential self-renewing capabilities. These findings suggest thymic turnover 
is not due to short-lived cell intrinsic programming, but instead is from the pressures of newly 
imported progenitors. This conflicts with the well accepted theory that a continuous 
progenitor input from the bone marrow is essential to sustain continuous T cell development 
(Martins et al., 2012; Peaudecerf et al., 2012) 
Several key mechanisms are in operation to drive thymic progenitor entry into the thymus. 
Chemokine signaling has been implicated in mediating T cell progenitor recruitment and 
colonization in both the fetal and adult thymic environments. Chemokines are produced and 
secreted by the thymic microenvironment, creating chemoattractant gradients that attract T 
cells progenitors and coordinate their migration into the organ. Investigations indentified the 
specific involvement of chemokine receptors CCR7 and CCR9 in recruitment of T cells 
progenitors to both the prevascular neonatal thymus (Liu et al., 2006) and to the adulthood 
vascularized thymus (Zlotoff et al., 2010). Moreover, recent studies have identified a role for 
an additional chemokine receptor, CXCR4 in fetal thymic progenitor seeding. Absence of 
CCR9, CCR7 and CXCR4 results in a vast reduction of thymic homing, consequently leading 
to a reduction in thymocyte cell numbers. In contrast, the absence of only two of the receptors 
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in any combination (CCR9 x CCR7, CCR9 x CXCR4 or CCR7 x CXCR4), has much milder 
effects on the number of progenitors capable of migrating to the neonatal thymus (Calderon 
and Boehm, 2011).  
Adhesions molecules have also been implicated in regulating the vasculature-dependent 
pathway of T cell progenitor entry into the adult thymus. Specificly, P-selectin and its ligand 
P-selectin glycoprotein ligand-1 (PSGL-1) have been identified to be critical in aiding thymic 
progenitor colonization.  PSGL-1 expressed by T cell progenitors binds P-selectin on the 
thymic endothelium. The expression of P-selectin by the vasculature is thought to be 
quantitatively regulated by the number of empty thymic progenitor niches and thus, this 
adhesion molecule may modulate the waves of recruits into the postnatal thymus (Rossi et al., 
2005).  
1.2.3 Early Stages In T Cell Development 
Following thymic colonization, the earliest CD4
-
 CD8
-
 double negative (DN) thymocytes 
undergo crucial events in thymocyte development including proliferation and pre-TCR gene 
rearrangement. The DN population represents 2-3% of total thymocytes and can be 
subdivided into four phenotypical and functional distinct subsets based on their differential 
expression of surface markers such as CD44 (phagocytic glycoprotein-1) and CD25 (IL-2 
receptor α chain) (Godfrey et al., 1993). The populations are named DN1 through to DN4 and 
each is characterized to have several distinctive features, along with specific localizations 
within the thymus. The earliest of the four subsets, the DN1 fraction, express CD44 on their 
cell surface, whilst lacking CD25 expression. These early thymic settlers migrate out from the 
CMJ across the cortex where they upregulate CD25 expression and undergo the transition to a 
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DN2 phenotype (CD25
+ 
CD44
+
), before down regulating CD44 to differentiate into a DN3 
maturation status (CD25
+ 
CD44
-
). The final stage in the DN developmental program involves 
down regulation of CD25 and the transition into the DN4 phase (CD25
- 
CD44) (Godfrey et al., 
1993; Zuniga-Pflucker and Lenardo, 1996). The earliest DN stage in development is the most 
proliferative stage in thymocyte development and each intrathymic progenitor is believed to 
expand approximately one million fold before reaching the DP stage in differentiation 
(Shortman et al., 1990).  
The expression of CD25 is largely T cell specific, unlike CD44 that is widely expressed on 
many non-T cell lineages (Ponta et al., 2003; Porritt et al., 2004). It is, therefore, assumed the 
components of the CD25
-
 CD44
+
 DN1 population consists of earliest thymic progenitors that 
posses multi-lineage potential, although intrathymic T cell lineage commitment still remains 
unconfirmed.  It is also thought that by CD25
+
 DN2 and DN3 stages in development 
thymocytes have made the commitment to a T cell fate and lost their potential to 
differentiated into multi-lineages.  Additional heterogeneity has been identified in the DN1 
populations, with the classification of multiple subsets based on phenotypically distinct 
surface expression profile, including CD24 and CD117. All DN1 subsets are believed to have 
the potential to give rise to T cells, but present with different abilities to diverge into other cell 
types of a myeloid or B cell lineage (Porritt et al., 2004).  
Thymocytes at the DN2 stage in development are found throughout the mid to outer cortical 
regions, whilst the most numerically abundant DN3 population are localized to the 
subcapsular zone, along with the most mature DN4 division (Lind et al., 2001). On transition 
to the DN2 stage in development, thymocytes shut down proliferation and initiate the process 
of TCR gene rearrangement to form the pre-TCR complex. The pre-TCR complex consists of 
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a TCR β chain paired to a glycosylated pre TCR α chain (gp33), in association with CD3 
proteins (Saint-Ruf et al., 1994). Signaling through the complex involves the tyrosine kinase 
p56Lck. The β chain V(D)J gene recombination and expression precedes that of the TCR α 
chain and is initiated at the DN2 stage in development, but is not complete until the DN3 
phase of differentiation (Dudley et al., 1994; Godfrey et al., 1993).  It is during this 
developmental window that cells are believed to commit to a αβ or γδ lineage. (Dudley et al., 
1994). The stage at which this lineage commitment occurs has been a topic of speculation, as 
evidence suggests progenitors can differentiate into cells of either lineage at the later stages of 
DN differentiation (Petrie et al., 1992). The successful arrangement of the pre-TCR complex 
acts as a key checkpoint in T cell development, with β selection driving survival, whilst 
unsuccessful generation results in apoptosis at the DN4 stage in development (Falk et al., 
2001).  
The generation of the pre-TCR enables the complex to induce signals to promote cell 
differentiation and clonal expansion, including the down regulation of CD25 for transition 
into the final DN4 developmental stage.(Dudley et al., 1994) Signaling through the pre-TCR 
complex also initiates α chain rearrangement. Thus, the α chain can bind the β chain to form a 
mature TCR, whilst initiating upregulation of CD4 and CD8 co-receptors for progression 
towards the CD4
+
 CD8
+
 double positive (DP) stage in development (Janas and Turner, 2010).  
Introduction of a mutation into either the RAG-1 or RAG-2 genes that induce TCR gene re-
arrangement results in a blockade of lymphocyte development with the absence of both T and 
B cells. T cell development arrests at the DN3 stage in both RAG-1 (Mombaerts et al., 1992b) 
or RAG-2 (Shinkai et al., 1992) mutant mice. These mutant mouse strains presents with 
considerable reductions to their thymocyte numbers, a total absence to DP or SP populations 
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and a failure of cells to express αβ or γδTCR on their cell surface (Mombaerts et al., 1992b; 
Shinkai et al., 1992). Mice deficient in TCR β genes have confirmed the particular importance 
of the TCR β gene rearrangement in the transition from DN to DP.  The reintroduction of the 
TCR β gene into arrested DN cells from a RAG-1 (Mombaerts et al., 1992a) or RAG-2 
deficient host (Shinkai et al., 1993) can completely rescue all stages in T cell differentiation. 
The β chain rearrangement has also specifically been identified in inducing CD3 surface 
expression (Shinkai et al., 1993). In contrast TCR α gene expression appears to be dispensable 
at this stage in development, during the transition from DN to DP maturation status 
(Mombaerts et al., 1992a). 
The pre-TCR and Notch signaling pathways together are regarded as the minimal 
requirements needed for the survival and continued development of thymocytes beyond β 
selection (Ciofani and Zuniga-Pflucker, 2005). However, other receptors are believed to play 
a role in promoting survival via pre-TCR signaling, including IL-7 receptor and the tumor 
suppressor p53 (von Freeden-Jeffry et al., 1997). The chemokine receptor CXCR4 has 
additionally been identified to play a role at this early stage in thymocyte development. 
CXCR4 has been suggested to regulate thymocyte localization in the SCZ to promote optimal 
pre-TCR signaling (Trampont et al., 2010). In addition, it has been proposed the receptor can 
behave as a co-stimulator, along with pre-TCR, to promote survival and proliferation. 
Specifically CXCR4 is thought to induce upregulation of B-cell lymphoma 2 A (BCL-2A), 
belonging to the family of apoptotic regulators BCL-2. Thus, it is now accepted signals from 
the pre-TCR, Notch and CXCR4 collectively are required to support continuous thymocyte 
development (Janas et al., 2010; Trampont et al., 2010).   
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After successful rearrangement of the TCR β gene, cells undergo transition to the DN4 stage 
of intrathymic differentiation. Thymocytes within this phase of development are commonly 
referred to as pre-DP, as they express detectable levels of TCRβ, CD3, CD4 and CD8 on their 
cell surface and can rapidly differentiate into DP without any additional stimulation. Thus, 
this population of thymocytes is thought to represents a subset in transition and an immediate 
precursor to DP cells (Petrie et al., 1990). At this stage in development thymocytes begin their 
TCR α chain rearrangement, whilst reinitiating proliferation and expansion. This is temporally 
stopped between the DN2 to DN3 stage when cells are undergoing TCR β rearrangement 
(Penit et al., 1995; Tourigny et al., 1997). Differentiating thymocytes then reverse their 
migratory pathway inwards, towards the inner cortex, which is highly populated by DP cells 
(Petrie and Zuniga-Pflucker, 2007).  
1.2.4 Positive Selection 
DP thymocytes expressing functional αβTCRs are selected to continue their development 
program, via the process of positive selection. The selection of such thymocytes is based upon 
the abilities of their receptors to recognize self-peptide MHC complexes, present by cTEC 
(Laufer et al., 1996). Successful recognition and binding of the TCR to the self-peptide MHC 
complex induces TCR signaling, rescuing the developing thymocyte from programmed cell 
death. The generation of MHC recognizing TCRs from randomly paired α and β chains is 
thought to be moderately infrequent, with only a 3% successful selection rate. Around 90% of 
DP thymocytes are believed to die by neglect within the cortex, after a relatively short life 
span of on average 3-4 days, without successfully undergoing this key checkpoint in 
intrathymic T cell development (Hernandez-Munain et al., 1999; Starr et al., 2003).  
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The brief life span of cells at this stage in development is regulated by several factors that 
collectively control the expression of the anti-apoptotic protein B cell lymphoma-extra large 
(Bcl-xL). BcL-xL acts to prolong the life of DP cells, extending the period of which 
developing thymocytes can successfully undergo positive selection and progress to the CD4
+ 
CD8
-
 or CD4
- 
CD8
+
 single positive (SP) stage in intrathymic T cell development (Guo et al., 
2002). Such factors include the transcription factor RAR-related orphan receptor gamma 
(RORγ), which has been identified as essential in the survival of DP cells. Shut off RORγ 
expression causes attenuated Bcl-xL expression resulting in accelerated apoptosis and death 
by neglect (Sun et al., 2000). The transcription factors T cell factor 1 (TCF-1) and lymphocyte 
enhancer factor 1 (Lef-1), along with their co-activator β-catenin, have all additionally been 
highlighted as pivotal in T cell survival at the DP stage in development (Ioannidis et al., 2001; 
Verbeek et al., 1995). The transcription effects of TCF-1 and Lef-1 are regulated by Wnt 
glycoproteins. Wnt glycoproteins are produced and secreted by the thymic epithelial cells and 
bind to the frizzled (Fz) transmembrane receptors expressed by developing thymocytes 
(Pongracz et al., 2003). Signaling through Fz receptors, upon Wnt binding, stabilizes β-
catenin and converts TCF-1 and Lef-1 into transcriptional activators. Both transcription 
factors act upstream of Bcl-xL to exert anti-apoptotic effects on DP thymocytes to prolong 
their life and increase their chances of undergoing successful positive selection (Ioannidis et 
al., 2001; Pongracz et al., 2003). 
The strength of TCR signaling upon binding to self-peptide MHC is critical in determining 
the cells fate. The affinity-avidity model postulates that low affinity binding results in partial 
signaling, generating positively selected thymocytes, whilst high affinity binding drives 
negative selection to induce cell death and elimination of any potentially self-reactive cells. 
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Thus, the process of positive and negative selection is mediated by the signaling strength 
generated through the same receptors binding the same ligands, but triggering opposing cell 
fates of either differentiation or cell death (Alam et al., 1996; Starr et al., 2003). 
There are several theories of how a TCR signaling threshold is established to drive positive 
selection, negative selection or peripheral activation, on exposure to foreign peptide. One 
strategy is that the kinetic threshold between positive and negative selection is based on the 
long avidity of the TCR self-peptide MHC complexes. Those complexes with weak 
interaction and short half-lives trigger positive selection, whilst those with longer half-lives 
induce the process of negative selection through the more complete signal received. Therefore, 
the cell fate of the developing thymocyte is determined primarily by the dissociation rate of 
the TCR (Williams et al., 1999). A second theory is that the signaling outcome is determined 
by TCR occupancy and ligand concentration. This model suggests the affinity of TCR 
engagement can be adjusted by the concentration of ligand present, with low occupancy 
resulting in positive selection and high occupancy resulting in negative selection. The process 
of positive selection, therefore, is driven by a lower affinity binding than those that undergo 
negative selection, yet very low affinity peptides can drive selection if present in large 
concentrations (Liu et al., 1998; Sebzda et al., 1994).  Although it is not clear the exact 
mechanisms regulating differentiation down the two pathways of selection the threshold must 
involve a precise TCR affinity.  
To maximize the chance of successful positive selection the rearrangement of the TCR α 
chain does not stop upon binding to the β chain, but continues and undergoes multiple cycles 
of secondary rearrangements within non-selected DP cells (Petrie et al., 1993). The Vα and Jα 
gene segment rearrangement can occur on both alleles simulations and precursors initiate α 
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locus recombination from the 5’ prime end of the Jα locus to 3’ prime end. Newly formed α 
chains compete with existing surface chains, enabling the substitution of any out of frame 
genes configurations or non-selected receptor combinations to generate TCRs with entirely 
new specificity. The multiple expression of the α chain in succession continues until the cell 
is selected on the basis of having a function αβTCR, or the cell dies by neglect via 
programmed cell death.  (Davodeau et al., 2001; Petrie et al., 1995; Petrie et al., 1993). TCR 
engagement with self-peptide MHC complexes during positive selection results in the down-
regulation of the expression of RAG genes, RAG-1 and RAG-2, to terminate further TCR α 
chain rearrangements (Brandle et al., 1992; Petrie et al., 1993). 
1.2.4.1 Conventional Single Positive Lineage Commitment  
Successful positive selection results in the commitment and differentiation of DP thymocytes 
into a CD4 or CD8 T cell lineage fate. During the transition from DP to the SP stage, 
developing thymocytes are required to commit to a CD4 or CD8 lineage, exclusively 
expressing only one of the two coreceptor glycoproteins and recognizing only one class of 
MHC molecules (Xiong and Bosselut, 2012). The defining mechanisms used by the DP cell 
to decide its lineage fate are relatively unclear and several models have been proposed. Two 
original lineage commitment models were proposed, stochastic and instructional, that aimed 
to explain how DP cells determine their co-receptor expression and MHC specificity (von 
Boehmer, 1996). The stochastic model suggests that early lineage commitment occurs 
independently of TCR specificity. With this model, only cells expressing a complimentry 
CD4 or CD8 co-receptor to the MHC Class I or Class II molecule bound upon TCR 
engagment continue their development (Robey et al., 1991). The instructive model proposes 
the recognition and co-engagement of a particular MHC by the TCR activates the specific 
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complimentary CD4 or CD8 differentiation program. Therefore, MHC Class I TCR 
recognition promotes the CD8 developmental program, including the switching off of CD4 
signaling and vice versa for MHC Class II binding. It has also been suggested that the distinct 
instructional program within this model is delivered directly via the co-receptors (Hernandez-
Hoyos et al., 2000; Robey et al., 1991; von Boehmer, 1996). More recent models have 
suggested a quantitative signaling model for lineage commitment. This is where the strength 
of the TCR signal received during positive selection instructs the developing DP precursor to 
commit to either the CD4 or CD8 lineage, with strong signals promoting CD4
+
 SP 
differentiation, whilst weaker signals drive a CD8
+
 SP cell fate (Hernandez-Hoyos et al., 
2000; Matechak et al., 1996). Other studies suggest the duration of the TCR signal during 
positive selection, rather than the strength of the signal, directs a CD4 versus CD8 T cell 
lineage fate. Sustained TCR signaling is thought to support CD4
+
 SP development, whereas 
transient receptor signaling promotes CD8 differentiation (Liu and Bosselut, 2004; Yasutomo 
et al., 2000). It has also been demonstrated that lineage commitment is additionally subject to 
temporal regulation, with the generation of the CD4 lineage occurring rapidly after positive 
selection, while the CD8 lineage has a more delayed emergence period of approximately 3 
days (Saini et al., 2010). 
Although it may be unclear what initial interactions are crucial in determining lineage 
commitment, various studies have identified a number of transcription factors with opposing 
repressive abilities that play a downstream role in promote lineage differentiation of DP 
thymocytes. Runt-related transcription factor (Runx) is a family of transcription factors 
involved in the differentiation of CD8
+ 
SP differentiation, by promoting CD8 gene 
transcription and lineage commitment. Specifically Runx3 has been identified in playing a 
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role at the DP stage of differentiation by binding and activating CD4 silencers, resulting in 
repression of CD4 gene transcription.  In contrast, Thpok is the transcription factor thought to 
be required for the acquisition of the CD4 T cells helper effector function, whilst inhibiting 
the genetic programming towards the cytotoxic CD8 lineage (Wildt et al., 2007). On TCR 
MHC class II engagement, Thpok is activated via the reversal of the Thpok silencer activity. 
Thpok directly binds the CD4 gene silencer, antagonizing the repressive functions of Runx3 
to activate the transcription of the CD4 gene.  The upregulation and maintenance of the 
surface expression of CD4 facilitates the prolonged TCR engagement with MHC class II. This 
continues to antagonize the Thpok silencer and mediates further Thpok upregulation, overall 
inducing a feed back loop to inhibit cytotoxic lineage differentiation (Muroi et al., 2008).  
Loss of Thpok function can result in the redirection of MHC class II restricted thymocytes 
into a CD8 lineage, whilst transgenic over-expression of transcription factor can induce MHC 
class I restricted cells to differentiate into a CD4 T cell fate (He et al., 2005; Sun et al., 2005). 
In comparison, Runx3 over expression cannot reverse lineage commitment and induce 
differentiation of MHC class II restricted thymocytes into a CD8 cell fate, even though over 
expression during DP development can strongly reduce CD4 expression (Grueter et al., 2005).  
These findings demonstrate Thpok is a master regulator of lineage commitment on initiation 
of positive selection and dominates the effects of Runx3. Interestingly, regardless of final 
commitment to a CD4 or CD8 fate, all thymocytes undergo a transitional differentiation state 
between the DP and SP stages in maturation, where cells initially down regulate CD8 to give 
a common CD4
+
CD8
low
 phenotype. Those cells that have committed to a MHC class II 
restricted lineage then progress directly into CD4
+
 SP cells, whilst those destined for a 
CD8
+
SP cell fate must undergo two additional intermediate phases of development: CD4
low
 
  
 36 
CD8
low
 followed by CD4
low
 CD8
+
, before finally maturing into a CD8
+
 CD4
- 
SP thymocyte 
(He et al., 2010; Lundberg et al., 1995).   
1.2.4.2 Nonconventional Lineage Commitment  
High affinity TCR binding does not always result in the negative selection, but can also 
trigger the differentiation of thymocytes down non-conventional developmental pathways, 
such as that of nTreg or invariant natural killer cells (iNKT). Some MHC Class II restricted 
thymocytes that receive stronger TCR stimulation high-affinity self-antigen binding, can be 
rescued from clonal deletion and differentiate into nTreg (Moran et al., 2011; Stritesky et al., 
2012). The precise affinity threshold needed for Treg development, however, is still unknown. 
It has been suggested the affinity of binding is not equal to, but only slightly lower than the 
strength of TCR interactions required to drive clonal deletion, thus proposing the affinity 
threshold is unlikely to be a major cell fate determinant (Stritesky et al., 2013). The antigenic 
niches for this selection process are typically limited and nTreg precursors are believed to 
have to compete for interaction with these rare self-antigens (Bautista et al., 2009). It is also 
thought this multistep differentiation program involves cytokines, co-stimulatory molecules 
and a variety of antigen presenting cells. The availability of these environmental factors may 
also provide additional competition, limiting nTreg development (Lio and Hsieh, 2011). The 
process of intrathymic Treg induction is believed to occur in at least two sequential stages. 
TCR stimulation initially stimulates the upregulation of CD25 on the surface of those cells 
differentiation into nTreg, before the intracellular expression of FoxP3. This establishes a 
Foxp3
-
CD25
+
 nTreg precursor population, thought to not require additional TCR stimulation 
to complete their development into Foxp3
+
CD25
+
 nTreg (Lio and Hsieh, 2008). The precise 
requirements driving maturation down this non-conventional CD4
+
 SP developmental route 
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remains poorly understood and a topic of great interest.  Thus, one of the main focuses of 
Chapter 4 is to address what essential cellular components are needed to support the 
development of this non-conventional nTreg lineage fate.   
1.2.4.3 Phenotypical Changes On Initiation Of Positive Selection 
Although the initiation of positive selection is critically dependent upon TCR self-peptide 
MHC interactions, subsequent events during this multi-stage process can occur independently 
of ongoing MHC engagement. The MHC independent intermediate stage of positive selection 
is classified by the expression of the activation marker CD69, which is rapidly upregulated by 
T cells after TCR stimulation (Hare et al., 1999). This marker is detectable on a small fraction 
of DP cells along with a subset of newly generated, immature CD4 and CD8 SP thymocytes. 
This transient surface expression pattern of CD69, therefore, can be used in the identification 
of thymocytes that are undergoing or have recently undergone this critical selection process 
(Yamashita et al., 1993).  
Additionally, induction of the positive selection process also drives thymocytes relocalization 
from the cortex into the medulla, where they undergo additional selection and differentiation. 
It is widely accepted this migratory pathway involves CCR7 (Kurobe et al., 2006; Kwan and 
Killeen, 2004; Nitta et al., 2009; Ueno et al., 2004). TCR engagement during positive 
selection elevates CCR7 surface expression on developing thymocytes (Davalos-Misslitz et 
al., 2007), which then migrate into the medulla via chemoattraction to CCR7 ligands: CCL19 
and CCL21, produced within the medullary thymic environment (Ueno et al., 2002). If CCR7 
signaling is disrupted it results in defective migration and consequently reduced negative 
selection (Nitta et al., 2009; Ueno et al., 2004). Following TCR stimulation, activated DP 
thymocytes are thought to also be strongly responsive to CCL25, expressed by cTEC, via 
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their surface expression of CCR9 at both the DP and the newly generated SP stages in 
maturation. Highly regulated expression of the protein PlexinD1 is thought to block the 
migrating of developing thymocytes down the CCL25 chemokine gradient, preventing their 
retention in the cortex. This inhibition facilitates newly selected thymocytes to migrate 
against the CCL25 chemokine gradient into the CCL19 and CCL21 enriched medullary 
thymic microenvironment, to continue their differentiation program (Choi et al., 2008). 
Although currently it is believed CCR7 and PlexinD1 exclusively orchestrate thymocyte 
trafficking, other chemokines have been speculated to play a role in this migratory pathway. 
Strong candidates that may contribute to the cortex-to-medulla migration include CCR4, 
reported to be upregulated on the thymocyte cell surface after the initiation of positive 
selection (Campbell et al., 1999). Its ligands, CCL17 and CCL22, are predominately 
expressed in the CD80
high
 AIRE
+
 mTEC population (Campbell et al., 1999; Laan et al., 2009). 
Specifically the most immature CD4
+
 SP, classified as the SP1 population (see Section 1.2.6 
for explanation of SP1 to SP4 classification system) demonstrate the highest CCR4 mRNA 
levels, likely to represent the most recent subset of cells to undergo the positive selection 
process. Ccr4 expression is then down regulated by the SP2 stage in CD4
+
 SP development 
(Teng et al., 2011). This tight window of CCR4 expression compliments the timing of when 
SP thymocytes are believed to undergo their re-localization to the medulla. However, the role 
of CCR4 in cortex to medulla migration needs additional investigation. We aim to explore the 
effects of the removal of this chemokine receptor in Chapter 5.  
1.2.5 Negative Selection 
The process of negative selection is a fundamental checkpoint in the establishment of central 
tolerance. The term central tolerance refers to the intrathymic mechanisms used to detect and 
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eliminate self-reactive T cells, before their export into the periphery, where they could 
potentially cause harm. Central tolerance mechanisms include clonal deletion of autoreactive 
cells via negative selection and clonal diversion of nTreg to suppress the activation of any 
self-reactive cells that escape into the periphery (Kyewski and Klein, 2006; Xing and 
Hogquist, 2012).  
High affinity TCR recognition of self-peptide induces negative selection and activates 
apoptotic pathways. This pathway of cell death is mediated by the pro-apoptotic Bcl-2 family 
of BH-3 proteins. The cooperation of BH-3 proteins, Bim and Puma, specifically results in 
apoptotic deletion of autoreactive cells and the prevention of organ-specific autoimmunity 
(Gray et al., 2012). The intracellular mediators of negative selection are members of mitogen-
activated protein kinases (MAPK) pathways, which included extracellular signal-regulated 
kinases  (ERK) and Jun amino-terminal kinase (JNK). It has been suggested that no single 
MAPK pathway is exclusively associated with positive or negative selection, but rather the 
kinetics of MAPK activation mediates the differences in the positive and negative selecting 
signals.  Both ERK and JNK are induced during positive and negative selection, however, 
high affinity binding induces rapid and robust activation of ERK to drive cell death, in 
contrast to low affinity binding which stimulates prolonged, lower intensity activation of the 
intracellular mediator (Daniels et al., 2006; Xing and Hogquist, 2012). The net result is the 
alteration to the activation patterns of these MAPK signaling intermediates determines the 
transcription factors that are triggered to control the cell fate, based upon the intensity of the 
ligands bound (Palmer, 2003).  
Negative selection can occur at various stages throughout thymocyte development, from early 
stages in thymocyte maturation, when cells reside within the cortex, to the later stages in 
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intrathymic development when thymocytes inhabit the medulla (McCaughtry et al., 2008; 
Surh and Sprent, 1994). Evidence suggests thymocytes are susceptible to negative selection as 
early as the transitional phase from DN to DP, upon TCR antigen encounter within cortical 
regions (Takahama et al., 1992). It is therefore assumed negative selection is not a sequential 
event following positive selection, but the two selection processes occur independently of one 
another (Palmer, 2003). It has also been proposed that DP thymocytes within the cortex 
undergo 2-3 times higher negative selection rates compared to their SP mature counterparts 
residing within the medulla (Stritesky et al., 2013). Antigen presentation by the cTEC 
population alone is not believed to be efficient at inducing cell apoptosis, although they 
represent the major stromal cell population within the cortical compartment and can interact 
with developing thymocytes to trigger TCR activation during positive selection (Laufer et al., 
1996). Instead, it is thought rare cortical DC populations mediate antigen specific clonal 
deletion within this region. (McCaughtry et al., 2008). 
Although the rate of negative selection may be higher within the cortical region, the thymic 
medulla is considered to be a specialized site for optimal negative selection in the 
establishment of central tolerance. This is due to the medullary environment having a high 
prevalence of APC and the unique ability of the mTEC population to express a wide array of 
antigen to developing thymocytes (Gray et al., 2005). The mTEC populations can cross-
present antigen to DC, in both their native and processed MHC-bound form. This facilitates 
both APC types to mediate deletion of potentially self-reactive T cells. This unidirectional 
transfer of self-antigen broadens the cellular base of self-tolerance and thus enhances it 
efficiency (Gallegos and Bevan, 2004; Koble and Kyewski, 2009).  The specialized role of 
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mTEC and DC in the establishment of self-antigen mediated negative selection will be 
discussed in greater detail in Section 1.3.3. 
In addition to TCR ligation, it has been suggested negative selection requires secondary 
signaling pathways provided by co-stimulatory molecules on APC. Although APC express a 
large variety of co-stimulatory molecules, it is not clear which are essential for successful 
negative selection. The co-stimulatory molecule CD28 has been implicated in driving cell 
apoptosis upon binding CD80/86, however the unaltered selection of CD28 deficient 
thymocytes demonstrates its role is nonessential, or alternatively, redundancy by other co-
stimulatory molecules mask the effects of its removal. When CD28 deficient cells are placed 
in a competitive environment with their wild type (WT) counterparts, CD28 expressing 
thymocytes have a selective advantage, suggesting the CD28 co-stimulatory pathway 
increases the efficiency of this selection process (Walunas et al., 1996).  
It is very difficult to accurately predict the number of potentially autoreactive thymocytes that 
undergo negative selection during their development within the thymus, with studies reporting 
a wide range of estimates. A recent report has predicted the rate of negative selection is far 
greater than the number of thymocytes undergoing positive selection. The estimated 
difference was reported to be as great as a 5-fold (Stritesky et al., 2013). This observation 
suggests the negative selection process must efficiently eliminate large numbers of 
intrathymically developing potentially self-reactive thymocytes.   
1.2.6 Post-Selection Maturation 
The medullary residency of newly generated SP thymocytes is commonly believed to be up to 
2 weeks (Scollay and Godfrey, 1995), during which time cells undergo their final 
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differentiation steps before emigrating into the periphery as naive T cells (Egerton et al., 
1990; Gabor et al., 1997a; Scollay and Godfrey, 1995).  Transgenic mice for green florescent 
protein (GFP) driven by the RAG-2 promoter (RAG-2 GFP) can be used to identify recent 
thymic emigrants (RTE) within the periphery. The GFP levels can also act as a ‘molecular 
timer’, as the gradual loss of GFP expression on the termination of the RAG genes at the DP 
stage can define the ‘age’ of the differentiating thymocyte (Boursalian et al., 2004). On re-
examination of developing thymocytes using this RAG-2 GFP transgenic mouse model, it has 
been proposed emigration of SP thymocytes into the circulation can occur after only a 4 to 5 
day inhabitance within the medulla (McCaughtry et al., 2007).  
During their occupancy within the medulla, SP thymocytes undergo a series of phenotypical 
and functionally distinct maturational stages. Newly generated SP thymocytes are 
characterized by a CD69
+
, heat-stable antigen (HSA)
high
, Qa2
-
, CD62L
low
 surface phenotype. 
SP thymocytes are estimated to express this surface phenotype for two thirds of their total 
residency time (Kelly and Scollay, 1990; Lucas et al., 1994; McCaughtry et al., 2007). SP 
cells then continue differentiating and the surface expression profile changes to CD69
-
 
HSA
low
 Qa2
high
 CD62L
high
. The mature thymocytes lose their susceptibility to apoptosis at this 
stage in development, but instead undergo proliferation upon antigen exposure (Gabor et al., 
1997b; Kelly and Scollay, 1990; Kishimoto and Sprent, 1997; Lucas et al., 1994; McCaughtry 
et al., 2007; Weinreich and Hogquist, 2008). CD4
+
 SP thymocytes have an additional sub-
classification system for their maturation status, separated into four distinct subsets, SP1 
(CD69
+
 6C10
+ 
Qa2
-
) SP2 (CD69
+
 6C10
- 
Qa2
-
) SP3 (CD69
-
 6C10
- 
Qa2
-
) and SP4 (CD69
-
 
6C10
- 
Qa2
+
).  This differentiation of CD4
+ 
SP thymocytes within the medulla is believed to 
follow a linear and unidirectional developmental pathway (Jin et al., 2008). Interestingly, 
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transition of thymocytes from the SP3 to SP4 stage in development is believed to be 
dependent upon an intact medullary environment. Disruption of medullary 
microenvironments results in a block in development at the SP3 stage, resulting in the 
absence of the most mature CD69
-
 Qa2
+ 
SP4 population (Li et al., 2007). The precise 
interactions provided by the medulla to support this important checkpoint in the conventional 
CD4
+
SP maturation program are unknown and this will be explored in greater detail in 
Chapter 4.  
Mature SP medullary residents undergo a wave of post-selection proliferation involving at 
least 6 rounds of cell divisions. This cellular expansion of SP thymocytes is evident at all 
development ages, but is more pronounced within the neonatal thymus, where it may aid the 
establishment of the neonatal peripheral T cell pool. The continued presence of thymic 
epithelial cells has been identified as both essential and sufficient to drive this proliferative 
wave. This stage in development can occur independently of ongoing TCR-MHC interactions, 
in the presence of MHC-deficient thymic stromal cells (Hare et al., 1999; Hare et al., 1998). It 
has instead been speculated that the essential role for mTEC is in its production of soluble 
factors, such as cytokines. Cytokine-mediated signaling has been implicated in the regulation 
of this late phase of intrathymic proliferation, specifically IL-7 and its receptor IL-7R. 
Successful TCR signaling during positive selection directly controls the upregulation of IL-
7R on the thymocyte cell surface. Signaling through this receptor, upon IL-7 binding, is 
believed to be pivotal for thymocyte differentiation, as the lack of expression of the IL-7R 
complex results in a dramatic reduction in post-selection proliferation (Hare et al., 2000). The 
upregulation of this receptor is not believed to be a passive process of maturation, but rather 
an event dependent upon the quality of the TCR signaling received during positive selection. 
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Thus, the expression pattern of IL-7R can additionally control the selection of the T cell 
repertoire (Sinclair et al., 2011). 
Mature thymocytes emigrate from the thymus via blood vessels at the cortical medullary 
junction. The process of thymic egress is regulated by the receptor sphingosine-1-phosphate 
receptor-1 (S1P1). S1P1 must be upregulated on the SP cell surface to aid migration towards 
the blood, where its ligand, S1P, is highly expressed (Allende et al., 2004). The absence of the 
receptor results in a complete lack of T cells within the periphery, due to a total block in 
thymic egress, whilst over-expression of S1P1 results in premature release of thymocytes into 
the circulation (Allende et al., 2004; Matloubian et al., 2004; Zachariah and Cyster, 2010). 
The expression of S1P1, therefore, plays a central role in regulating the number of peripheral 
T cells and its induction is directly dependent upon the transcription factor Kruppel-like factor 
(KLF) 2 (Carlson et al., 2006). The upregulation of both KLF-2 and S1P1 increases with SP 
maturity, with the greatest expression of both molecules being in thymocytes displaying the 
most mature phenotype, based upon high CD62L/Qa2 and low RAG-2 GFP levels 
(McCaughtry et al., 2007). The mechanisms inducing KLF-2 expression, however, remains 
poorly understood. The transcription factor forkhead box O (Foxo) -1 has been implicated, at 
least in part, in the control of KLF-2 expression, but the exact process is unknown (Kerdiles et 
al., 2009). 
Thymic export does not appear to be regulated by downstream alterations to the size of the 
peripheral T cell pool, as the complete deletion of total peripheral T cells has no influence on 
emigration rates of RTE (Gabor et al., 1997b). Instead emigration from the thymus is thought 
to occur via a ‘conveyor belt mechanism’. The oldest, most mature SP thymocytes exit into 
the periphery, once they have completed their maturation program and express the correct 
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‘exit’ phenotype, complementary to the profile expressed by recent thymic emigrant (RTE) 
within the circulation. This suggests that, the multi-step developmental program of SP 
thymocytes within the medullary is essential before cells can be exported into the periphery as 
naive T cells (Gabor et al., 1997a; McCaughtry et al., 2008).  
  
  
 46 
1.3 THYMIC MICROENVIRONMENTS  
1.3.1 The Ontogeny Of Thymic Epithelial Cells  
1.3.1.1 Classification of cTEC and mTEC 
TEC populations are commonly defined as CD45 negative cells that express the surface 
marker Epithelial Cell Adhesion Molecule 1 (EpCAM1) (Trzpis et al., 2007).  In an adult 
mouse, cTEC and mTEC populations can be distinguished based on their expression of 
several phenotypical markers. The cortical epithelium is frequently characterized by the 
expression of a panel of markers including the intracellular expression of cytokeratin 8 (K8) 
and MTS44, in addition to the surface expression of Ly51. The cTEC population also acquires 
CD40 and high levels of MHC Class II. More recently cTEC specific proteosomal subunit 
β5T has been used as a tool for recognition of this distinct TEC population. This proteasomal 
subunit is expressed exclusively in cTEC and is responsible for the generation of a unique set 
of self-peptides presented by MHC Class I, key to the positive selection of CD8
+
 SP 
(Anderson and Takahama, 2012; Gray et al., 2006; Murata et al., 2007). In contrast Prss16 
encodes thymus-specific serine protease (TSSP), which participates in self-peptide MHC 
class II presentation during the positive selection of CD4
+
 SP thymocytes and is also 
specifically expressed by cTEC (Gommeaux et al., 2009). The endocytic receptor CD205 
(also known as DEC-205) aids uptake and presentation of self-antigen and is an extra marker 
used in the identification of cTEC, but its expression is shared with thymic DC (Shrimpton et 
al., 2009).  
In contrast to cTEC identification, the cell surface and cytoplasmic markers used for mTEC 
identification include cyokeratin5 (K5), CD80, AIRE, MTS10, the lectin UEA1 and claudin-
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3/claudin-4. The mTEC population can be further subdivided into two main subsets, based 
upon the levels of expression of MHC class II and the co-stimulatory molecule CD80: 
CD80
high
 MHC Class II
high
 mTEC (typically referred to as mTEC
high
) and CD80
low
 MHC 
Class II
low
 mTEC (mTEC
low
) (Anderson and Takahama, 2012; Gray et al., 2006). These two 
mTEC subsets also display different levels of expression of promiscuous genes for tissue-
restricted self-antigen (TRA) synthesis and autoimmune regulator (AIRE) protein (see Section 
1.3.3.1). The mTEC
high 
subset exhibit much greater levels of AIRE and present a greater range 
of TRAs compared to their mTEC
low 
counterparts (Derbinski et al., 2005; Gray et al., 2007).  
1.3.1.2 Differentiation Of cTEC And mTEC Lineages 
At the early stages in thymic organogenesis, around E12, the thymic rudiment exists as a 
simple structure, consisting of a core of TEC progenitors. It has been observed that 
functionally detectable Foxn1-dependent progenitors at this stage in embryogenesis are bi-
potent, giving rise to epithelial of both cortical and medullary lineages. (Bleul et al., 2006; 
Rossi et al., 2006). Clonal assays of single, individually selected, thymic epithelial 
progenitors at E12 demonstrated this bi-potent potential, with progenitors displaying the 
capacity to differentiate into both mTEC and cTEC phenotypes (Rossi et al., 2006). In vivo 
cell lineage assays further confirmed the existence of this common TEC progenitor, in 
addition to indicating its continued presence within the post-natal thymus, suggesting a 
possible role for the progenitor in cTEC and mTEC production later in life (Bleul et al., 
2006). Although this common epithelial precursor has been identified, its phenotypical 
identity still remains relatively unclear. Initial studies into the phenotypical characteristics of 
thymic epithelial progenitor identified heterogeneity within the TEC precursor population, 
based upon the expression of the cell surface glycoprotein MTS24. It was demonstrated both 
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MTS24
+
 and MTS24
-
 populations had different progenitor potentials to reconstitute the 
complex thymus microenvironment, identifying this as a possible progenitor marker (Bennett 
et al., 2002; Gill et al., 2002). However, upon reassessment no discrimination was observed 
between the progenitor potential of MTS24
+ 
and MTS24
-
 populations, with both 
demonstrating the capability to give rise to fully functional cortical and medullary thymic 
epithelium (Rossi et al., 2007a), highlighting the current lack of a cTEC/mTEC bi-potent 
precursor identification system.  
The events occurring downstream of the bi-potent progenitors and the mechanisms that 
regulate the commitment and differentiation of distinct cortical and medullary areas are also 
poorly understood. Down stream of the bi-potent precursors, distinct lineage restricted 
progenitors are believed to initiate the emergence of cTEC or mTEC differentiated progeny 
(Rodewald et al., 2001). Further analysis of cTEC/mTEC lineage emergence has particular 
focus on the development of the specialized mTEC
 
population, whilst the stages and 
mechanisms of cTEC differentiation remain more poorly understood. A correlation between 
lymphoid progenitor settling and the emergence of a cTEC population has been identified at 
E12, with the detection of EpCAM1
+ 
TEC populations expressing cTEC lineage identifiers, 
including CD205 and β5T (Shakib et al., 2009). Nude mice, deficient in Foxn1 expression, 
demonstrate an absence of such cTEC define subsets, suggesting acquisition of such cTEC 
markers during the TEC development program is a FOXN1 dependent process at this early 
developmental stage. This Foxn1-dependepent cTEC population was also identified as a 
possible cTEC progenitor cell, due to its lack of expression of mature cTEC markers such a 
CD40 and MHC class II. This suggests this initial CD205
+
 CD40
-
 population would be 
positioned between the bi-potent cTEC/mTEC progenitor and the mature cTEC population, 
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before the occurrence of CD40 and MHC Class II upregulation. Although the emergence of 
the CD205
+
 TEC population can occur in the absence of thymocyte-derived signals, their 
continued development to the mature CD40
+
 MHC Class II
+
 phenotype demonstrated a 
dependency on the presence of DN thymocytes, illustrating an essential requirement of 
thymic cross talk in the cTEC differentiation program (Shakib et al., 2009). A more recent 
investigation has identified that CD205
+ 
progenitors are capable of differentiating into both 
cortical and medullary microenvironments able to support thymocyte maturation, if purified 
and transplanted under the kidney capsule of a WT mouse. This population was detectable as 
early as E11 and was capable of simultaneously expressing hallmarks of both the cTEC and 
mTEC lineages, with the co-expression of the cTEC maker CD205 and the mTEC marker 
RANK. Collectively this data argues against the model that lineage restricted progenitors 
diverge simultaneously from a common bi-potent progenitor early in TEC development (Baik 
et al., 2013). 
The idea of lineage-restricted mTEC progenitor pools was first founded on the discovery a 
single mTEC progenitor can give rise to individual medullary epithelial islets (Rodewald et al., 
2001). Studies have also suggested a precursor-product relationship within the mTEC lineage, 
with the emergence of CD80
+
 Aire
+ 
mTEC
high 
cells from the immature CD80
-
 Aire
- 
mTEC
low
 
subset, establishing mTEC heterogeneity and suggesting AIRE expression is a late event in 
mTEC differentiation (Gray et al., 2007; Rossi et al., 2007b). The AIRE
+
 mTEC
high 
population 
demonstrates more rapid, steady state turner over rates compared to their more mature 
precursors, with an estimated turnover every 10-14 days. This suggests that AIRE not only 
drives TRA expression, but also promotes cellular changes to raise efficiency of cross-
presentation, which may include down stream enhancement of cell death (Gray et al., 2007; 
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Gray et al., 2006). The initial emergence of mTEC committed progenitors occurs as early as 
E13, based on the expression of tight junction components claudin -3 and -4 (Cld3,4), along 
with more well known mTEC markers such as MTS10 and UEA1 (Hamazaki et al., 2007).  
A simplified overall scheme of TEC lineage development is displayed within Figure 1.3. 
1.3.2 The Regulation Of mTEC Development   
Thymic crosstalk has been identified as being essential in mTEC development, with the 
requirement for αβTCR expression specifically for mTEC generation and maintenance (van 
Ewijk et al., 1994). The elimination of αβTCR expressing thymocytes, by disruption the Tcr α 
gene, results in a block in development at the DP stage (Philpott et al., 1992). Absence of the 
Tcrα gene consequently causes a dramatic reduction to the numbers of mTEC, suggesting 
mTEC development is dependent upon successful αβTCR interactions (Palmer et al., 1993). 
Additional lymphocyte deficient mouse models, such as RAG-1 or RAG-2 knock out mice, 
which have a halt in thymocyte development at the DN stage in differentiation, also present 
with similar reductions to mTEC cell numbers and obliteration of the medullary architecture 
(van Ewijk et al., 1994). Therefore, collectively this data highlights the dependency of 
interactions between haemopoietic cells and the mTEC population for the formation of intact 
medullary compartments, essential for the establishment of T cell tolerance.  
The essential role of thymic crosstalk in TEC development has highlighted the importance of 
understanding the molecular basis of thymocyte-derived signals driving the successful 
development of the cTEC and mTEC compartments. Particular focus has been placed on the  
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Figure 1. 3 TEC Lineage Development From a Bipotent Progenitor 
The Figure displays the developmental pathway of medullary thymic epithelal 
(mTEC) cells and cortical thymic epithelial cells (cTEC) from a common bipotent 
progenitor. EpCAM
+
 progenitors can differentiate into either immature mTEC or 
immature cTEC, in a FOXN1 dependent manner (red arrow). The immature cTEC 
population has been demonstrated to give rise to immature mTEC (the alternative 
lineage potential is indicated as a curved dashed arrow). Both the immature cTEC and 
mTEC populations undergoing additional differentiation into a mature cTEC/mTEC 
phenotype based upon their surface expression and intracellular expression patterns of 
the stated markers.         
                                                    h
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environmental cues underpinning the generation of an intact medullary compartment, 
specifically the involvement of members of the tumour necrosis factor receptor superfamily 
(TNFRSF). This large family of surface receptors mediate nuclear factor (NF)κB transcription 
factors and activates NFκB signaling pathways, which are important in peripheral lymphoid 
tissue development, along with organization of an intact medulla microenvironment 
(Anderson and Takahama, 2012). Mice deficient in RelB, a subunit of the NFκB complex, 
present with severe blocks in mTEC development and lack of medullary compartments, 
resulting in a breakdown of clonal deletion of autoreactive thymocytes and multi-organ 
autoimmunity (Burkly et al., 1995; Naspetti et al., 1997). TNFRSF expression is widespread 
in the mTEC population, but have a more restricted expression profile in cTEC.  To date, four 
receptors of this family have been identified as playing a critical and distinct role in thymic 
organogenesis, specifically mTEC differentiation; receptor activator of nuclear factor κB 
(RANK), Osteoprotegerin (OPG) (a decoy receptor for RANK), CD40 and lymphotoxin β 
receptor (LTβR) (Anderson and Takahama, 2012).  
Both CD40 and RANK have been identified as essential regulators of mTEC development, 
via signaling through the TNF receptor-associated factor (TRAF) 6. Mice deficient of TRAF6 
have disorganized disruption of mTEC, with a particular absence of the AIRE
+
 mature mTEC 
subset (Akiyama et al., 2005). Absence of RANK or RANK ligand (RANKL) results in the 
complete absence of AIRE
+
 mTEC in the mouse embryonic thymus, whilst within the adult 
thymus the population is present, but at significantly reduced frequencies (Akiyama et al., 
2008; Hikosaka et al., 2008). In contrast, the CD40 signaling pathway does not appear 
essential for development of the mTEC compartment, with CD40 or CD40 ligand (CD40L) 
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deficient adult mice presenting with no alterations to mTEC numbers, generation of AIRE
+
 
mTEC or medulla formation (Dunn et al., 1997; Hikosaka et al., 2008). Collectively, this data 
suggests RANK signaling is fundamental in the differentiation of AIRE
+
 mTEC during 
embryogenesis and indicates the CD40 signaling pathway is redundant. It has been suggested, 
however, that cooperation between the two signaling pathways is crucial in postnatal mTEC 
development. After birth CD40-CD40L signals have been demonstrated to contribute to the 
development and maintenance of mTEC and this signaling pathway is thought to compensate 
for RANK-RANKL deficiency within the postnatal thymus (Akiyama et al., 2008; Desanti et 
al., 2012).  
Further investigations into the essential role of RANK in mTEC differentiation identified 
intrathymic lymphoid tissue inducer (LTi) cells as the main provider of RANKL during 
embryogenesis. RANKL signals from the LTi population are thought to regulate the 
differentiation of CD80
+
 AIRE
+
 mTEC from their CD80
-
 AIRE
-
 progenitors. The 
transplantation of RANK deficient embryonic thymic lobes, with absent AIRE
+
 mTEC 
compartments, into a T cell deficient nude host results in autoimmunity, identifying RANK as 
a prenatal key regulator of AIRE induction and central tolerance establishment (Rossi et al., 
2007b). Specific subsets of γδ T cells, named V5+ dendritic epidermal T cells, have also been 
implicated in providing RANKL for AIRE
+ 
mTEC induction in the embryonic thymus 
(Roberts et al., 2012). Within the adult thymus, SP thymocytes with an immature CD69
+
 
phenotype are thought to be the main intrathymic physiological source of RANKL and 
CD40L to the developing mTEC population. Interactions between the RANKL produced by 
positively selected thymocytes and RANK expressed on mTEC, drives positive-selection 
mediated medullary formation of AIRE
+
 mTEC (Hikosaka et al., 2008). Additional 
  
 55 
observations suggest positive selection of conventional CD4
+
 SP T cells induces sequential 
acquisition of first, RANKL and then CD40L on their cell surface. Interestingly, however, 
CD4
+
 SP that have committed to an nTreg cell fate provide RANKL, but lack CD40L 
expression, regardless of their maturation status. The expression of CD40 by the mTEC 
population is also dependent upon previous RANK signaling and occurs prior to the 
differentiation of mTEC into the AIRE
+
 CD80
high
 mature phenotype. Collectively this data 
suggests mTEC development in the adult setting is controlled by a sequence of thymic 
crosstalk events, initially involving RANK signaling, followed by CD40, which is influenced 
by distinct CD4 SP subsets (Desanti et al., 2012).  
Deficiency of LTβR results in more of an overall disruption to medullary organization, 
compared to RANK and CD40, with no reduction in the AIRE
+
 mTEC fraction. The absence 
of LTβR leads to a decrease in mTEC cell numbers and thymic retention of mature 
thymocytes, associated with inducing autoimmunity. This LTβR deficient phenotype suggests 
continuous signaling transduction through the receptor is required for the maintenance of the 
medullary architecture. Overall the suggests LTβR it is an additional member of the TNF 
receptor super-family involved in the crosstalk mechanisms controlling the development of 
mTEC, for the establishment of central tolerance (Boehm et al., 2003).  
1.3.3 Specialization Of The Thymic Medulla In Tolerance Induction 
The widely accepted role of the thymic medulla is in the establishment of immunological 
tolerance. This role is subdivided into the elimination of potentially self-reactive cells via 
clonal deletion and the generation of nTreg to suppress any escapee self-reactive T cells 
within the periphery (Li et al., 2007). The medulla is a complex three-dimensional structure 
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that has multiple mechanisms to ensure the successful production of a self-tolerant T cell 
pool. This involves the integration of signals from various stromal cellullar components, 
particularly mTEC and DC.  
1.3.3.1 The Role Of mTEC In Central Tolerance 
mTEC are a specialized type of stromal cell that supports clonal depletion by their ability to 
undergo promiscuous gene expression. This ectopic gene expression enables mTEC to 
express a vast range to TRA on their surface for either direct presentation to developing 
thymocytes or cross-presentation to DC. The TRA repertoire represents virtually all organ-
specific antigens, mirroring peripheral self. This enables the pre-emptive encounter of 
potentially self-destructive T cells with peripheral self-antigens to purge them from the T cell 
repertoire, or drive their differentiation down the nTreg lineage. The intrathymic expression 
of TRA is a distinct characteristic of the mTEC cell type (Derbinski et al., 2001; Kyewski and 
Klein, 2006).   
The precise mechanisms regulating the promiscuous gene expression of TRA by mTEC is 
currently poorly understood. However, the regulator protein, AIRE, has been identified as 
critical in promoting the ectopic expression of peripheral antigens. AIRE is a 545 amino acid 
protein localized to the nucleus, where it functions as a transcriptional factor to promote 
promiscuous gene expression of TRA (Anderson et al., 2002; Liston et al., 2003). Mutations 
to the AIRE gene in man results in a multi-organ autoimmune condition know as autoimmune 
polyendocrinopathy candidiasis ectodermal dystrophy syndrome (APECED) (Bjorses et al., 
1998). AIRE deficiency in mice leads to a reduction in the expression of TRA by mTEC, but 
not a total absence, resulting in a similar multi-organ autoimmune phenotype to that observed 
in man (Anderson et al., 2002). Overall the consequence of AIRE removal in either mice or 
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man demonstrates its key role in regulating TRA expression and the establishment of 
tolerance to peripheral antigen. It has been reported, however, that the crucial role of AIRE 
becomes largely indispensible once a self-tolerant adult T cell pool has been established. At 
this stage in maturity regulatory mechanisms of peripheral tolerance are sufficient to control 
any self-reactive T cells that should arise from an AIRE deficient thymus (Guerau-de-
Arellano et al., 2009). 
AIRE has been implicated in mediating central tolerance by mechanisms independent of the 
regulation of TRA expression. This includes a role for AIRE in regulating the differentiation 
program of mTEC, therefore controlling the organization of the medullary thymic 
compartments. AIRE deficient mice, therefore, exhibit alterations to their medullary 
architecture (Gillard et al., 2007; Yano et al., 2008). AIRE expression by mTEC may also 
have additional functions in the regulation of chemotatic gradients within the medullary 
environment, controlling both the migratory pathway of newly selected SP thymocytes (Laan 
et al., 2009) and facilitating TRA cross-presentation from mTEC to DC, by bringing together 
these two APC types to enable this unidirectional antigen transfer (Hubert et al., 2011). AIRE 
has been identified as an essential regulator for the expression of several intrathymic 
chemokines. This includes the AIRE-dependent mTEC production of XCL-1, which is 
believed to mediate thymic DC accumulation (Lei et al., 2011), along with the mTEC 
expression of CCR4 and CCR7 ligands, which may be involved in DP to SP cortex to medulla 
migration (Laan et al., 2009). 
1.3.3.2 The Specialized Role Of DC In Establishing Tolerance  
The common functions ascribed to thymic resident DC are cross-presentation of TRA to 
developing thymocytes to mediate negative selection and the induction of nTreg generation 
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(Proietto et al., 2008b). The thymic DC population is comprised of heterogeneous subsets, 
classified into two distinct groups CD11c
+
 B220
+
 plasmacytoid DC (pDC) and CD11c
+
 B220
-
 
conventional DC (cDC). The cDC can be further divided into two subsets, a majority CD11b
-
 
CD8
+
 Sirpα- DC population and a minority CD11b+ CD8- Sirpα+ DC population (Wu and 
Shortman, 2005). The most common CD11b
-
 CD8
+
 Sirpα- cDC are believed to be 
intrathymically generated from common lymphoid progenitor settlers at the DN stage in 
development, specifically before the DN3 maturational stage (Wu and Shortman, 2005; Yui et 
al., 2010) In contrast, the two additional subsets; the pDC and the less common CD11b
+
 CD8
- 
Sirpα+ cDC, are thought to be of extrathymic origin and continually migrate in from the blood 
to the thymus (Li et al., 2009).  
Each DC subset is hypothesized to have individual functional capabilities to support the 
establishment of tolerance. Both divisions of cDC display the ability to cross-present antigen 
and induce T cell proliferation, superior to their splenic DC counterparts. The intrathymically 
generated Sirpα− DC population, however, demonstrates a higher antigen presentation 
capacity in comparison to the more modest capabilities of the extrathymically produced 
Sirpα+ DC subset, suggesting the thymic derived Sirpα− cDC subset may be more efficient in 
mediating the essential process of negative selection (Proietto et al., 2008a). In comparison, 
the Sirpα+ cDC subset migrating in from the periphery exhibit a greater efficiency for in vitro 
induction of functional nTreg generation, in contrast to the other thymic DC divisions 
(Proietto et al., 2008b). The Sirpα+ cDC display a phenotypically mature profile compared to 
the Sirpα- cDC, expressing higher levels of MHC Class II, CD86, CD69 and the co-
stimulatory molecules CD40 and CD80 (Proietto et al., 2008b). In addition the different DC 
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subsets display distinct chemokine expression profiles, which may also aid their functional 
abilities (Proietto et al., 2008a).   
1.3.3.3 The Integrative Role Of mTEC And DC In Central Tolerance  
Both the mTEC and DC populations within the medulla are believed to share the same 
common functions to support the establishment of central tolerance. The precise labor 
contribution of mTEC versus DC in both the process of negative selection and nTreg 
generation, however, remains unclear. It has been speculated that mTEC involvement in 
antigen presentation is limited and non-redundant, with the population merely serving as an 
antigen reservoir. Evidence has gone against this theory and demonstrated mTEC can mediate 
tolerance by directly presenting TSA to developing SP thymocytes. However, it is thought the 
indirect presentation of self-antigen by DC is optimal for APC mediated thymocyte deletion 
(Hubert et al., 2011; Klein et al., 2001).  The mTEC population instead has been suggested to 
be the most likely cell type to foster nTreg cell generation. The contribution made by DC in 
driving nTreg induction, however is still unknown (Aschenbrenner et al., 2007).  Interestingly 
in the absence of a MHC class II-expressing hemopoietic compartment the number of nTreg 
is only reduced by 30%, suggesting nTreg induction is not exclusively to MHC Class II 
mTEC and additional cell types must obtain the ability to facilitate induction of this specialist 
cell type (Proietto et al., 2008b). Additional studies have highlighted the possible plasticity of 
the thymic stroma for supporting the differentiation of this cell type, demonstrating that nTreg 
can promiscuously accept signals critical for their development from different cellular sources, 
delivered by either mTEC or DC (Spence and Green, 2008; Wirnsberger et al., 2009). 
Regardless of the contributions of antigen presentation by these two APC subsets, the 
functional abilities of thymic DC are heavily dependent upon their interactions with mTEC, 
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particularly the AIRE
+
 division. The AIRE dependent, XCL1 mediated cross-presentation of 
TRA by mTEC to the DC subsets is essential for this specific APC to mediate antigen 
presentation (see Section 1.3.3.1). It is as of yet to be confirmed which specific thymic DC 
subsets express XCR1 and are dependent upon a XCL1 gradient for their medullary migration 
and positioning. The removal of XCL1 results in defective medullary accumulation of total 
DC, which consequently leads to a reduction in the generation of intrathymic nTreg (Lei et al., 
2011). The reduction in the medullary thymic DC population and nTreg numbers observed 
within XCL-1 deficient microenvironments are also observed within AIRE deficient mice 
(Aschenbrenner et al., 2007; Lei et al., 2011), indicating that the XCL1-mediated medullary 
accumulation of thymic DC contributes to the differentiation of nTreg, which is indirectly 
regulated by AIRE expression by the mTEC population (Lei et al., 2011).  
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1.4 GENERAL AIMS 
The complex thymic medullary microenvironment is home to SP thymocytes that have 
successfully undergone positive selection. During their medullary residency SP thymocytes 
undergoing a multiple- step developmental program and are screened for potential specificity 
to self. This SP medullary dwell time is evidently indispensible in the establishment of 
tolerance, at both the level of negative selection and nTreg generation. The precise 
multifaceted interactions between the various cellular components of this unique 
microenvironment facilitating these essential stages intrathymic T cell development, however, 
remain unidentified. We, therefore, aimed to explore the role of the thymic medulla in greater 
detail by addressing two key questions: 
1) What is the role of the thymic medulla, in particular the mTEC population, in the post-
positive selection maturation processes of conventional and Foxp3
+
 regulatory SP 
thymocytes? 
2) What chemotactic signals control the cortical-to-medullary transition of developing SP 
thymocytes?  
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2.1 MICE 
All mice used throughout this study were housed and maintained within the Biomedical 
Sciences Unit (BMSU), at the University of Birmingham, in accordance with Home Office 
regulations. Mice we obtained from the BMSU in-house stock, as a kind gift from research 
groups or from external commercial suppliers. Details of all mouse strains used throughout 
the study are listed in Table 2.1.  
Wild type (WT) mice were used to characterize a normal, un-manipulated thymic 
microenvironment, whilst genetically manipulated mouse strains enabled precise 
investigations into the functions of specific genes and mechanisms involved in the T cell 
developmental process. All adult mice used through out this study were culled by cervical 
dislocation of the neck, in accordance with Home Office regulations.  Mice were age and sex 
matched within each experimental condition and sacrificed between 6-12 weeks of age. WT 
mice were from the C57BL/6 colony, unless otherwise stated and all manipulated mice strains 
were on a C57BL/6 background. Timed matings were achieved by the housing of one male 
with two females overnight. Vaginal plug (VP) detection is then used to identify any 
successful timed matings, classified as day 0 of gestation (E0). The average gestation period 
for mice is between 18 and 21 days. This timed mating system made it possible to acquire 
embryonic tissue at specific developmental stages.                              h           
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Table 2. 1 Wild Type And Genetically Modified Strains Used In This Study. 
Mouse Stain CD45 Isotype Phenotype Source 
BALB/c CD45.2 Wild type BMSU or externally 
sourced from Harlan  
C57BL/6 CD45.2 Wild type BMSU 
Boy J CD45.1 Congenic C57BL/6 Wild type BMSU 
C57BL/6 x Boy J CD45.1 x 
CD45.2 
Wild type BMSU 
Ccr9-/- CD45.2 Deficiency in CCR9 results in a failure of 
thymocytes to display any chemotactic 
response to CCL25. 
B.W. Agace, 
University of Lund, 
Sweden 
Ccr7-/- 
 
CD45.2 Deficiency in CCR7 results in thymocytes 
displaying no chemotactic response to CCL19 
or CCL21. 
Antal Rot, University 
of Birmingham 
Ccr4-/- 
 
CD45.2 Deficiency in CCR4 results in thymocytes 
displaying no chemotactic response to CCR4 
ligands 
The Jackson 
Laboratory 
Ccr4-/- x Ccr7-/- 
 
CD45.2 Deficiency in CCR4 and CCR7 results in 
thymocytes displaying no chemotactic 
response to either CCR4 or CCR7 ligands 
Cross Ccr7-/- and 
Ccr4-/- strains at the 
BMSU 
Relb-/- CD45.2 Targeted mutation of the RelB gene results in 
a multi-organ inflammatory phenotype as a 
consequence of several immune disruptions, 
including severe disruptions to the thymic 
structure (Weih et al., 1995). 
J. Caamano, 
University of 
Birmingham 
RAG-2 GFP CD45.2 Transgenic mice carrying bacterial artificial 
chromosomes (BACs) modified by 
homologous recombination to encode a green 
fluorescent protein (GFP) reporter within the 
RAG-2 gene (Yu et al., 1999) 
The Jackson 
Laboratory 
Foxp3-GFP 
Knockin 
CD45.2 Introduction of enhanced green fluorescent 
protein (EGFP) into the Foxp3 locus results in 
the ability to track Foxp3-expressing 
regulatory T cells (Bettelli et al., 2006) 
T.Strom, 
Beth Israel 
Deaconess Medical 
Center, Boston 
ZAP 70-/- CD45.2 Deletion of the entire gene segment encoding 
Zap 70 results in a halt stage in T cell 
development at the positive selection stage 
resulting in a total absence of CD4+ and CD8+ 
single positive thymocytes, (Negishi et al., 
1995). 
B. Seddon, National 
Institute for Medical 
Research 
C57BL/6 nude CD45.2 Deficiency in the FoxN1 gene results in 
abnormal thymic epithelial cell development. 
The thymic rudiment in not populated by 
lympoid precursors and consequently mice do 
not have T cells. 
BMSU 
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2.2 MEDIUM AND TISSUE CULTURE REAGENTS 
2.2.1 Medium 
The short term handling of isolated tissues and cells was completed within a medium of 
RF10-H (preparation detailed in Table 2.2), whilst long term cultures were placed within a 
media of Dulbecco’s Modified Eagle’s Medium (DMEM) (Table 5.3 and Table 5:4). Aliquots 
of both mediums were prepared in advance and stored at 4
o
C. All mediums and additives 
were purchased from Sigma, Poole, UK, unless otherwise stated. 
2.2.2 Additives 
To selectively eliminate all cells of a hematopoietic lineage from fetal thymic organ cultures 
(FTOC) (see Section 2.7) , 2- deoxyguanosine (2-dGuo) was added to the culture media of 
DMEM. Exposure to 2-dGuo results in a depletion of lymphoid cells, whilst thymic epithelial 
cells are undisrupted, resulting in the thymic lobes becoming ‘empty’, but maintaining their 
ability to support recolonisation by T cell progenitors. A final concentration of 1.35mM 2-
dGuo was added to culture mediums of DMEM when desired. A stock solution of 9mM 2-
dGuo was stored at -20°C until needed.  
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Table 2.2 Preparation Of RPMI-1640 Hepes (RF10-H) 
Medium and Additives Volume Final Concentration 
RPMI-1640 + 20mM Hepes, with L-glutamine, 
without bicarbonate 
10mls - 
200nM L-glutamine 100μl 2mM 
5000 IU/ml Penicillin and Streptomycin 200μl 100 IU/ml 
Heat-inactivated fetal calf serum (FCS) 1ml 10% 
 
Table 2.3 Preparation Of Dulbecco’s Modified Eagle’s Medium (DMEM) 
Medium and Additives Volume Final Concentration 
Dulbecco’s Medium with 3.7g/l 
bicarbonate,without glutamine 
20ml - 
100x non-essential amino acids (for component 
details see Table 2.4) 
200ml - 
1M Hepes- Final conc. 200ml 10mM 
5x103 M2 Mercaptoethanol 200ml - 
200mM L-Glutamine -Final conc. 400ml 4mM 
5000 IU/ml Penicillin and Streptomycin 400ml 100 IU/ml 
Heat-inactivated FCS 2ml 10% 
 
  
  
 67 
Table 2. 4 Constituents Of 100x Non-Essential Amino Acids 
Constituent Concentration (mg/ml) 
L-Alanine 8.9 
L-Asparagine 15.0 
L-Aspartic acid 13.0 
Glycine 7.5 
L-Glutamic acid 14.2 
L-Proline 11.5 
L-Serine 10.5 
 
2.3 DISSECTION OF MOUSE TISSUE 
Thymic lobes, spleen and lymph nodes (LN) were dissected from adult mice and placed into 
RF10-H. Tissues were then carefully cleaned to remove any unwanted excess material, such 
as fat or blood, using fine forceps under a dissection microscope.  All handling of murine 
tissue was performed within a laminar flow hood to provide a sterile environment, using 
sterile surgical instruments and sterile medium. For the preparation of fetal material, embryos 
were removed from pregnant mice at the preferred day of gestation, separated from the womb 
and egg sac and washed in a solution of 1:1 Phosphate Buffered Saline (PBS) to RF10-H. 
Embryonic lobes were then dissected out from the thoracic tree, under a dissection 
microscope and transferred into a medium of RF10-H for short term handling, before being 
used as fresh material or prior to being placed into the FTOC system described in Section 2.7. 
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2.4 ISOLATION OF DISTINCT CELL TYPES 
2.4.1 Isolation Of Thymocytes Or Peripheral T cells 
To obtain a cell suspension of thymocytes, or peripheral lymphocytes, the thymus, LN and 
spleen were gently teased apart by glass slides to release the cells into a medium of RF10-H. 
All cell types were then filtered through a mesh-membrane filter to remove any cell clumps 
and centrifuged to form a pellet. The thymus/LN samples were then re-suspended in a known 
volume of RF10-H and placed on ice until needed. Alternatively splenocytes were re-
suspended in 2mls red blood cell lysis buffer (Sigma-Aldrich) and left at room temperature 
for 5-10 minutes. An equal volume of RF10-H was then added the cell suspension to 
neutralize the buffer properties and centrifuged. Splenocytes were then re-suspended in a 
known volume of RF10-H and placed on ice until needed. Haemocytometer counts were 
acquired and absolute cell numbers calculated within each cell suspension. All cell counts and 
absolute numbers obtained throughout this study were via haemocytometer counts. The 
typical centrifugation settings used throughout the study were 4 minutes, at 4
o
C, at a speed of 
1200rpm, unless otherwise stated.    
2.4.2 Isolation Of Stromal Cell Populations 
To obtain a single cell suspension of thymic stromal cells, freshly dissected embryonic thymic 
lobes or thymic lobes placed into the FTOC system for 5-7 days, with or without 2-dGuo 
treatment (Section 2.7), underwent enzyme digestion. Thymic lobes were transferred to 1.5ml 
eppendorfs and washed three times with Ca
2+
/Mg
2+
 
free Phosphate Buffered Saline (PBS-). 
This removed any traces of serum that could possibly inactivate the enzyme function. The 
  
 69 
lobes were then re-suspended in 600μl 1:10 trypsin dilution made up with 0.2% 
Ethylenediaminetetraacetic acid (EDTA) and incubated for 10-15 minutes at 37°C to 
disaggregate the structure and release the stromal cells into the suspension. The trypsin was 
then neutralized with an equal volume of RF10-H and centrifugation. The pellet was then re-
suspended in 1ml RF10-H total volume and cell numbers were calculated from 
haemocytometer counts.  
2.4.3 Immunomagnetic Separation Of Embryonic Stromal Cells 
The isolated 2-dGuo treated FTOC thymic stromal cells described in Section 2.4.2 were 
subject to additional selection using the immunomagnetic separation technique to deplete any 
possible contaminating CD45
+
 hematopoietic cells that may remain within the cell suspension. 
This immunomagnetic separation technique used Dynabeads
®
 sheep anti-Rat IgG beads, 
coated with tissue culture derived anti-mouse CD45 supernatant.  Beads in a stock 
concentration of 4 x 10
8 beads/ml were aliquoted into 500μl samples in 1.5ml eppendorfs and 
stored at 4
O
C until needed. Aliquoted bead samples were prepared the day before needed by 
washing in RF10-H three times to remove sodium azide and then incubated at 4
0
C overnight 
in the presence of 500μl neat anti-mouse CD45 supernatant. After overnight culture beads 
were washed three times with RF10-H to remove any excess antibody and re-suspended in 
100μl RF10-H.  A 10μl sample of beads was added per stromal cell suspensions, within a 
total volume of 200l of RF10-H.  
Samples were then centrifuged for 10 minutes at 1000 rpm, at 4°C in round bottomed sterile 
cryogenic vials (Cryovial, Quebec, Canada). The round bottomed vial ensures a large surface 
area for optimal cell to bead interactions. The cell/bead pellet was then gently re-suspended 
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and the centrifugation step repeated for a second time. The cell/bead pellet was again gently 
re-suspended and the suspension was checked for ‘rosettes’, clusters of cells bound to beads, 
visualized by light microscopy. This step ensured the beads had successfully bound any 
remaining CD45
+
 cells, whilst confirming the beads were in excess of the stromal cells. Once 
positive binding was detected, unwanted CD45
+ 
cells bound to magnetic beads were separated 
from CD45
- 
unbound cells using an Eppendorf (1.5ml) Dynal Magnetic Particle Concentrator 
(Dynal). Supernatant containing the CD45
-
 population was removed and centrifuged, before 
re-suspension in 1ml RF10-H and a cell count was obtained. The beads and any CD45
+
 bound 
cells were discarded.  
2.4.4 Isolation Of Dendritic Cells 
To obtain the most efficient isolation of DC subsets the adult thymus or thymic grafts were 
subject to enzyme digestion. The thymic samples were cut into small pieces within a 1 ml 
medium of RPMI + 2% FCS and transferred into polypropelene FACs tubes. A solution of 
2.5mg/ml Collagenase Dispase (Roche) and a 1:20 dilution of DNase 1 (Sigma) were added 
to the 1ml RPMI + 2% FCS medium and incubated at 37
0
C within a water bath for 45minutes. 
The supernatant was removed and transferred on ice into an equal volume of MACs buffer 
(PBS, 0.5% FCS and 2mM EDTA). The digestion step was repeated on any remaining tissue 
fragments for an additional 15 minutes and an equal volume of MACs buffer then added.  The 
two cell suspensions were combined and a 5mM concentration of EDTA added. The medium 
was left on ice for 5 minute. The cell suspension was centrifuged and re-suspended in 1ml 
MACs buffer, before a cell count was obtained. Cells were handelled in the MACs buffer 
from this point. 
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2.5 IMMUNOLABELLING AND FLOW CYTOMETRY 
2.5.1 Antibodies  
All primary antibodies used for flow cytometry during this study are listed within Table 2.5 
and secondary antibodies are listed within Table 2.6. The antibodies used were either directly 
conjugated to a fluorochrome or biotinylated and thus, required a secondary fluorochrome 
conjugated antibody for their detection. For surface staining of CCR7, cells were first labeled 
with recombinant CCL-19 fusion protein, followed by a biotinylated antibody (Table 2.5), 
which was then detected by a tertiary fluorochrome conjugated antibody (Table 2.6).  Prior to 
usage, all antibodies we titrated to optimize working concentrations.  
2.5.2 Immunolabelling For Flow Cytometric Analysis 
After the isolation and preparation of the desired cell populations for staining, approximately 
1 x 10
6  
or 3 x 10
6  
cells (dependent upon the frequency of cell population of interest) were 
aliquot into 1.5ml eppendorfs and centrifuged to form a pellet. After the removal of the 
supernatant, cells pellets were re-suspended in 50μl (1 x 106 ) or 100μl (3 x 106 ) of the 
desired primary, secondary or tertiary antibodies. All antibody suspensions were made up in 
Fluorescence-activated cell sorting (FACS) medium, consisting of PSB- with 3% FCS.  The 
samples were then indicated on ice for 30 minutes. A single colour sample for each individual 
fluorochrome was prepared to set compensation parameters. A control sample for each 
biotinylated antibody was prepared to measure non-specific binding and set a negative peak 
of florescence. This was achieved by having an additional sample to which 50μl FACS 
medium was added at the primary antibody stage in substitution for the biotinylated antibody. 
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Once the incubation period was completed the samples were washed with 1ml FACS medium 
and centrifuged. Each wash step was repeated twice. At this point, if required the relevant 
secondary or tertiary antibodies were added, in an identical manner to the primary and 
incubated on ice for an additional 30 minutes, before repeating the to times washing step. 
After the final wash, samples were re-suspended in 200μl FACS buffer and transferred in 
12.5ml polystyrene FACS tubes (Becton) in preparation of FACS acquisition. 
2.5.3 Intracellular Immunolabelling For Flow Cytometric Analysis 
For the intracellular staining of Foxp3, cells were first surface stained as described in Section 
2.5.2.  After the final washing step the surface stain was fixed and the cells were 
permeabilized using the Foxp3/Transcription Factor Staining Buffer Set (eBioscience) 
according to the manufacturer’s protocol. Each sample was re-suspended in 200μl 
Fixation/Permeabilization solution made up of 1 part concentrate to 3 parts diluent. Cells were 
then stored at 4°C for 30 minutes. Cells were washed two times in 1ml 10% permeabilization 
buffer, made up with distilled water. After the permeabilization step was completed cells were 
stained with a directly conjugated Foxp3 antibody (see Table 2.5), in the same manner as 
surface stain technique stated in Section 2.5.2, however, the FACS buffer was substituted 
with the permeabilization buffer for any handelling or wash steps. 
To analysis intracellular IFNγ cytokine production cells were stimulated on plates coated with 
5μg/ml anti-CD3 antibody and 0.5μg/ml of soluble anti-CD28 antibody, (BD) in the presence 
of GoliStop (BD), in vitro for 4 hrs at 37
o
C. Plates were coated approximately 12hrs in 
advance and left at 4
0
C until needed. After stimulation, cells were transferred to Eppendorf 
tubes and the plate was washed two times with 1ml RF10-H. Cell suspensions were then 
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centrifuged and re-suspended in 1ml RF10-H, before a cell count was obtained. Cells were 
then surface stained as described in Section 2.5.2. After the final washing step the cells were 
fixed and permeabilization with Cytofix/Cytoperm Plus (BD) in accordance to the 
manufactures instructions. The permeabilized cells were then stained with a directly 
conjugated IFNγ antibody (see Table 2.5). 
2.5.4 Flow Cytometric Analysis 
The acquisition of all samples was performed on a BD LSR Fortessa flow cytometer using 
BD FACS diva software. Subsequent analysis was performed using FlowJo software. Prior to 
the acquisition of the experimental samples, single colour controls were obtained to adjust the 
compensatory levels between various fluorochrome detection channels, whilst examination of 
the negative samples enable the negative peaks of expression levels to be set for specific 
antibodies. The number of events recorded during analysis was dependent upon both the cell 
numbers prior to immunolabelling and the frequency of the cell population of interest. On 
average 500,000 events were recorded per experimental sample, with a minimal event rate of 
approximately 100,000. The forward and side scatter gates were set to exclude any non-viable 
cells.   
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Table 2. 5 Primary Antibodies Used For Flow Cytometric Immunolabelling 
Specificity (Clone) Fluorochrome Working Dilution Supplier 
Anti-CD4 
Clone GK1.5 
 
PECy7 
Alexa Fluor 700 
PE 
1:1500 
1: 200 
1:800 
eBioscience 
eBioscience 
eBioscience 
Anti-CD4 
Clone RM4-5 
PerCP-Cy5.5 
APC eFluor 780 
APC 
V500 
eFluor 450 
 
1:400 
1:100 
1:400 
1:200 
1:100 
eBioscience 
eBioscience 
eBioscience 
BD Bioscience 
eBioscience 
Anti-CD8 
Clone 53-6.7 
eFluor 450 
FITC 
V500 
PE 
1: 200 
1: 800 
1:200 
1:200 
eBioscience 
eBioscience 
BD Bioscience 
eBioscience 
Anti-TCRβ 
Clone H57-597 
APC eFluor 780 1:100 
eBioscience 
 
Anti-CD69 
Clone H1.2F3 
FITC 
APC 
PerCP-Cy5.5 
1:200 
1:200 
1:200 
eBioscience 
eBioscience 
eBioscience 
Anti-CD62L 
Clone MEL-14, 
APC 1:3000 BioLegend 
Anti- CD44 
Clone IM7, 
FITC 
Alexa Fluor 700 
1:200 
1:100 
eBioscience 
eBioscience 
Anti-CD3 
Clone 145-2C11 
PE 1:200 eBioscience 
Anti-mouse HSA/CD24 Clone M1/69 
APC eFluor 780 
PE 
1:500 
1:500 
eBioscience 
BD Bioscience 
Anti-Qa2 
Clone 695H1-9.9 
Biotinylated 
FITC 
1:200 
1: 50 
BioLegend 
eBioscience 
Anti-CD45.1 
Clone A20 
eFluor 780 
eFluor 450 
1:200 
1:200 
eBioscience 
eBioscience 
Anti-CD45.2 
Clone 104 
PE 
Alexa Fluor 700 
1:200 
1:200 
eBioscience 
Anti-CCR9 
Clone eBio CW-1.2 
PE 1:200 eBioscience 
Anti-CD25 
Clone PC61/PC61.5 
APC 
PE 
1:500 
BioLegend 
eBioscience 
CCR7 staining 
1: Recombinant CCL19-Ig 
2: Goat anti–human Ig 
 
- 
Biotinylated 
 
1:500 
1:500 
 
eBioscience 
eBioscience 
Anti–IFNγ 
Clone XMG1.2 
APC 1:100 BD Bioscience 
Anti-Foxp3 
Clone FJK-16s 
PE 1:100 eBioscience 
Anti-CCR4 
Clone 2G12 
APC 
Biotinylated 
1:200 
1:200 
BioLegend 
BioLegend 
Anti-CXCR4 
Clone 2B11 
APC 1:50 eBioscience 
Rat 1gG2b isotype 
Clone eB149/10HS 
APC 1:50 eBioscience 
Anti-Sirpα+ 
Clone P84 
Biotinylated 1:200 eBioscience 
Anti-B220 
Clone RA3-6B2 
FITC 1:200 eBioscience 
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Specificity (Clone) Fluorochrome Working Dilution Supplier 
Anti-CD205 (DEC205) 
Clone NLDC145 
Biotinylated 1:50 AbCAM 
Anti- EpCAM-1 
Clone G8.8 
 
APC 1:800 eBioscience 
Anti-CD40 
Clone 3/23 
PE 1:100 BD Bioscience 
Anti-CD80 (B7.1) 
Clone 16-10A1 
FITC 1:100 eBioscience 
Anti-CD45 
Clone 30-F11 
APCCy7 1:800 eBioscience 
Anti-CD11c 
Clone N418 
PE 1:200 eBioscience 
Table 2.5 Primmary Antibodies continued….. 
 
Table 2. 6 Secondary Reagents Used For Flow Cytometric Immunolabelling 
 
2.6 PREPARATION OF CELLS FOR HIGH SPEED SORTING 
Cells populations were immunolabelled in preparation for high speed sorting by the same 
technique as used for flow cytometry. The total cell number labeled, however, was greatly 
increased for cell sorting, with each experimental sample containing a maximum of 30 x 10
6 
cells, re-suspended in a total volume of 350μl antibody solution. Following immunolabelling, 
samples were re-suspended in 500μl RF10-H and pooled together if required. The cell 
suspensions were then filtered to remove any adherent cell clumps through a 30 mm mesh-
membrane filter unit (Miltenyi Biotech). The samples were transferred to polypropylene 
Specificity (Clone) Fluorochrome Working Dilution Supplier 
Streptavidin PECy7 
 
1:1500 
 
eBioscience 
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FACS tubes (Becton Dickinson) in preparation of sorting. Purified populations were sorted 
using a MoFlo XDP sorted (Beckman Coulter). Isolated cell populations were collected into 
FACS tubes containing 500μl RF10-H and then centrifuged before re-suspension in 1ml 
RF10-H. The cell numbers were then calculated and a small fraction of cells were extracted 
for FACS re-analysis on the BD LSR Fortessa flow cytometer to determine purification rates.  
The gates used for the isolation of specific cell populations were set in accordance to negative 
and positive peaks generated from the control samples. 
2.7 FETAL THYMUS ORGAN CULTURE (FTOC) 
The well established FTOC systems supports the full program of T cell development in vitro, 
whilst maintaining the integrity of the complex three-dimensional architecture of the thymic 
stroma. The unaltered structure of the fetal lobes promotes efficient interactions between the 
developing thymocytes and stromal cells, thus, mimicking a typical thymic microenvironment 
in vivo (Jenkinson and Anderson, 1994).  
Thymic lobes were dissected from embryos at the desired E15 stage of gestation. The lobes 
were placed onto 0.8μm sterile nuclepore filters (purchased from Millipore), which lay on top 
of a sterile artiwrap sponge support, approximately 1cm
2
 in size
 
(purchased from Medipost 
Ltd) within a DMEM medium (Figure 2.1). Lobes were transported to the surface of the 
nuclepore filters using a finely drawn, mouth-controlled sterile glass pipette. All WT fetal 
lobes were set up in 90 mm petri dishes (sterilin) containing a 4ml DMEM volume. Up to six 
individual lobes were cultured on one sponge-filter complex and two complexes were added 
per dish. In the case of heterogeneous matings of genetically modified mouse strains, when 
the genotype of each embryo was unknown, lobes were handled separately and set up in  
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Figure 2. 1 Fetal Thymic Organ Culture 
Thymus lobes were dissected from mouse embryos day 15 of gestation. The thoracic 
cavity was exposed to allow the thymus lobes to become visible (contained within 
yellow based box), positioned above the heart (labeled H) (A). Lobes were isolated (B) 
and placed within the organ culture system (C). 
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individual 35mm petri dishes (sterilin) containing a 2ml DMEM volume. When desired, 2-
dGuo was added to the DMEM medium, with 600μm added to a 4ml DMEM medium volume 
within a 90 mm petri dishes and 300μm added to the 2ml DMEM medium volume in a 35mm 
petri dishes. Petrie dishes were then placed in sterile humidified chambers and gassed with 
10% CO2 for approximately 10 minutes, to achieve a desired pH of 7.2-7.4. The chambers 
were then sealed to keep the environment sterile and placed into a 37°C incubator for 
approximately 5- 7 days (Anderson and Jenkinson, 2007).   
2.8 REAGGREGATE THYMIC ORGAN CULTURE (RTOC) 
The formation of reaggregate thymus organ cultures (RTOCs) enables the investigation of the 
differentiation of a single thymocyte cohort, at a specific intra-thymic developmental window, 
within an in vitro 3D thymic microenvironment (Hare et al., 1999; Jenkinson et al., 1992). 
Desired thymocytes subsets were isolated from adult mice by MoFlo cell sorting, as stated in 
Section 2.6. The isolated thymocyte populations were mixed with a cell suspension of E15 
dGuo treated FTOC cultured 5-7 days, that had be subject to both enzyme digestion (Section 
2.4.2) and CD45
+
 depletion (Section 2.4.3). The input number of thymocytes varied, 
dependent upon the desired population and the disparity between sorts, whilst commonly 2.5 
x 10
5
 stromal cells were added per RTOC. The combined stromal and thymocytes cell 
suspension were centrifuged at 1000rpm for 10 minutes at 4
o
C. The supernatant was carefully 
removed and the cell pellet vortexed to produce a suspension of cells within an approximate 
2-3l volume. Using a mouth pipette, the cell suspension was transferred into a finely drawn 
pipette and onto the centre of a 0.8m sterile Whatman filter, under a dissection microscope.  
Filters were placed on top of a sterile anti-wrap sponge support in a culture system, in an 
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identical manner to the FTOC system described in Section 2.7 (see Figure 2.1). Each filter 
was limited to a singular reaggregate and cultured for a desired period of time, before the 
gentle disaggregation of the structure to explore thymocyte development, via flow cytometric 
analysis. 
2.9 IMMUNOHISTOLOGY TECHNIQUES 
2.9.1 Sectioning And Fixation Of Frozen Tissues 
 
After the dissection and isolation of the adult tissued desired for immunohistology (Section 
2.3) the material was frozen as soon as possible. Tissues were frozen on dry ice, on top of tin 
foil sections. Thymic grafts were frozen within Optimal Cutting Temperature (OCT) 
compound on the tin foil, due to their small size, whilst larger adult thymic lobes were frozen 
alone. All thymic tissue was frozen at a defined orientation and mounted onto a microtome 
within additional OCT compound. 7μm thick section were cut and mounted onto 4 spot glass 
slides (Hendley- Essex). All slides were left to dry at room temperature for an hour, followed 
by fixation in acetone (Baker) for 20 minutes at 4°C. Sections were then air dried for 10 
minutes and stored within polythene grip seal bags at -20°C until wanted for 
immunolabelling. 
2.9.2 Immunolabelling Of Frozen Tissue Sections 
Sections were removed from storage at -20°C and left at room temperature to dry for 
approximately 30 minutes prior to immunolabelling. Tissue sections were rehydrated in a 
PSB (Sigma) bath for 10-15 minutes. The tissue sections were stained with fluorochrome 
conjugated anti-mouse antibodies. The details of all primary antibodies used for confocal 
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analysis through out this study are listed with Table 2.7 and all secondary/tertiary antibodies 
are within Table 2.8. Antibody solutions were made up in PBS containing 1% bovine serum 
albumin (BSA). A 75μl volume of antibody mixed was applied directly to each section and 
incubated for 45 minutes, in a dark humidified chamber at room temperature. Sections were 
then washed within a PBS bath for 5-10 minutes. Once all staining steps were complete, if 
required section were fully emerged in a DAPI (4',6-diamidino-2-phenylindole) solution for a 
maximum of 30 seconds and then washed four times with PBS. DAPI is a strong nuclear stain 
that facilitates the visitation of all nucleated cellular components of the whole tissue section. 
A small drop of DABCO (1,4 diazabicyclooctane), in glycerol at pH 7, was added to each 
tissue section, to preserve the flurochromes. The slide was mounted with a cover slip (Sigma) 
and sealed with a thin layer of clear nail varnish. Slides were stored at  -20°C until needed for 
confocal analysis.   
2.9.3 Confocal Analysis 
Confocal images were obtained using a LSM 780 microscope at an x 25 magnification (unless 
otherwise stated) and analyzed using LSM software (Carl Zeiss). The digital images were 
recorded in four channels and each was scanned separately, with no overlap in the detection 
of emissions from individual fluorochromes. TRITC and Alexa 555/594 conjugated 
antibodies were excited with a 561nm helium laser, FITC/Alexa 488 conjugated antibodies 
were excited with a 488nm argon laser, Alexa 647 conjugated antibodies were excited with 
the 633nm helium laser and DAPI were exited by the 405nm diode laser.   
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Table 2.7 Details Of Primary Antibodies Used For Immunohistology 
 
Table 2. 8 Details Of Secondary And Tertiary Reagents Used For Immunohistology 
Specificity (Clone) Host/Isotype Working Dilution Supplier 
Purified anti-mouse CD4 
(Monoclonal GK 1.5) 
conjugated to Alexa 647 by D. 
Withers, University of 
Birmingham 
Rat IgG1  
1:100 
eBioscience 
Anti-mouse CD8β Biotinylated 
Monoclonal Clone YTS156.7.7 
Rat IgG2b 1:200 BioLegend 
ERTR5 
mTEC marker 
 1:2000 W.van Ewijk, 
Riken Yokohama Institute,  
Kanagaw, Japan.  
Anti-mouse β5T 
cTEC marker  
Polyclonal  
Rabbit 1:100 MBL 
Anti-mouse CD45.1 
Biotinylated 
Monoclonal Clone A20 
 
Mouse IgG2a 1:100 eBioscience 
Anti-mouse CD45.2 
FITC 
Monoclonal Clone 104 
Mouse IgG2a 1:100 eBioscience 
Anti-mouse CD11c FITC  
Monoclonal Clone N418 
Armenian Hamster IgG 1:300 
 
eBioscience 
Anti-mouse IgG FITC Goat 1:100 SouthernBiotech 
Specificity (Clone) Host/Isotype Working Dilution Supplier 
Anti FITC 
Polyclonal 
Rabbit 
1:200 
 
Invitrogen 
Anti-Rabbit IgG Alexa 
Fluor 488 Monoclonal 
Goat 1:200 Invitrogen 
Anti-rat IgM Alexa Fluor 
594 Monoclonal 
Goat 1:300 Invitrogen 
Streptavidin  Alexa Fluor 
647 
Monoclonal 
 1:200 Invitrogen 
Streptavidin Alexa Fluor 
488 
Monoclonal 
 1:200 Invitrogen 
Streptavidin Alexa Fluor 
405 Monoclonal 
 1:50 Invitrogen 
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2.9.4 Confocal Quantification  
To explore if cortex to medulla migration was effected by the absence of CCR4 or CCR7 
expression, individually or combined, we counted the number of CD4
+
 SP and CD8
+
 SP cells 
within a given medullary area of WT and deficient thymic sections (Ccr4
-/-
, Ccr7
-/-
 and Ccr4
-/-
x Ccr7
-/-
). Numerical quantitation of the number of CD4
+
 SP and CD8
+
 SP was achieved by 
adopting a previously published technique (Ueno et al., 2004). Adult thymic lobes were 
frozen and serial sections cut as described in Section 2.9.1. Sections were then 
immunolabeled for confocal analysis (Section 2.9.2 and 2.9.3). The sections were stained for 
CD4 and CD8, in conjunction with cortical (β5T) and medullary markers (ERTR5), to aid the 
identification of the two distinct microenvironments and establish the positioning of the CMJ. 
Pictures were taken containing both cortical and medullary regions at an x 25 objective. Using 
LSM software (Carl Zeiss) 100μm x 100μm square areas were arbitrarily set within the 
medullary region, at least 100μm inside the CMJ. The number of CD4+ SP and CD8+ SP cells 
within this selected medullary area was quantified using the LSM software. This strategy was 
adopted for all sections and the numbers of CD4
+
 SP and CD8
+
 SP populations within each 
medullary area was recorded within the Prism 4 file to enable the average numbers of both SP 
populations to be complied, per adult mouse, from serial sections. For confocal quantification 
of thymus sections of mixed bone marrow chimeras, the same strategy was applied, but the 
numbers of CD45.2
+
 cells were calculated within a 100μm x 100μm area of both medullary 
and cortical regions. The areas were arbitrarily set at least 100μm inside the CMJ for both the 
cortical and medullary regions.   
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2.10 THYMIC KIDNEY CAPSULE TRANSFER 
To compare intrathymic T cell development within a WT and Relb
-/-
 deficient 
microenvironment, E15 Relb
-/-
 or WT (litter mate) 2-dGuo FTOC were transferred under the 
kidney capsule of WT or nude hosts (experimental design described in Figure 4.1). Mice 
undergoing surgery were between 5-6 weeks in age and were weighed prior to surgery to 
calculate the correct dose of analgesia to administer. Mice were initially anaesthetized within 
a chamber containing 4% isoflurane (May and Barker, Dagenham, UK) carried within oxygen. 
Once mice lost consciousness and displayed deep, slow breathing patterns, they were 
transferred onto a heat pad and the anesthesia was administered through a facemask, at a 2% 
isoflurane rate. At this point 2mg per kg pre-operative Buprenorphine (Tamgesic, AnimalCare, 
UK) was administered subcutaneously, in the back of the neck, using a 25-gauge needle. The 
loss of the pedal withdrawal reflex was confirmed before surgery commenced, to ensure a 
sufficient depth of anesthesia.   
Mice were positioned on their front and fur surrounding the site of incision, above the left 
lumbar region, was removed using an electrical shaver.  The area was then cleaned using 70% 
alcohol. A small cut was first made to the skin, using blunt ended scissors, in a region slightly 
below the assumed position of the left kidney. The incision was then increased to 
approximately 0.5 to 1 cm in length, dependent upon the size of the host. A space was created 
between the skin and the peritoneum using a closed pair of blunt ended scissors. A similar cut 
was then made in the peritoneum, approximately 0.5cm in size. The kidney was gently drawn 
out of the body cavity by grasping the fat attached at the lower end of the organ with blunt 
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ended forceps. Once the kidney was externalized, it was held in position by the skin layer and 
kept rehydrated with sterile PBS soaked gauze. 
A small cut was made in the fibrous kidney capsule with fine forceps, under a dissection 
microscope. Extreme care was needed at this point to ensure no damage to the kidney 
parenchyma. The embryonic material for transplantation was transferred under the kidney 
capsule, via the edge of forceps. Up to three E15 thymic lobes were grafted under the capsule 
of one kidney. The kidney was gently drawn back into the body cavity by the elevation the 
edge of the peritoneum. The peritoneum layer was sutured (Vicryl, 16mm round bodied 
sutures) and the skin sealed by a surgical staple. The mice were removed from the anesthesia 
facemask and placed within a warm box, until consciousness was regained. The recovery of 
the mice was closely monitored at regular intervals by BMSU staff post-operation, until 
sacrificed between 6 to 12 weeks later.     
2.11 ANALYSIS OF AUTOIMMUNITY 
The assessment of autoimmunity was performed on nude hosts, scarified 6 weeks after 
receiving either WT or Relb
-/-
 grafts. The LN of nude hosts were harvest for intracellular 
staining of IFNγ cytokine production within the peripheral T cells subset, as described in 
Section 2.5.3.  In addition, the blood serum of the each host was investigated for the presence 
of autoantibodies. The peripheral blood sample was obtained via cardiac punctures of the host, 
under anesthesia, in accordance to the Home Office regulations. The samples acquired were 
left at room temperature for up to 4hrs to aid blood cell coagulation. The samples were 
centrifuged and the serum supernatant removed carefully and transferred into Eppendorfs 
tubes, for storage at -4
0
C until needed.  
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We detected autoantibody in blood serum of the hosts as previously described (Gaspal et al., 
2011). The serum samples were loaded onto slides of composite tissue blocks containing rat 
liver/kidney/stomach (INOVA Diagnostics). The tissue slides were stored at -4
0
C prior to 
usage and thus, were left at room temperature for approximately 30 minutes before serum 
loading. Before the addition of serum samples, slides were blocked with 10% anti-goat serum, 
made up in PBS and incubated for 20 minutes in a dark humidified chamber at room 
temperature. Excess goat serum was tapped off slides and a 50μl sample of blood serum 
added directly to each section, at a 1:40 concentration, made up in PBS.  The sections were 
incubated for 20 minutes and then washed within a PBS bath for 5-10 minutes. 
Autoantibodies were then detected with goat anti-mouse IgG FITC (Table 2.7), with a 50μl 
sample added to each section at a 1:100 concentration. Slides had an additional 20 minutes 
incubation period, followed by a wash step. The slides were then fully emerged in a DAPI 
solution and mounted with a cover slip, as described in Section 2.9.2, however the mounting 
medium was substituted with Polyvinyl alcohol mounting medium (Sigma). Confocal images 
were taken of the slides using the method described in Sections 2.9.3. 
As an additional sign of autoimmunity, liver sections from the nude hosts were analyzed for 
the presence of lymphocytic infiltrates. Liver sections were isolated from the nude hosts and 
fixed and stored within Formalin solution, neutral buffered, 10% (Sigma). Tissues were then 
paraffin-embedded and sections cut and stained with Hematoxylin & Eosin (H & E) as 
previously described (Rossi et al., 2007b). The pathology department at the University of 
Birmingham performed all H & E stains. The images of the section were acquired using the 
DM6000 Leica microscope, at an x20 objective.  
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2.12 INTRAVENOUS (IV) CELL TRANSFER  
Desired thymocyte populations for IV cell transfer were isolated via high-speed cell sorting 
(as described in Section 2.6) from adult WT or Foxp3-GFP ‘knockin’ donors. The purity level 
of each sort was determined and a cell count obtained. The desired cell numbers for transfer 
was extracted from the total volume into Eppendorf tubes and the populations undergoing co-
transfer were combined. The freshly purified cells samples were centrifuged and re-suspended 
in a 300μl of sterile PBS, (without calcium and magnesium) (Sigma). The 300μl cell 
suspensions were transferred into 25 gauge needles, attached to a 1ml syringes and all air 
bubbles were removed. Total cell suspensions were then transferred into the WT host, 
intravenous, via the tail vein.  
The transferred cell numbers varied between specific populations and the efficiency of the 
sort. On average 2.5 x 10
5 
thymocytes of the DP, immature CCR7
-
CCR9
+
CD69
-
 CD4
+
 SP or 
mature CCR7
+
CCR9
-
CD69
-
 CD4
+
 SP subsets were transferred into a WT host. In comparison, 
the numbers obtained from the purity of Foxp3
-
CD25
+ 
CD69
+
nTreg precursors was 
considerably lower and thus, commonly bellow 5 x 10
4 
cells were transferred per host.  
2.13 COMPETITIVE BONE MARROW CHIMERAS 
To explore if Ccr4
-/-
 thymocytes displayed deficiency in their ability to undergo cortex to 
medulla migration or SP maturation within a competitive environment with their WT 
counterparts, mixed bone marrow chimeras were generated (experimental design detailed in 
Figure 5.10). Bone marrow (BM) was obtained from the femur and tibia bones of the WT or 
Ccr4
-/-
 donors. BM was flushed from the bones into a medium of RF10-H using a syringe 
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attached to a 27 gauge needle. The extracted BM was passed through the needle to break up 
any clumps. The cell suspensions were then filtered through a 30 mm mesh-membrane filter 
unit (Miltenyi Biotech). Samples were centrifuged and re-suspended in red blood cell lysis 
buffer (Sigma-Aldrich) (1ml buffer per donor mouse sacrificed) and left at room temperature 
for 3-5 minutes. An equal volume of RF10-H was added to each cell suspension to neutralize 
the buffer properties and centrifuged. The BM samples were re-suspended in PBS (without 
calcium and magnesium) and cell counts obtained.   
At this point BM samples undergoing T cell depletion were immunolabelled as described in 
Section 2.5.2 for CD4, CD8 and CD3, all directly conjugated to PE (see Table 2.5). T cell 
depletion of samples removes the possibility of mature T cells within the BM recirculating 
into the thymus. Cells were surface stained within MACs Buffer (PBS, 0.5% FCS and 2mM 
EDTA). After the final wash step of immunolabelling cells were resuspended within a 1:10 
dilution of Anti-PE microbeads (miltenyi Biotec). 10μl of beads were added per 1 x 107 cells, 
diluted in MACs buffer.  BM cells were incubated at 4
o
C for 15 minutes and tapped every 5 
minutes to resuspend the medium, increasing the possibility of cell-bead interaction. Cells 
were then washed x 2 with MACs buffer. On the final wash step the BM samples were 
resuspended in 500μl MACs buffer and added to MACs separation 25 LS columns (miltenyi 
biotec), previously primed with 3ml MACs buffer, on a QuadroMACs separator magnets. All 
PE labeled cells with the medium bind the magnets, enabling the collection of non-PE (CD4
-
 
CD8
-
 CD3
-
) BM cells. Columns were washed x 3 with 3mls MACs buffer. Samples were then 
centrifuged and resuspended in 5mls RF10-H, before a cell count was obtained.   
The desired cell numbers were extracted from each sample (non- T cell depleted or T cell 
depleted) and mixed with their corresponding WT or Ccr4
-/- 
counterparts. Each host received 
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5 x 10
6
 bone marrow cells per condition (WT or Ccr4
-/-
), resulting in a 1x10
7
 total cell 
transfer. The mixed bone marrow donor samples were then centrifuged and each re-suspended 
in 300μl PBS (without calcium and magnesium), in preparation of their transfer into irradiated 
hosts. 
The WT hosts receiving the BM transfers received baytril antibiotic drinking water for one 
week prior to irradiation. On the 7
th
 day of treatment hosts were irradiated using a CIS IBL 
437 Cs-137 irradiator (CIS BIO International, Cedex, France). Mice were irradiated with two 
times 450 Rad (900 Rad total), with a 3-hour gap between the two administrations.  The bone 
marrow transfer was performed the following day, into irradiated hosts. The fresh 300μl BM 
suspensions were transferred into each host using a 25 gauge needle, attached to a 1ml syringe, 
intravenous via the tail vein. BMSU staff monitored recipient mice closely after transfer to 
ensure successful reconstitution and the baytril antibiotic drinking water was continued for an 
additional week, post I.V. The chimera mice were harvest 5 weeks post BM transfer and the 
post-selection localization and maturation of WT or Ccr4
-/-
 thymocytes was explored by flow 
cytometry and confocal analysis.   
2.14 PREPARATION OF SAMPLES FOR GENE EXPRESSION ANALYSIS 
All gene expression analysis was carried in collaboration with S. Parnell, University of 
Birmingham. 
2.14.1 Snap Freezing Of Cell Populations 
Isolated cell populations obtained by MoFlo sorting for gene expression analysis were 
transferred into 1.5ml RNase-free Eppendorf tubes (Camlab) and centrifuged at 1000rpm, at 
  
 91 
4
0
C, for 10 minutes. The supernatants were removed to leave a dry pellet and immersed in 
liquid nitrogen, before storage at -80C until needed 
2.14.2 mRNA Extraction And cDNA Synthesis 
mRNA was extracted directly from the isolated MoFlo cell sorted populations using a 
μMACSTM  one-step mRNA Isolation and reverse transcription kit (Miltenyi Biotec). All 
lysis/binding and wash buffers were left at room temperature to equilibrate prior to use. Snap 
frozen cell pellets were re-suspended within approximately 1ml lysis/binding buffer. Cells 
were vigorously vortexed for 3 to 5 minutes, or passed through a 21gauge needle, to ensure 
their complete lysis. Cell lysates were then centrifuged at 13,000g for 3 minutes in 
LysateClear columns. A 50μl sample of µMACS oligo deoxy-thymidine (dT) microbeads was 
added to each lysate sample and gently mixed to facilitate the polyA tails of any present 
mRNA to hybridise to the oligo microbeads. The mixtures were then loaded into MACSm 
columns, which had been previously primed with 100ml Lysis/Binding buffer and placed 
within a magnetic field of the MACS
TM
 Separator. As the samples passed through the 
columns any magnetically labeled mRNA present within the samples bound to the columns. 
The columns were then washed twice with 200ml of lysis/binding buffer to remove any 
protein or DNA, followed by an additional rinse with 100μl wash buffer, four times, to 
remove ribosomal RNA and DNA. cDNA was then synthesis directly from the retained 
mRNA, within the same separation columns. 100ml equilibration/wash buffer was added 
twice to each column matrix and allowed to run through. The lyophilised reverse transcription 
mastermix was dissolved in 20ml re-suspension buffer and then added to columns, followed 
by the addition of 1ml sealing solution, to prevent sample evaporation. The columns were 
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incubated at 42
o
C for 1 hour on a thermo block, for reverse transcription to occur.   Following 
this incubation period columns were washed twice with 100ml of equilibration/wash buffer. 
To release the cDNA, 20ml of release solution was applied to each sample, which were 
incubated at 42
o
C for an additional 30 minutes. The cDNA was then eluted from the columns 
by the addition of 50ml of cDNA elution buffer and collected in eppendorfs. The cDNA was 
stored at 20
o
C until needed.  
2.14.3 Real Time Quantitative PCR 
Real Time quantitative PCR was performed on the RotorGene RG-3000 (Corbett Research) 
using SYBR green with primers specific for the variety of genes of interest. The details of all 
primers used through out this study are summarized within Table 2.9. Prior to the 
amplification of target genes of interest, β-actin was selected as the housekeeping gene for 
sample normalization. Oligonucleotides were synthesized by Sigma-Genosys. PCR reactions 
were performed in either triplicates or duplicates within a 15μl reaction buffer. This buffer 
comprised of 7.5μl qPCR mastermix at a 2 x concentration (Bioline Sensimix NoRox 
SybrGreen), 0.15μl (20μM stock concentration) forward and reverse primers (final 
concentration of 0.2μM), 6.2μl DNAse-free/RNAse-free PCR grade water (Sigma) and 1μl 
cDNA template. The master mix contained heat activated Taq polymerase, dNTPs, MgCl2 
and reaction buffer.  In order to avoid any pseudogenes within the endogenous reference gene, 
β-actin primers were designed and synthesized by QIAGEN (QuantiTect Mm Actb 1SG 
Primer Assay: QIAGEN QT00095242) and used at a 1 x concentration. The amplification 
program included an initial ‘hot start’ at 95°C for 10 minutes, followed by cycling at 95°C for 
15 seconds, 58 to 62°C (dependent upon the specific primer pair) for 20 seconds and 72°C for 
15 seconds. This cycling stage was repeated for 39 cycles.  At the end of each cycle the 
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fluorescent signal produced from the amplicon was obtained and at the final amplification a 
dissociation curve was generated (72-99°C, hold 30 seconds on the first step, then 5 seconds 
on subsequent steps), per primer pair, to verify the specificity of the amplicon. The reaction 
amplification efficiency and Ct values were acquired from Rotor Gene 6.0 software (Corbett 
Research, Sydney Australia) using standard curves predominantly generated from mouse 
universal cDNA (Biochain). The Pfaffl model was adopted to calculate the relative expression 
values of each sample, normalized to β-actin. The Pfaffl model was selected as it takes into 
account gene dependent efficiencies within the amplification process.  
Table 2.9 Details Of Primers Used for qPCR 
Primer Forward 5’ end primer sequence Reverse 3’ end primer sequence 
CCR4 AACAGAGCAGTGCGCATGAT  CGTTGTACGGCGTCCAGAA 
CCR7 CTAGCTGGAGAGAGACAAGA TATCCGTCATGGTCTTGAGC 
CCR9 ACCATGATGCCCACA- GAACT GGGAAGAGTGGCAAGAAAGA 
Foxo1 TGTCAGGCTAAGAGTTAGTGAGCA GGGTGAAGGGCATCTTTG 
S1pr1 AAATGCCCCAACGGAGACT CTGATTTGCTGCGGCTAAATTC 
Klf2 CTCA- GCGAGCCTATCTTGCC CACGTTGTTTAGGT- CCTCATCC 
Plxnd1 AGGACTCACCCACCAACAAG  GCCACCACCTGTTCAAACTT 
RANKL CACACCTCACCATCAATGCTG GAAGGGTTGGACACCTGAATGC 
CD40L CCTTGCTGAACTGTGAGGAGA CTTCGCTTACAACGTGTGCT 
Foxp3 CCCAGGAAAGACAGCAACCTT TTCTCACAACCAGGCCACTTG 
CCL22 CTGATGCAGGTCCCTATGGT GGAGTAGCTTCTTCACCCAG 
CCL17 AGTGGAGTGTTCCAGGGATG CCAATCTGATGGCCTTCTTC 
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2.15 GRAPHS AND STATISTICAL ANLAYSIS 
All graphs presented within this study were created using Prism 4 software. All statistical 
analysis of data was also performed using this program. An unpaired student two-tailed T test 
was performed for all statistical analysis and any P values obtained below 0.05 were 
considered significant.  
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CHAPTER 3: DYNAMIC CHANGES IN CHEMOKINE 
RECEPTOR EXPRESSION PATTERNS REVEAL MULTIPLE 
CHECKPOINTS DURING THYMOCYTE POSITIVE 
SELECTION. 
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3.1 INTRODUCTION 
The process of positive selection is an essential checkpoint in intrathymic T cell development. 
Thymocytes that successfully rearrange and express functional TCRs are positively 
selected via TCR engagement with self-peptide MHC complexes, expressed on the cell 
surface of cTEC (Laufer et al., 1996). Positively selected cells escape apoptosis and continue 
on with their developmental program, committing to either a CD4 or CD8 SP lineage fate.  
The transition from DP to SP on the initiation of selection is accompanied with thymic 
relocalization from cortical to medullary regions (Takahama, 2006).  
Positive selection is a multistep process involving a transitional phase through an intermediate 
CD69
+
CD4
+
CD8
+
 DP phenotype (Hare et al., 1998). Newly generated SP thymocytes 
undergo subsequent post-selection maturation stages, before their export out into the 
periphery to become naive T cells.  The multiple developmental steps of SP thymocytes are 
defined by changes in expression levels of several surface markers. These include the 
progressive down regulation of HSA and CD69 and the upregulation of CD62L and Qa2 
(Figure 3.1) (Gabor et al., 1997a; Kelly and Scollay, 1990; Lucas et al., 1994).  The 
differentiation program of CD4 SP thymocytes has been further characterized with the aid of 
additional markers such as 6C10 (Jin et al., 2008). The functional relevance of the majority of 
surface markers used in the classification system of SP thymocytes, however, remains 
relatively unknown. 
Chemokine receptors are thought to play a major role in the relocation of thymocytes from the 
cortex to the medulla, during the positive selection process. CCR7 specifically has been  
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Figure 3. 1 A Current Model Of The Phenotypic Changes Associated With The 
Multistep Positive Selection Process 
On the initiation of positive selection CD4
+
CD8
+
 DP thymocytes rapidly upregulate 
CD69 on their cell surface, and differentiate into either CD4 or CD8 SP thymocytes. 
Newly generated CD4
+
 and CD8
+ 
SP thymocytes are defined by a surface expression 
pattern displaying high levels of CD69 and HSA. With increased maturity both CD4 
and CD8 SP thymocytes downregulate CD69 and HSA, whilst upregulating CD62L 
and Qa2 to exhibit a mature surface profile of CD69
-
 HSA
-
 CD62L
+
 Qa2
+
 before their 
exit into the periphery to develop as naive T cells.   
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identified in playing a major role in this process, which involves migration towards CCL19 
and CCL21 gradients within medullary areas (Kwan and Killeen, 2004; Ueno et al., 2004). 
Whether CCR7 is solely responsible for this thymic relocalization, however, remains unclear. 
The blockade of all chemokine-mediated migration by Pertussis Toxin treatment resulted in 
the inability of SP cells to cross the corticomedulla junction, leading to their retention within 
cortical regions and medullary areas devoid of SP thymocytes (Ehrlich et al., 2009; Suzuki et 
al., 1999). Deficiency in CCR7 or its ligands, however, has less severe consequences, which 
include the formation of small medullary areas that still contain SP4 and SP8 thymocytes, 
albeit at reduced numbers (Ueno et al., 2004). Thus, absence of CCR7 signaling does not 
result in a total arrest in thymocyte migration to the medulla. Additional investigations have 
questioned the importance of CCR7 in guiding cortex to medulla migration of positively 
selected thymocytes, speculating the removal of CCR7 signaling has only a minor influence 
on CD4 SP migration and the defect on migration is exclusive to the CD8 SP population 
(Davalos-Misslitz et al., 2007). Moreover, on initiation of positive selection, CCR7 
expression is reportedly upregulated on only a small fraction of CD69
+
 DP thymocytes, 
complimenting data that suggests this population migrates poorly towards CCR7 ligands in 
vivo (Campbell et al., 1999; Davalos-Misslitz et al., 2007). Collectively this implies CCR7 
may not exclusively control cortex to medulla relocalization of developing thymocytes and 
suggests possible redundancy by other chemokines receptor in orchestrating thymocyte 
trafficking at this key developmental checkpoint.  
The goal of this chapter is to investigate chemokine receptor surface expression patterns at 
different maturational stages of the multistep positive selection process. The exploration of 
the chemokine receptor profile of cells undergoing the selection process, along with post 
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selection maturation of CD4 and CD8 SP thymocytes, will aid the classification of the 
differentiation stages of thymocyte maturation using molecules with known function, as an 
alternative to the markers widely used of unknown function. By attempting to define multiple 
checkpoints in the development of positively selected thymocytes, we also aim to reveal other 
possible chemokine receptor candidates, in addition to CCR7, that may be involved in 
directing cortex to medulla migration of positively selected thymocytes.  
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3.2 RESULTS 
 3.2.1 Changes In Chemokine Receptor Expression Patterns During The 
Initiation Of Positive Selection  
To determine the changes in chemokine receptor expression during positive selection, the 
chemokine receptor profile of thymocytes at a pre-positive selection stage was first 
established by flow cytometric analysis of adult thymocytes from Zap70
-/- 
mice, in which 
absence of TCR signaling results in an arrest in thymocyte development at the pre-selection 
DP stage (Negishi et al., 1995). Surface staining of co-receptors CD4 and CD8 with CD69 on 
WT and Zap70
-/-
 thymocytes revealed all DP Zap70
-/-
 thymocytes were CD69
-
, with a total 
absence of CD69
+
 DP cells, readily detectable in WT mice (Figure 3.2 A and C). Analysis of 
the expression of additional chemokine receptors was then performed, chosen on the basis of 
two criteria. Firstly, the availability of relevant reagents for reliable flow cytometric analysis 
as assessed. Secondly, ‘The Immunological Genome Project’ (http://www.immgen.org) was 
used to identify expression of those chemokine receptor genes showing an induction of 
expression during thymocyte positive selection. From this process, we focused analysis on 
CCR7, CCR4, CXCR4 and CCR9. Gating on the pre-selection total DP Zap70
-/-
 thymocyte 
population for chemokine receptor expression identified that all cells during this 
developmental window expressed high levels of CCR9 and CXCR4, but lacked surface 
expression of CCR7 or CCR4 (Figure 3.2 B). To establish whether the initiation of positive 
selection altered the expression of chemokine receptors, the profile of adult WT CD69
+
 DP  
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Figure 3. 2 Changes In Chemokine Receptor Expression Patterns During The 
Initiation Of Positive Selection 
Thymocytes from adult Zap70
-/-
 (A and B) or WT C57BL/6 (C to F) were isolated and 
stained for flow cytometry analysis.  
The CD4
+
CD8
+
 DP fraction of Zap70
-/-
 (A) or WT (C) thymocytes were gated using a 
CD4 vs CD8 contour plot and their expression of CD69 displayed as a histogram. The 
CD69
-
 DP population of Zap70
-/-
 thymoytes (B) or the CD69
+
 DP subsets of WT 
C57BL/6 thymocytes (D) were analyzed for expression of CCR9, CCR7, CCR4 and 
CXCR4. Grey shaded histograms represent negative controls of CD69
- 
or CD69
+
 DP 
thymocytes from the equivalent: Ccr9
-/-
, Ccr7
-/- 
or Ccr4
-/-
 adult mice, or a CXCR4 
isotype control. The numbers displayed on the histograms and contour plots represent 
the percentage of cells within the gates.   
(E) The percentages of CD69
+ 
(white bar) and CD69
- 
(grey bar) WT DP cells positive 
for each receptor: CCR9, CCR7, CCR4 and CXCR4 are displayed in mean bar graphs. 
The bar graph represents 7 independent experiments with the exception of CXCR4 
staining, where data is representative of 3 experimental replicates. The standard error 
bars indicate the SEM.  
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thymocytes were analyzed. Flow cytometry analysis revealed that at this stage in intrathymic 
development thymocytes maintained high levels of CCR9 on their cell surface, but showed 
evidence of downregulation of CXCR4 expression, with less than 40% of CD69
+
 DP cells 
displaying high levels of CXCR4 on their cell surface, in comparison to over 80% of the 
population at the pre-selection stage (Figure 3.2. D and F). In addition the initiation of the 
selection process resulted in the induction of both CCR4 and CCR7 expression, with 
approximately 20% of CD69
+
 DP thymocytes acquiring CCR7 and just fewer than 50% 
upregulating CCR4. 
Collectively the chemokine receptor profile of DP thymocytes pre-selection, in comparison to 
CD69
+
DP thymocytes undergoing the selection process, suggests that the initiation of positive 
selection results in downregulation of CXCR4 and upregulation of CCR4 and CCR7. In 
contrast, the initiation of positive selection does not alter the surface expression of CCR9, 
detectable at high levels on the cell surface at both DP CD69
-
 and DP CD69
+
 stages. 
3.2.2 Newly Generated CD69
+
 And Late Stage CD69
-
 SP4 Thymocyte 
Subsets Have Distinct Chemokine Receptor Profiles 
Having characterized the changes in chemokine receptor expression on the initiation of 
positive selection we went on to classify changes in chemokine receptor expression during 
later stages of this process, including the different maturational stages of SP4 thymocyte 
development (Figure 3.3). The immature CD69
+
 and mature CD69
-
 subsets of TCRβhigh SP4 
thymocytes were explored for their surface expression of CCR9, CCR7, CCR4 and CXCR4. 
A large fraction of newly generated immature CD69
+
 SP4 thymocytes maintained high levels  
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Figure 3. 3 The Chemokine Receptor Expression Profile Of Positively Selected 
CD4
+
 SP Thymocytes 
(A) Thymocytes obtained from adult WT C57BL/6 mice were analysed for expression 
of CD4, CD8, CD69 and TCRb.  
(B) The TCRβhigh  SP4 population was subdivided based on their CD69+ or CD69- 
status and gated for their expression of chemokine receptors CCR9, CCR7, CCR4 and 
CXCR4. The shaded grey area on each histogram represents a negative control of 
CD69
+
 or CD69
- 
 TCRβhigh CD4+ SP thymocytes from the equivalent: Ccr9-/-, Ccr7-/- or 
Ccr4
-/-
 adult mice, or a CXCR4 isotype control.  
(C) The percentage of positive cells for each chemokine receptor from the CD69
+
 
TCRβhigh SP4 population (white box), the CD69- TCRβhigh SP4 subset (gray bar) and 
TCRβhigh CD4+ splenocytes (striped bars) are displayed as a mean bar graph from 7 
independent experimental repeats, with the stand error bars representing the SEM. 
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of CCR9 on their cell surface, while approximately 40% of the population also expressed 
CCR4 and CCR7 (Figure 3B and C).  However, from this staining analysis it is not clear if 
these receptors are co-expressed by the same thymocyte cohort or by two distinct populations. 
In contrast to the positive staining acquired for CCR9, CCR4 and CCR7, at the CD69
+
 SP4 
stage in development, CXCR4 was absent from the cell surface. Moreover, CXCR4 was also 
absent on the mature CD69
-
 SP4 subset (Figure 3.3B and C). This would suggest CXCR4 
undergoes rapid downregulation upon the initiation of positive selection, which is completed 
before the transition into SP4 thymocytes and remains absent from the surface of cells 
committed to this lineage during the rest of their thymic residency.   
The more mature CD69
- 
fraction of SP4 thymocytes displayed a distinct chemokine receptor 
phenotype, compared to their immature CD69
+
 counterparts. At this advanced developmental 
stage SP4 thymocytes lack surface expression of both CCR9 and CCR4, while approximately 
90% express CCR7 (Figure 3.3B and C). Collectively, this suggests that with increasing 
maturity, during the transition from a CD69
+
 to CD69
- 
phenotype, SP4 thymocytes 
downregulate CCR9 and CCR4, whilst upregulating CCR7. The chemokine receptor profile 
of TCRβhighCD4 T cells within the spleen of WT adult mice closely mirrors that of mature 
CD69
-
 SP4 thymic residents (Figure 3.3C), with the large majority of the spleen-resident 
CD4
+
 T cells expressing high levels of CCR7, whilst lacking CCR9 and CCR4.  
3.2.3 Simultaneous Analysis Of Chemokine Receptor Expression Patterns 
Reveals Distinct Subsets Of SP4 Thymocytes  
After establishing the chemokine receptor profile of SP4 thymocytes at both their immature 
CD69
+ 
and mature CD69
- 
stages in development, we were interested to continue to explore 
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SP4 thymocyte development using analysis of simultaneous expression of a panel of 
chemokine receptors. As CXCR4 did not have detectable levels of expression during any 
phase of SP4 differentiation, we focused our investigations on the relationship between the 
expression patterns of CCR7, CCR4 and CCR9 during the maturation of WT adult SP4 
thymocytes (Figure 3.4 A). On examination of the relationship between CCR9 and CCR7 
expression within the immature CD69
+
 and mature CD69
-
 cohorts of SP4 cells, we identified 
distinct heterogeneity within the CD69
+
 fraction. Simultaneous flow cytometry analysis of 
CCR9 and CCR7 expression of the CD69
+
 immature SP4 population revealed thymocytes do 
not co-express both chemokine receptors during this maturational stage. Rather, the majority 
of CD69
+
 SP4 thymocytes expressed high levels of CCR9, whist expressing low levels of 
CCR7, with a small fraction of the population displaying the reverse expression pattern. In 
contrast, analysis of CCR9 versus CCR4 expression within the CD69
+
 SP4 population 
revealed that approximately 35% of cells co-expressed both chemokine receptors, suggesting 
that downregulation of these chemokine receptors during development occurs in unison, 
perhaps with CCR9 undergoing downregulation slightly later than CCR4. The expression 
pattern of CCR4 against CCR7 within the immature CD69
+
 SP4 subset displayed 
heterogeneity that essentially reflected the relationship of expression between CCR9 and 
CCR7, offering additional confirmation of co-expression of CCR4 and CCR9. 
With the identification of heterogeneity within the immature fraction of SP4 thymocytes, we 
were interested to explore the maturation status of the different populations identified on the 
basis of their chemokine receptor profiles. To achieve this we analysed different SP4 
thymocyte populations from RAG-2 GFP adult mice. We used RAG-2 GFP levels as an age 
defining marker of thymocyte differentiation, as decreasing levels of GFP expression is  
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Figure 3. 4 The Dynamic Changes In Chemokine Receptor Expression Patterns 
Reveals Distinct Subsets Of SP4 Thymocytes 
(A) CD69
+
 and CD69
-
 TCRβhigh SP4 thymocytes subsets from adult RAG-2 GFP mice 
were analysed for expression of CCR7, CCR9 and CCR4 (B) The levels of HSA, Qa2, 
CD62L and RAG-2 GFP are displayed in the following subsets, as overlays on a 
histogram:  
CCR7
-
CCR9
+
CD69
+TCRβhigh SP4 (red line)  
CCR7
+
CCR9
-
CD69
+TCRβhigh SP4 (blue line)  
CCR7
+
CCR9
-
CD69
-TCRβhigh SP4 (green line)  
The black line on the RAG-2 GFP histogram displays the expression levels on total 
CD4
+
 CD8
+
 DP thymocytes. All data is representative of at least 3 experimental 
replicates. 
 
  
 113 
  
 114 
  
  
 115 
directly linked to increasing maturity (Boursalian et al., 2004). We compared the RAG-2 GFP 
levels of expression between each SP4 population, along with a control DP thymocyte cohort, 
displaying the brightest RAG-2 GFP signal. We also used additional, well-established 
markers of maturation status; HSA Qa2 and CD62L to define the maturity of the different 
SP4 populations (Figure 3.4 B). We explored the expression levels of all four age defining 
markers in the newly define three independent SP4 TCRβhigh populations: CCR7-
CCR9
+
CD69
+
, CCR7
+
CCR9
-
CD69
+
 and CCR7
+
CCR9
-
CD69
-
. Although we did not include 
the CCR4 staining profile in our gating strategy, data obtained (Figure 3.4A) suggested CCR4 
expression mimics that of CCR9, due to their closely related surface expression profiles and 
therefore, the CCR7CCR9
+
CD69
+ TCRβhighSP4 cells were assumed to also include the 
CCR4
+
 CD69
+
SP4 population. Figure 3.4B shows that the most immature SP4 cells had a 
surface expression profile of CCR7
-
CCR9
+
CD69
+
, based upon their high levels of HSA and 
RAG-2 GFP expression and their low expression levels of Qa2 and CD62L, in comparison to 
the additional two SP4 thymocyte subsets. The expression levels of this collection of markers 
also showed that the CCR7
+
CCR9
-
CD69
+TCRβhighSP4 fraction of thymocytes had an 
intermediate maturational status, as cells displaying this specific chemokine receptor profile 
demonstrated intermediate levels of expression for all four differentiation markers; HSA, 
RAG-2 GFP, Qa2 and CD62L. As anticipated from their CD69
-
 status, the CCR7
+
CCR9
-
CD69
-TCRβhighSP4 population displayed the most mature phenotype, exhibiting the lowest 
levels of HSA and Rag-2 GFP of all three populations, whilst displaying the highest levels of 
Qa2 and CD62L.  Collectively, from this data we propose the following sequence of 
TCRβhighSP4 development: CCR7-CCR9+CD69+ cells develop into CCR7+CCR9-CD69+SP4, 
which differentiate into CCR7
+
CCR9
-
CD69
-
 SP4 thymocytes. 
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3.2.4 The Chemokine Receptor Expression Patterns Of Positively Selected 
SP8 Thymocytes 
As with our SP4 thymocyte analysis, we next investigated the surface expression profile of 
SP8 thymocytes for an identical chemokine receptor panel and used CD69 levels to 
distinguish between the immature and mature fractions (Figure. 3.5).  The proportions of 
immature versus mature cells within the SP8 population differs to that of SP4 cells, with the 
largest percentage of the population expressing a mature CD69
-
 SP8 phenotype, as opposed to 
SP4 cells, where the majority of thymocytes display a immature CD69
+
 profile.  
The separation of immature CD69
+
 and mature CD69
-
 SP8 populations revealed little 
phenotypical changes to the chemokine receptor profile with increasing maturity (Figure 3.5 
B and C). In general, at both the CD69
+
 and CD69
-
 developmental stages of SP8 
differentiation cells displayed high levels of CCR9 and CCR7 on their cell surface. 
Interestingly, however within the CD69
+
SP8 subset a small fraction of cells express lower 
levels of surface CCR7, with only approximately 80% of the population displaying a high 
frequency of the receptor. Furthermore, both CD69
+
 and CD69
-
 fractions of thymocytes 
lacked surface expression of CCR4 and CXCR4, suggesting neither of these receptors are 
expressed by SP8 at any stage of their maturational program (Figure 3.5 B) The total lack of 
CXCR4 throughout SP8 differentiation mirrors the absence of this receptor on all SP4 
thymocytes. The absence of CCR4 on both SP8 populations, however, differs greatly to the 
newly generated SP4 subset that displays this chemokine receptor on their cell surface.   
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Figure 3. 5 The Chemokine Receptor Expression Patterns Of Positively Selected 
CD8
+
 SP Thymocytes 
Thymocytes obtained from WT C57BL/6 mice were stained for FACS analysis. (A) 
CD4
-
CD8
+
 SP cells were identified via a CD4 vs CD8 contour plot, and the TCRβhigh 
population was gated from a histogram and CD69 expression explored.  
(B) The TCRβhigh SP8 population was subdivided based on their CD69+ or CD69- 
status and gated for their expression of chemokine receptors CCR9, CCR7, CCR4 and 
CXCR4. The shaded grey area on each histogram represents a negative control of 
CD69
+
 or CD69
- 
 TCRβhigh CD8+ SP thymocytes from the equivalent population of 
Ccr9
-/-
, Ccr7
-/- 
or Ccr4
-/-
 thymocytes, or a CXCR4 isotype control. 
(C) The percentage of positive cells for each chemokine receptor from the CD69
+
 
TCRβhigh SP8 population (white box) CD69- TCRβhigh SP8 subset (gray bar) and 
TCRβhigh CD8+ splenocytes (striped bars) are displayed as a mean bar graph from 7 
independent experimental repeats, with the stand error bars representing the SEM. 
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Comparison of mature SP8 thymocytes and CD8
+
 T cells residing with the spleen identified a 
similar chemokine receptor expression profile between the two populations in regards to 
CCR7, while a smaller proportion of CD8 T cells within the spleen expressed CCR9 (Figure 
3.5C).  
3.2.5 Simultaneous Analysis Of Chemokine Receptor Expression Patterns 
During SP8 Thymocyte Development 
As CCR4 and CXCR4 did not have detectable levels of expression during either phase of SP8 
differentiation, we next explored possible further heterogeneity within the SP8 thymocyte 
subsets by performing simultaneous analysis of CCR7 and CCR9 expression (Figure 3.6). By 
analyzing the relationship between CCR9 and CCR7 expression using an identical gating 
strategy to that applied to the SP4 subsets, we observed potential heterogeneity in the 
population based upon their expression of CCR7. Although the populations we not as distinct 
as those detected within the SP4 subset, a small fraction of the CD69
+ 
SP8 population 
expressed lower levels of CCR7 on their cell surface (as identified in Figure 3.5 B), whilst 
expressing high levels of CCR9. This resulted in a tail of CCR7 expression and the possible 
distinction of two SP8 populations; CCR9
+
CCR7
low
CD69
+
 and CCR9
+
CCR7
+
CD69
+
 (Figure 
3.6A). Overall, however, the staining confirmed that the vast majority of SP8 cells co-express 
high levels of CCR9 and CCR7 through out their maturation.  
We explore further the possible heterogeneity within the SP8 population by investigating the 
maturational status of the newly identified TCR
high 
SP8 subsets (CCR9
+
CCR7
low
CD69
+
, 
CCR9
+
CCR7
+
CD69
+ 
and CCR9
+
CCR7
+CD69). We classified the ‘age’ of each population  
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Figure 3. 6 Changes In Chemokine Receptor Expression During The Maturation 
Of SP8 Thymocytes, Post Positive Selection 
(A) CD69
+
 and CD69
-
 TCRβhigh SP8 thymocytes subsets from adult RAG-2 GFP mice 
were analysed for expression of CCR7, CCR9.  
(B) The levels of HSA, Qa2, CD62L and RAG-2 GFP are displayed as overlays on a 
histogram for the following: 
CCR7
low
CCR9
+
CD69
+TCRβhigh SP8 (red line)  
CCR7
+
CCR9
+
CD69
+TCRβhigh SP8 (blue line)  
CCR7
+
CCR9
+
CD69
-TCRβhigh SP8 (green line)  
The black line on the RAG-2 GFP histogram displays the expression levels of total 
CD4
+
 CD8
+
 DP thymocytes. All data is representative of at least 3 experimental 
replicas.  
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based upon their expression of RAG-2 GFP, HSA, Qa2 and CD62L (Figure 3.6B). By using 
these age defining markers we identified the CCR9
+
CCR7
low
CD69
+ 
TCR
high
SP8 cohort to be 
the most immature phenotype, exhibiting the highest level of HSA and the lowest levels of 
CD62L and Qa2. Interestingly, RAG-2 GFP levels between the CCR9
+
CCR7
low
CD69
+ 
and 
CCR9
+
CCR7
+
CD69
+ 
cohorts, was indistinguishable and therefore this was not a suitable 
marker to distinguish the maturation statuses of these two subsets. The CCR9
+
CCR7
+
CD69
+ 
TCR
high
SP8 subset displayed an intermediate maturational phenotype, based upon its 
expression levels of HSA, Qa2 and CD62L, which resided in-between of the other two SP8 
populations. The pattern of expression for all four age defining markers clearly identified the 
CCR9
+
CCR7
+
CD69
-
TCR
high
SP8 subset as the most mature, in comparison to the additional 
two SP8 fractions. This population displayed the lowest expression levels of RAG-2 GFP and 
HSA, whilst exhibiting the highest levels of CD62L and Qa2.    
3.2.6 Gene Expression Patterns Of Distinct SP4 Thymocyte Subsets  
Having identified heterogeneity within the SP4 population, based upon their expression 
patterns of CCR9 and CCR7, it was of interest to gain more insight into the maturational state 
of these three distinct populations. The three populations of TCRβhighSP4 thymocytes 
classified in Figure 3.4 (CCR7
-
CCR9
+
CD69
+
, CCR7
+
CCR9
-
CD69
+ 
and CCR7
+
CCR9
-
CD69
-
) 
along with CD4
+
CD8
+ 
DP cells, were isolated via cell sorting from adult WT thymocyte 
samples. These populations were then analysed by quantitative PCR for their mRNA 
expression levels of a panel of genes linked to thymocyte development (Figure 3.7).  
Initially, expression of Ccr4, Ccr9 and Ccr7 was analyzed to confirm if mRNA levels 
corresponded to the surface protein expression profiles of these chemokine receptors  
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Figure 3. 7 Gene Expression Patterns Of Distinct SP4 Thymocyte Subsets 
Quantitative real time PCR was performed on the indicated thymocyte populations, 
cell sorted from BALB/c WT adult mice: 
CD4
+
CD8
+
 DP (white bars)  
CCR7
-
CCR9
+
CD69
+TCRβhigh SP4 (right horizontal strip bars)  
CCR7
+
CCR9
-
CD69
+TCRβhigh SP4 (grey bars)  
CCR7
+
CCR9
-
CD69
-TCRβhigh SP4 (left horizontal strip bars) 
Error bars indicate the SEM and mRNA levels were normalized to house keeping gene 
β-actin. Data is from at least two independently sorted biological samples, with each 
gene analyzed a minimum of two times and each PCR ran in triplicates to obtain a 
SEM. 
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demonstrated within Figures 3.3 and 3.4.  Ccr4 mRNA levels were greatest within the 
immature, newly generated CCR7
-
CCR9
+
CD69
+TCRβhigh SP4 population, when the majority 
of cells are expressing this receptor on their surface. Ccr7 mRNA was highest within the 
intermediate CCR7
+
CCR9
-
CD69
+ TCRβhigh SP4 fraction, while, Ccr9 gene expression was 
highest within the DP fraction of thymocytes, when it is highly expressed on the thymocyte 
cell surface. Interestingly, however, Ccr9 mRNA levels were substantially reduced during the 
transition from DP to the immature CCR7
-
CCR9
+
CD69
+ TCRβhigh SP4 stage, although high 
levels of surface protein expression of CCR9 is maintained at both developmental phases, 
suggesting a delay between the cessation of Ccr9 gene expression and the downregulation of 
the receptor on the cell surface. A similarly surprising result was observed with the decrease 
in Ccr7 mRNA expression levels between the intermediate CCR7
+
CCR9
-
CD69
+ TCRβhigh 
SP4 and the late stage CCR7
+
CCR9
-
CD69
-TCRβhigh SP4 populations, which does not fully 
correspond to the maintained levels of surface expression of this chemokine receptor during 
this transition. The DP population of thymocytes demonstrated very low levels of Ccr4 
mRNA expression and an almost absent level of Ccr7 mRNA. These findings fit well with the 
surface expression of these two chemokine receptors on this thymocyte subset, as they are 
both induced on the surface of only a fraction of CD69
+
DP cells undergoing the positive 
selection process, which represents less than 10% of the total DP population  (Figure 3.2).   
Isolated thymocyte populations were also explored for their expression patterns of genes 
associated with late stage intrathymic T cell development, including Foxo1, Kruppel-like 
factor 2 (Klf2) and Sphingosine-1-phosphate receptor-1 (S1pr1). Foxo1 and Klf2 are both 
transcription factors known to regulate thymic emigration, along with recirculation to 
peripheral lymphoid organs (Carlson et al., 2006; Gubbels Bupp et al., 2009). High levels of 
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Foxo1 and Klf2 mRNA expression were detected within the CCR7
+
CCR9
-
CD69
+ 
and 
CCR7
+
CCR9
-
CD69
- TCRβhighSP4 populations (Figure 3.7). In contrast, mRNA encoding 
S1pr1, an additional regulator of thymic egress (Matloubian et al., 2004), was limited to only 
the most mature CCR7
+
CCR9
-
CD69
-TCRβhigh SP4 population. Collectively the gene 
expression patterns of these three late stage thymocyte regulators offers additional support to 
the proposed sequence of development for SP4 thymocyte subsets in which immature CCR7
-
CCR9
+
CD69
+
 cells develop into a CCR7
+
CCR9
-
CD69
+
 phenotype, before maturing into 
CCR7
+
CCR9
-
CD69
-
 thymocytes. In addition the gene expression patterns of Klf2 and Foxo1 
would suggest that both CCR7
+
CCR9
-
CD69
+ 
and CCR7
+
CCR9
-
CD69
- 
populations represent 
SP4 cells of an advance developmental state and thus, proposes CCR7 acquisition occurs as a 
relatively late stage maturational event in SP4 thymocyte positive selection.        
The expression of additional genes was also explored within the four thymocyte populations, 
including plexinD1 (Plxnd1), which has been suggested to control the migration of positively 
selected thymocytes into the medulla, via the repression of CCR9 signaling (Choi et al., 2008). 
Complementary to this proposed function, DP thymocytes express high levels of mRNA for 
Plnxd1, which is reduced within the most immature CCR7
-
CCR9
+
CD69
+ TCRβhighSP4 subset 
and further still within the additional two SP4 populations. The levels of Rankl and Cd40lg 
mRNA within the different thymocyte populations were also examined and both were readily 
detectable in the intermediate CCR7
+
CCR9
-
CD69
+ 
population. While RankL mRNA was also 
present within the CCR7
-
CCR9
+
CD69
+ 
SP4 fraction, Cd40lg expression was detectable in the 
CCR7
+
CCR9
-
CD69
- 
SP4 subset (Figure 3.7).
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3.2.7 Determining Precursor-Product Relationships Within Heterogonous 
CD4 SP Thymocyte Subsets 
To directly confirm the maturation sequence of the three distinct SP4 thymocyte populations 
defined above, we used the reaggregate thymus organ culture (RTOC) system to follow the 
development of a single cohort of CCR7
-
CCR9
+
CD69
+
 SP4 thymocytes.  Cells were isolated 
via high speed cell sorting from total adult WT thymocytes and reaggregated with WT 
stromal cells from disaggregated 2-dGuo treated FTOC. As a comparison, the CCR7
+
CCR9
-
CD69
-
 SP4 thymocyte subset was also isolated and placed into the RTOC system. Each input 
population is displayed in Figure 3.8 A and B. The RTOC were harvested after 5 days in 
culture and analyzed to explore the maturation status of the input populations (Figure 3.8). 
Analysis of the CCR7
-
CCR9
+
CD69
+
 SP4 input population after culture revealed the presence 
of both SP4 and SP8 thymocyte lineages (Figure 3.8 A, C and D). This finding is compatible 
with the notion that these cells represent an SP4 thymocyte subset at an immature stage, prior 
to commitment to a particular SP4 or SP8 lineage. Closer investigations into the SP4 
thymocyte subset demonstrated that cells had down regulated CD69 and CCR9, whilst 
upregulating CCR7, to reach the mature SP4 surface phenotype of CCR7
+
CCR9
-
CD69
-
 
(Figure 3.8 A and C) In comparison, the CCR7
+
CCR9
-
SP4 input population remained 
committed to a SP4 lineage, had downregulated CD69 and maintained a CCR7
+
CCR9
-
 
surface profile after 5 days in culture (Figure 3.8 B, C and D). Collectively, data obtained 
from RTOC analysis of thymocyte developmental potential enabled the direct confirmation of 
a precursor-product relationship within newly defined SP4 thymocyte subsets, providing 
evidence for a maturation sequence in which CCR7
-
CCR9
+
CD69
+
 SP4 cells, representative of  
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Figure 3. 8 Determining Precursor-Product Relationships Within Heterogeneous 
SP4 Thymocyte Subsets  
CCR7
-
CCR9
+
 SP4 and CCR7
+
CCR9
-
 CD4 SP populations were isolated from adult 
BALB/C WT thymocyte sample and incorporated into RTOC system with 2dGuo 
treated E15 WT FTOC (Input populations A and B- top FACS plots).  
RTOC were cultured for 5 days and outputs stained for FACS analysis of CD4, CD8, 
CD69, CCR7 and CCR9 expression (Output populations A and B- bottom FACS 
plots).  
(C and D) The percentages of cells recovered from CCR7
-
CCR9
+
 SP4 input RTOCs 
(white bars) and CCR7
+
CCR9
-
 CD4 SP input RTOC (gray bars) are displayed as mean 
bar graphs. The percentages of total CD4 SP cells (C-left graph), CCR7
-
 CCR9
+
 
CD69
- 
SP4 thymocytes (C- right graph) and total CD8
+
 SP cells (D) recovered from 
the RTOC system are displayed, and graphs represent at least 4 independent 
experiments per condition. Error bars indicate SEM.  
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newly generated SP4 thymocytes after positive selection, give rise to CCR7
+
CCR9
-
CD69
+ 
thymocytes, which then give rise to the mature CCR7
+
CCR9
-
CD69
- 
SP4 stage. 
3.2.8 The Developmental Emergence Of Foxp3
+
 T Regulatory CD4 SP 
Thymocytes 
During their maturation, SP4 thymocytes can differentiate into non-conventional 
developmental pathways, including the Foxp3
+
 natural T-regulatory cell (nTreg) lineage. The 
process of intrathymic nTreg induction is believed to occur in a series of sequential stages; the 
initial upregulation of CD25 on the cell surface, followed by intracellular expression of the 
transcription factor Foxp3. Therefore, the Foxp3
-
CD25
+ 
SP4 population represents an nTreg 
precursor population to their Foxp3
+
CD25
+
 nTreg progeny (Lio and Hsieh, 2008). We aimed 
to explore at which stage in development nTreg SP4 thymocytes and their precursors emerge, 
in relation to the newly defined SP4 thymocyte subsets. We therefore examined the presence 
of Foxp3
+
CD25
+
 SP4 nTreg and Foxp3
-
CD25
+
 SP4 nTreg precursor populations within the 
CCR7
-
CCR9
+
CD69
+
, CCR7
+
CCR9
-
CD69
+ 
and CCR7
+
CCR9
-
CD69
- 
subsets of WT adult 
TCRβhighSP4 thymocytes, via flow cytometric analysis. 
Data shown in Figure 3.9 A and B shows that the immature, newly generated CCR7
-
CCR9
+
CD69
+
 SP4 population did not include any Foxp3
+
CD25
+
 nTreg and contained a 
barely detectable population of Foxp3
-
CD25
+ 
SP4 nTreg precursors. In contrast, both 
populations were readily detectable at the intermediate CCR7
+
CCR9
-
CD69
+ 
stage in SP4 
development, suggesting it is during this developmental window when SP4 thymocytes 
initiate differentiation down this non-conventional T cell lineage. The most mature
 
CCR7
+
CCR9
-
CD69
- 
SP4 cohort included the largest proportion of nTreg, but no nTreg  
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Figure 3. 9 The Developmental Emergence Of Foxp3
+
 T Regulatory CD4 SP 
Thymocytes 
Thymocytes were isolated from Foxp3-GFP ‘knockin’ adults. 
 (A) The surface expression of CD25 and intracellular expression of Foxp3 was 
identified on three developmental subsets of TCRβhigh SP4 population; CCR7-
CCR9
+
CD69
+
, CCR7
+
CCR9
-
CD69
+ 
and CCD7
+
CCR9
-
CD69
-
.  
(B) The frequency of CD25
+
Foxp3
-
 and CD25
+
Foxp3
+ 
cells from each SP4 subset are 
displayed as mean bar graph, representative of three individual experimental repeats. 
Stand error bars display the SEM.  
(C) Quantitative real time PCR of Foxp3 mRNA expression was performed on 
indicated cell populations, isolated from BALB/c WT adults:  
CD4
+
CD8
+
 DP (white bars)  
CCR7
-
CCR9
+
CD69
+TCRβhigh SP4 (right horizontal striped bars)  
CCR7
+
CCR9
-
CD69
+TCRβhigh SP4 (grey bars) 
CCR7
+
CCR9
-
CD69
-TCRβhigh SP4 (left horizontal striped bars) 
 Error bars indicate the SEM and mRNA levels were normalized to house keeping 
gene β-actin. Data is from two independently sorted biological samples, with each 
gene analyzed two times. 
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precursors were detectable. Consistent with the data obtained by flow cytometry analysis, the 
most immature CCR7
-
CCR9
+
CD69
+
 SP4 population did not display detectable levels of 
Foxp3 mRNA (Figure 3.9 C), while it was readily detectable in both CCR7
+
CCR9
-
CD69
+ 
and 
CCR7
+
CCR9
-
CD69
- 
SP4 subsets. Collectively these results indicate that Foxp3
+
 nTreg 
development is evident at the CD69
+
 stage in SP4 development, after CCR7 induction and 
loss of CCR9 expression, with the appearance of both nTreg and nTreg precursors 
populations first occurring during this maturational period. 
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3.3 DISCUSSION 
Positive selection is an essential checkpoint in intrathymic T cell development where DP 
thymocytes are induced to differentiate into mature SP thymocytes, committing to a CD4 or 
CD8 T cell fate. This multistep developmental process includes the relocalization of 
positively selected thymocytes from the cortex into the thymic medulla, a process thought to 
be essential for the establishment of central tolerance (Kurobe et al., 2006). Chemokines and 
their receptors have been implicated in cortex to medulla migration of positively selected 
thymocytes, as inhibition of the receptors results in the complete halt in SP migration into 
medullary regions (Ehrlich et al., 2009; Suzuki et al., 1999). CCR7 specifically has been 
identified as a major regulator in this relocalization process (Kwan and Killeen, 2004; Ueno et 
al., 2004), although it’s essential involvement in this migratory pathway is under some 
dispute (Davalos-Misslitz et al., 2007). Post-positive selection, SP thymocytes continue on 
with their development program, undergoing several phenotypical changes, classified by 
alterations to the surface expression profiles of several age defining markers, many of which 
have unknown functions, before their exit into the periphery as naive T cells (Jin et al., 2008). 
The studies within this chapter aimed to explore the chemokine receptor profile of thymocytes 
throughout the multiple stages of the positive selection process. We hoped this would offer 
greater insight into the receptors that may be driving this essential relocalisation step, whilst 
trying to use these functional molecules as phenotypical markers in the identification of 
different stages of SP development.  
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3.3.1 Classification Of Distinct SP Populations Based On Their Chemokine 
Receptor Expression Profiles 
The surface receptor expression patterns of CCR9, CCR7, CCR4 and CXCR4 were mapped 
throughout intrathymic T cell development, on pre-positive selection DP thymocytes, DP 
cells undergoing selection and post-selection CD4 and CD8 SP subsets. This analysis 
identified distinct stages of CD4 SP and CD8 SP thymocyte development, as well as nTreg, 
based upon their chemokine receptor expression profiles. A model for the developmental 
sequence of these newly classified SP populations is shown in Figure 3.10. This chemokine 
receptor classification system, therefore, enabled the substitution of commonly used age 
defining markers such as HSA and Qa2, with markers of known function within the 
intrathymic T cell development process. 
Within the conventional SP4 population, examination of the relationships between different 
chemokine receptors revealed three distinct subsets: CCR7
-
CCR9
+
CD69
+TCRβhighSP4, 
CCR7
+
CCR9
-
CD69
+TCRβhighSP4 and CCR7+CCR9-CD69-TCRβhighSP4. The proposed 
developmental sequence of the three individual cohorts was established via comparison of 
their expression levels of HSA, Qa2, CD62L and RAG-2 GFP. This model suggests the most 
immature, newly generated SP4 thymocytes that have recently undergone selection display a 
CCR7
-
CCR9
+
CD69
+ 
phenotype. With increased maturity cells downregulate CCR9 and 
upregulate CCR7 to reach an intermediate CCR7
+
CCR9
-
CD69
+
 stage, before down regulating 
CD69 and undergoing the transition into the most mature SP4 population, exhibiting a surface 
phenotype of CCR7
+
CCR9
-
CD69
-TCRβhighSP4. The maturational sequence of the three 
individual SP4 subsets was confirmed via the use of RTOC systems. Interestingly, this  
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Figure 3. 10 A Model Of The Developmental Sequence Of Conventional And 
Foxp3
+
 nTreg SP Thymocytes 
DP thymocytes pre-positive selection express high levels of CCR9 on their cell surface. 
On the initiation of selection, DP thymocytes rapidly upregulate CD69 whilst CCR7 
and CCR4 expression is induced within a fraction of cells at this developmental stage.  
Newly generated SP4 thymocytes express high levels of CD69, CCR9 and CCR4 but 
express only low CCR7 surface expression. At this phase of maturation SP4 
thymocytes maintain the ability to differentiate into the SP8 lineage. Those cells that 
commit to a SP4 lineage down regulate both CCR9 and CCR4 and upregulate CCR7, 
before the downregulation CD69 to reach their most mature intrathymic phenotype of 
CCR7
+
CCR9
-
CCR4
-
CD69
-TCRβhigh.  
At the intermediate CCR7
+
CCR9
-
CCR4
-
CD69
+
 stage of SP4 differentiation T-
regulatory precursors emerge, displaying a surface expression profile of CD25
+
Foxp3
-
CCR7
+
CD69
+
. These cells continue with their maturation to become 
CD25
+
Foxp3
+
CCR7
+
CD69
+
 before the down regulation of CD69 to reach their most 
mature nTreg phenotype of CD25
+
Foxp3
+
CCR7
+
CD69
-
.  
Those SP4 thymocytes still capable of differentiating into SP8 thymocytes have an 
immature phenotype expressing low levels of CCR7. With increasing maturity SP8 
increase their surface expression of CCR7 before downregulating CD69 to become 
mature SP8 thymocytes expressing high levels of both CCR9 and CCR7.  
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in vitro system also revealed the ability of the most immature CCR7
-
CCR9
+
CD69
+
SP4 to 
differentiate into both CD4 and CD8 SP lineages, a characteristic not shared by the more 
mature CCR7
+
CCR9
-
SP4 population. Thus, at the most immature SP4 stages in development, 
newly selected SP thymocytes have yet to commit to a specific SP lineage, which is fitting 
with lineage commitment models that suggest regardless of MHC class restriction, most 
thymocytes will initially downregulate CD8 to achieve a CD4
+
CD8
low 
transitional phenotype, 
before maturing into either a CD4
+
CD8
- 
or CD4
-
CD8
+
 SP thymocytes (He et al., 2010). 
Differences in the gene expression patterns of the three distinct SP4 populations offered 
additional confirmation to the phenotypical distinctions of the subsets. Considerable 
differences were detected between the mRNA expression levels of Rankl and Cd40lg, where 
both genes were highly expressed within the intermediate CCR7
+
CCR9
-
CD69
+
SP4
 
population, 
but showed differences within the additional two populations. Rankl mRNA was highly 
expressed in the immature CCR7
-
CCR9
+
CD69
+ 
SP4 population, whilst demonstrating low 
expression in the mature CCR7
+
CCR9
-
CD69
-
SP4 subset, in contrast to Cd40lg that displayed 
the opposite expression pattern. This mRNA expression pattern matched the surface 
expression difference of these ligands that had previously been detected by flow cytomotery 
(Desanti et al., 2012).  
With regard to the SP4 nTreg lineage, we identified the initial detection of both Foxp3
-
CD25
+ 
nTreg precursors and their Foxp3
+
CD25
+
 nTreg progeny within the intermediate 
CCR7
+
CCR9
-
CD69
+
SP4 population. The most mature CCR7
+
CCR9
-
CD69
-
SP4 subset, 
however, displayed a large number of nTreg, but no nTreg precursors were detectable at this 
late developmental stage. This was confirmed via intracellular staining of Foxp3 via flow 
cytometry analysis and Foxp3 mRNA levels within the different populations.  Collectively, 
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this data suggest that branching point for nTreg differentiation from selected conventional 
SP4 thymocytes occurs at an intermediate stage in maturity, when cells have downregulated 
CCR9, but are expressing high levels of CCR7 and have fully committed to a CD4 SP lineage.  
The analysis of CCR7 and CCR9 expression patterns of the SP8 population also suggested 
heterogeneity within this thymocyte lineage. Although SP8 subsets were not as distinct as 
those identified in the SP4 lineage, a ‘tail’ for CCR7 expression could be detected with in the 
immature CD69
+ 
SP8 fraction. The maturational status of the three identified 
CCR9
+
CCR7
low
CD69
+
, CCR9
+
CCR7
+
CD69
+
 and CCR9
+
CCR7
+
CD69- SP8 populations was 
explored via flow cytometry analysis of HSA, Qa2, CD62L and RAG-2 GFP. The results 
suggested newly generated SP8 thymocytes express only low levels of CCR7 on their cell 
surface, which they upregulated during their early maturation, resulting in a CCR9
+
CCR7
+
 
profile, which they maintain throughout their remaining intrathymic differentiation program.  
The use of RAG-2 GFP transgenic mice has been an extremely beneficial tool in the 
identification of the maturational status of SP thymocytes. Interestingly, while identifying SP 
thymocyte subsets expressing progressively lower levels of RAG-2 GFP, analysis also 
indentified a subset of SP4 cells, particularly within the CD69
-
CCR7
+
CCR9
-
 subset, that 
entirely lacked RAG-2 GFP expression. At this stage it is not clear whether these cells 
represent peripheral T cells that have recirculated back to the thymus, or SP thymocytes that 
have persisted intrathymically and hence lost detectable RAG-2 GFP expression levels 
(McCaughtry et al., 2007).  
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3.3.2  The Role Of Chemokine Receptors In Positive Selection And Cortex 
To Medulla Migration 
The examination of chemokine receptors changes during multiple stages of intrathymic T cell 
development raises the possibility that cortex-to-medulla migration involves multiple 
chemokine/chemokine receptors. The comparison of chemokine receptor expression patterns 
pre-positive selection and cells undergoing the selection process revealed the initiation of the 
selection stimulates CCR4 and CCR7 induction, whilst initiating CXCR4 downregulation. 
CCR4 induction occurs within just under half the thymocyte population undergoing this 
selection process, whilst upregulation of CCR7 is estimated to be limited to only 20% of this 
subset. Complimentary to the flow cytometry data, Ccr7 mRNA levels within the DP 
population are at almost undetectable rates and considerably reduced in comparison to the 
Ccr4 mRNA levels within the same population. As CCR7 is the main chemokine thought to 
mediate the relocation of thymocytes into the thymic medulla on the initiation of positive 
selection, it is surprisingly that only a small fraction of the cells undergoing the selection 
process express this chemokine receptor on their cell surface. This finding is consistent with 
previous data (Davalos-Misslitz et al., 2007) and questions the dominant role of CCR7 in 
mediating cortex to medulla migration, following the initiation of positive selection. The rapid 
down regulation of CXCR4 on initiation of selection and its total absence on the cell surface 
of both SP4 and SP8 throughout their developmental suggests this receptor could have a 
possible role in cortex retention, maintaining DP thymocytes positioning within cortical 
regions pre-selection. Interestingly, CXCR4 and its ligand CXCL12 have been identified to 
play a role in retention of immature DP human thymocytes within cortical regions, adding 
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additional support to our suggested role for this receptor within the mouse thymic 
microenvironment (Halkias et al., 2013).   
The chemokine receptor profile of SP4 thymocytes offers additional doubt to the role of 
CCR7 in the migration of positively selected cells. The suggested sequence of development of 
SP4 thymocytes implies the most immature SP4 thymocytes, recently to have undergone 
positive selection, express CCR9 and CCR4, but importantly lack CCR7, which is not 
acquired until later stages in SP4 development. The gene expression profiles of known 
regulators of late stage intrathymic T cell development within these three distinct SP4 
population further verified CCR7 upregulation is a later stage event of SP4 development. 
Both the intermediate CCR7
+
CCR9
-
CD69
+
SP4
 
and the most mature CCR7
+
CCR9
-
CD69
-
SP4 
subsets display a mature developmental phenotype based upon their high levels of mRNA for 
Foxo1 and Klf2 expression, compared to very low mRNA levels within the immature CCR7
-
CCR9
+
CD69
+ 
SP4 fraction. Interestingly, the expression pattern of CCR7 on SP8 thymocytes 
differs to that of SP4 thymocytes. Although we predict the newly generated SP8 cells express 
lower levels of CCR7, the receptor is not totally absent on the cell surface and only a very 
small fraction of CD69
+
 SP8 cells display this low level CCR7 phenotype. Thus, we would 
predict the increase in expression of CCR7 occurs at a very early SP8 maturational stage. We, 
therefore, cannot speculate CCR7 is not involved in cortex to medulla migration of SP8 
thymocytes based on its surface expression pattern of cells committed to this lineage.  
Interestingly, CCR7 upregulation has been linked to CD8 lineage commitment. It has been 
reported that MHC Class I mediated positive selection leads to CCR7 upregulation on DP 
thymocytes and the enforced over expression of CCR7 has been demonstrated to increase 
CD8 SP development (Yin et al., 2007). Therefore it is a possibility the small fraction of 
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CCR7
+
CD69
+
DP are destined for a CD8 SP cell fate and migrate from the cortex to the 
medulla under the control of this receptor, down a gradient of CCR7 ligands. This would offer 
an explanation as to why deficiencies in CCR7 signaling results in more severe defects in SP8 
medullary numbers in comparison to SP4 thymocytes (Davalos-Misslitz et al., 2007; Nitta et 
al., 2009).  
Regardless of the role of CCR7 in directing SP8 migration, the low induction level of CCR7 
on the initiation of positive selection and the absence of the receptor on newly generated SP4 
thymocytes raises the possibility that other chemokine receptors are also involved in the 
cortex to medulla migration of MHC class II restricted cells. This offers an explanation to the 
phenotypical effects observed within CCR7 deficient hosts, with reduced, but not absent SP 
thymocytes within thymic medullary areas (Nitta et al., 2009; Ueno et al., 2004). The data 
also compliments previously published data that suggests no significant reductions are 
detectable in SP4 cell numbers as a consequence of CCR7 deficiency, but alternatively 
suggest this chemokine receptor is involved in negative selection of SP thymocytes (Davalos-
Misslitz et al., 2007). 
A very attractive alternative chemokine receptor to be involved in cortex to medulla migration 
of positively selected thymocytes, highlighted through our investigations, is CCR4. Although 
CCR4 is not upregulated on the surface of all CD69
+ 
DP thymocytes undergoing the selection 
process, the rapid induction of CCR4 on the initiation of positive selection within close to half 
the population and the detectable levels of Ccr4 mRNA within the DP thymocytes population, 
would highlight this receptor as a strong candidate. CCR4 surface expression, post-positive 
selection, is restricted to thymocytes committed to a CD4 SP lineage, sustained on only 
immature CD4 SP and downregulated with increased maturity. Moreover, CCR4 ligands 
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including CCL17 demonstrate high gene expression patterns within both the mTEC 
populations (Griffith et al., 2009) and the thymic DC cell subsets (Lieberam and Forster, 
1999).  Currently, the intrathymic role of CCR4 is not well understood.  It has been 
demonstrated that on initiation of positive selection CD69
+ 
DP thymocytes become responsive 
to CCL22, which is maintained with the most immature CD4 SP population (CD69
+
 CD62L
-
), 
but disappears, however, at the latest stages of CD4 SP development (CD69
-
 CD62L
+
) 
(Campbell et al., 1999). Complementary to this data, Ccr4 mRNA levels have also been 
identified to be upregulated with CD69
+
DP and immature CD69
+
 CD4 SP thymocytes subsets 
(Campbell et al., 1999; Suzuki et al., 1999), strengthening the hypothesis CCR4 and its 
ligands are involved in the repositioning of positively selected thymocytes into medullary 
areas. While CCR4 deficient mice have been generated, analysis has specifically focused on 
the role of CCR4 in the context of peripheral Th2 CD4 T cells (Chvatchko et al., 2000). The 
consequence of the removal of CCR4 signaling on intrathymic T cell development remains to 
be confirmed. In view of this the major aim of Chapter 5 is to analysis the potential 
involvement of CCR4 in cortex to medulla migration of positively selected cells.   
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CHAPTER 4: THE THYMIC MEDULLA IS REQUIRED FOR 
FOXP3+ REGULATORY, BUT NOT CONVENTIONAL SP4 OR 
SP8 THYMOCYTE DEVELOPMENT. 
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4.1 INTRODUCTION 
Within both primary and secondary lymphoid tissues, anatomical compartmentalization 
provides functionally distinct microenvironments that support the generation, selection and 
function of T cells expressing the cell receptor. In the thymus, the cortex supports the 
generation of immature CD4
+
8
+
 thymocytes expressing a diverse repertoire of TCR 
specificities. Interactions with cortical thymic epithelial cells (cTEC) trigger the positive 
selection of those thymocytes capable of recognizing self-peptide/MHC at low avidity/affinity 
(Laufer et al., 1996), a process characterized by upregulation of the αβTCR and CD69 (Hare 
et al., 1999; Yamashita et al., 1993). Importantly, positive selection also induces changes in 
thymocyte chemokine receptor expression, which enables the accumulation of newly selected 
CD4
+
8
-
 and CD4
-
8
+
 TCRhigh cells in the thymic medulla (Campbell et al., 1999). Tolerance 
induction occurs within thymic medullary regions, a process involving both DC and mTEC, 
including the subset defined by Aire expression. While negative selection of potentially 
autoreactive thymocytes occurring through the induction of programmed cell death represents 
a key function of the thymus medulla (Xing and Hogquist, 2012), this site has also long been 
thought to be important in supporting further maturation of SP4 and SP8 thymocytes 
following initial positive selection in the cortex. Indeed, many studies have highlighted how 
maturation markers such as Qa2, HSA, CD62L are acquired and lost during SP thymocyte 
maturation (Gabor et al., 1997a; Kelly and Scollay, 1990; Lucas et al., 1994), while our own 
data in Chapter 3 has shown how changes in chemokine receptor expression can be used to 
monitor the maturational state of SP thymocytes.  
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The length of time that SP thymocytes spend within the thymic medulla is not fully clear. 
Initial estimates suggested that medullary dwell time could be as long as 14 days (Scollay and 
Godfrey, 1995), consistent with the notion that prolonged interactions with medullary stromal 
cells are important during SP thymocyte maturation. In agreement with this, the progression 
of SP4 cells through distinct intrathymic developmental stages defined by downregulation of 
CD24/CD69 and acquisition of CD62L/Qa2 is altered in the absence of normal development 
of the thymic medulla (Li et al., 2007). However, using RAG-2 GFP mice it has been 
suggested that following positive selection, SP4 and SP8 thymocyte medullary residency may 
be much shorter than previously thought, with cells having an average dwell of 4-5 days, 
which results in an ordered ‘conveyor belt’ style emigration process (McCaughtry et al., 
2007). 
In addition to conventional αβTCRhigh SP4 thymocytes, medullary regions of the thymus 
contain SP4 thymocytes expressing the transcription factor Foxp3. These Foxp3
+
 natural 
regulatory T cells (nTreg) have important regulatory roles and aid in the control of unwanted 
T cell autoreactivity (Sakaguchi et al., 1995). However, the developmental requirements of 
this specific SP4 subset remain unclear, in particular the involvement of the thymic medulla. 
While some studies have suggested a specific role for mTEC in the intrathymic generation of 
Foxp3
+
 nTreg (Aschenbrenner et al., 2007; Hinterberger et al., 2010), other studies 
demonstrate a role for thymic dendritic cells (Proietto et al., 2008b; Spence and Green, 2008; 
Watanabe et al., 2005a; Wirnsberger et al., 2009). Recently, it has also been reported that 
nTreg development in the thymus is a multi-stage process (Lio and Hsieh, 2011; Wirnsberger 
et al., 2011) in which signaling mediated via TCR-MHC (Lio and Hsieh, 2008) and CD28-
CD80/86 (Hinterberger et al., 2011; Lio et al., 2010; Vang et al., 2010) interactions results in 
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the generation of Foxp3
-
CD25
+
 nTreg precursors. This precursor population gives rise to 
Foxp3
+
CD25
+
 nTreg in a process that is independent of further TCR-mediated interactions, 
but instead requires continued IL-2, IL-7 or IL-15 cytokine signaling (Burchill et al., 2008; 
Lio and Hsieh, 2008). However, the potential for mTEC involvement during the generation of 
Foxp3
-
CD25
+
 nTreg precursors is unestablished.  
Given the heterogeneity within SP4 and SP8 thymocytes post-positive selection, the finding 
that SP thymocytes spend upwards of 4 days within the thymic medulla and the known links 
between nTreg and mTEC, the main aim of this chapter is to map the requirements for 
medullary thymic epithelial cell microenvironments during the continued development of 
both conventional and nTreg SP4 cells following positive selection. To study this, we 
exploited the well-known and severe mTEC defect that occurs in Relb
-/- 
mice and combined 
this with thymus transplantation into WT adult mice, to study the consequences of mTEC 
deficiency in the presence of an otherwise intact immune system. 
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4.2 RESULTS 
4.2.1 An in vivo Model To Study T Cell Development In The Selective 
Absence Of mTEC 
Recent studies have suggested a correlation between defective thymic medullary 
compartments and the generation of the most mature CD69
-
Qa2
+
 SP4 thymocyte subset (Li et 
al., 2007). This relationship has been explored within Relb
-/-
 mice, which present with an 
absence of medullary areas, caused by a severe blockade in development of their mTEC 
compartment (Burkly et al., 1995; Weih et al., 1995) and interestingly a lack of late stage SP4 
thymocytes (Li et al., 2007)(also confirmed in Figure 4.3A).  This multistep SP4 
developmental program was reportedly critically dependent not only on mTEC, but also 
expression of Aire, as Aire
-/- 
mice were found to have the same severe block in the transition 
from immature CD69
+
Qa2
-
 to mature CD69
-
Qa2
+
 SP4 thymocytes (Li et al., 2007). The 
effects of RelB deficiency, however, are not exclusive to mTEC development and Relb
-/-
 mice 
present with dramatic multi-organ autoimmunity as a consequence of numerous severe 
defects, including reduced frequencies of thymic DC and failed lymph nodes organogenesis 
(Burkly et al., 1995; Weih et al., 1995; Wu et al., 1998). Therefore, although the absence of 
the mature SP4 subset within the adult Relb
-/- 
mouse suggests that the completion of SP4 
thymocyte development requires signals from mature mTEC, detailed analysis of the possible 
role of mTEC during SP thymocyte development in Relb
-/-
 mice is confounded by the 
complex phenotype of these mice.  
In order to isolate and define the potential role of mTEC in the maturation of SP4 thymocytes, 
we transplanted alymphoid 2-dGuo treated FTOC from either E15 Relb
-/-
 or WT (litter mate 
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control) embryos, under the kidney capsule of background matched un-manipulated C57BL/6 
mice (Rossi et al., 2007b) (model illustrated in Figure 4.1). The confocal analysis of WT and 
Relb
-/-
 TEC grafts (Figure 4.2 A) confirmed a severe defect within the mTEC compartment 
within the latter, with a total absence of ERTR5
+
 areas compared to their WT counterparts 
(Figure 4.2A). This data is consistent with a cell autonomous role for RelB in mTEC 
development and its role in the alternative NF-kB signaling pathway activated by the 
TNFRSF members RANK, CD40 and LTR, all of which are linked to mTEC development 
(Mouri et al., 2011). Importantly, as described previously (Zhang et al., 2007), the 
transplantation of Relb
-/- 
2dGuo thymic grafts into T-lymphopaenic nude hosts presented with 
symptoms of autoimmunity (Figure 4.2). Interestingly, in marked contrast, Relb
-/-
 TEC 
transplantation into a WT host did not induce detectable autoimmunity, with host mice 
displaying no signs of disease in accordance to home office regulations, including no recorded 
weight lost (Figure 4.2 B), up to 12 weeks post surgery. Moreover, nude hosts receiving Relb
-
/- 
2dGuo grafts had to be culled due to sickness 5 to 8 weeks post transplantation. Nude hosts 
presented with significant weight loss (Figure 4.2 B), detectable autoantibodies within blood 
serum samples and tissue infiltrates within liver sections (Figure 4.2 C). Analysis of 
peripheral CD4 T cells also revealed an increased percentage of CD44
+
 CD62L
-
 effector 
memory cells recovered from nude host receiving Relb
-/-
 TEC grafts compared to their WT 
counterparts and increased IFNγ production by these peripheral CD4 T cells (Figure 4.2 D).  
Collectively Figure 4.2 demonstrates that Relb
-/-
 TEC grafts display major disruption to the 
development of medullary epithelial cell compartment, which triggers a severe autoimmunity  
 
  
 158 
 
 
 
Figure 4. 1 A Schematic View Of The Model Used To Explore The Impact Of 
mTEC Deficiency In The Absence Of Autoimmunity 
(A) Relb
-/-
 adult mice display an mTEC deficient thymic mircoenvironments. RelB 
deficiency also, however, results in additional severe phenotypical defects such as a 
reduced population of thymic dendritic cells, lack of lymph node formation and 
consequently multi-organ autoimmunity.  
(B) We developed a model system where we grafted E15 2-dGuo treated Relb
-/- 
FTOC 
under the kidney of a un-manipulated WT C57BL/6 host, 6 to 8 weeks in age. We 
sacrificed the host and harvested the grafts 6-12 weeks post transplantation and 
explored T cell development within the RelB-dependent mTEC deficient thymic 
microenvironment, via flow cytometry analysis or confocal microscopy.
  
 159 
  
 160 
  
  
 161 
Figure 4. 2 The Grafting Of A RelB Dependent mTEC Deficient Thymic 
Microenvironment Into An Athymic Host Induces Autoimmunity 
E15 Relb
-/- 
or WT (littermate controls) 2-dGuo treated FTOC were grafted under the 
kidney capsule of a WT C57BL/6 adult host (A and B) or a nude adult host (B, C and 
D) 6- 8 weeks in age. The grafts were then harvest 6-12 weeks post surgery for 
confocal and FACS analysis. (A) WT (left) and Relb
-/- 
(right) grafts were frozen for 
immunoflorescence staining. 7μm sections were cut and stained for β5t and ERTR5. C 
denotes cortex, and M denotes medulla. The bars per condition (WT or Relb
-/- 
) on the 
left represent 200μm and on the  right represent 100μm.  
(B) Weight (g) per mouse of each host before grafting (white bars) and on day of 
sacrifice (gray bars) for WT or Relb
-/- 
grafts into either WT hosts (left) or nude hosts 
(right). Data is displayed as mean bar graphs, where error bars represent the SEM.  
Assessment of autoimmunity was performed in nude hosts receiving WT or Relb
-/-
 
grafts (C and D). (C top) The presence of autoantibodies in blood serum from nude 
mice (top) receiving WT (left) or Relb
-/- 
(right) TEC grafts was analyzed on sections of 
composite tissue blocks containing stomach and liver, and detected with goat anti–
mouse IgG FITC, and counterstained with DAPI. (C bottom) Lymphocytic infiltrates 
(black arrows) were detected by histological analysis of Haematoxylin & Eosin 
stained paraffin wax liver sections from the same mice. Bars represent 100μm. (D) 
Lymph node CD4 T cells were recovered from the nude host receiving WT (top) or 
Relb
-/- 
TEC
 
grafts (bottom) and antibody labeled for flow cytometric analysis. LN cells 
were gated on CD3
+ 
CD4 T cells and analyzed for CD44 versus CD62L expression 
(left), along with intracellular IFNγ. 
All data is typical of at least three experimental replicates. 
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phenotype when grafted into a T-lymphopaenic nude hosts, but has no detected effects when 
placed under the kidney of a WT host. Therefore grafting un-manipulated WT host with grafts 
harboring this cell intrinsic RelB-dependent mTEC deficiency provides a model to investigate 
the role of mTEC during T cell development in the absence of other compounding factors, 
such as autoimmunity.  
4.2.2 Conventional SP4 And SP8 Thymocytes Can Develop Independently 
Of Medullary Epithelial Cell Support  
Analysis of conventional SP4 development within the Relb
-/- 
TEC grafts within
 
a WT host 
revealed the presence of both immature CD69
+
Qa2
-
 and mature CD69
- 
Qa2
+
 TCRβhigh SP4 
fractions, at similar proportions to those present within a WT grafts (Figure 4.3 B). The block 
in SP4 maturation at this development stage observed within the Relb
-/-
 adult (Figure 4.3 A), 
therefore, has been restored within mTEC deficient thymus grafts. Both the percentages and 
absolute numbers of the thymocytes recovered from either WT TEC grafts or Relb
-/- 
TEC 
grafts displayed comparable rates within the total SP4 population, immature CD69
+
 Qa2
- 
TCRβhigh SP4 fractions and mature CD69- Qa2+ TCRβhigh SP4 subsets, with no significant 
alterations observed within any of these three populations (Figure 4.3 C). Therefore 
conventional SP4 thymocyte development can occur independently of mTEC interactions 
within a Relb
-/-
 mTEC deficient microenvironment, in the absence of other compounding 
factors that may be present within a Relb
-/- 
adult that could effect SP4 maturation.  
The development of conventional SP8 thymocytes was also explored within the same Relb
-/- 
or WT TEC grafts transferred into a WT host (Figure 4.4). Relb
-/-
 adult mice displayed 
disrupted development of CD69
- 
Qa2
+
 TCRβhigh SP8 thymocytes, in comparison to the WT  
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Figure 4. 3 Grafting Of An mTEC Deficient Thymic Microenvironment Into A 
WT Host Restores Conventional SP4 T Cell Development 
(A) Thymocytes from adult Relb
-/-
 (bottom) or WT C57BL/6 (top), 5 weeks in age 
were isolated and stained for flow cytometry analysis. The Qa2 and CD69 expression 
was explored within the TCRβhigh SP4 fraction of cells and represented as contour 
FACS plots. (B) The same expression patterns for Qa2 and CD69 were explored 
within the TCRβhigh SP4 fraction of thymocytes recovered from WT (top panel) and 
Relb
-/-
 (bottom panel) TEC grafts into WT hosts. 
(C) The percentages (top) and absolute numbers (AN) (bottom) of three thymocyte 
subsets: total SP4 thymocytes, CD69
+
 Qa2
- TCRβhigh SP4 and CD69- Qa2+ TCRβhigh 
SP4, were calculated and displayed as bar graphs. Each bar graph represents the mean 
percentage or AN of thymocyte subsets recovered from either WT TEC grafts (white 
bars) or Relb
-/-
 TEC grafts (gray bars) into WT host from a minimum of 5 individual 
grafts per conditions. The standard error bars display the SEM, and a student’s two 
tailed unpaired T test was performed on all results, where ns denoted a non-significant 
difference as P > 0.05.  
 
 
  
 166 
  
 167 
  
  
 168 
controls. This mature SP8 population was not as severely disrupted as the conventional CD69
- 
Qa2
+
 TCRβhigh SP4 fraction of cells detected within this deficient adult thymic 
microenvironment (Figure 4.4 A). The disrupted development of mature CD69
- 
Qa2
+
 
TCRβhigh SP8 thymocytes was restored, however, within the Relb-/- TEC graft transplanted into 
a WT host. The percentages of both the immature CD69
+ 
Qa2
-
 TCRβhigh SP8 and mature 
CD69
- 
Qa2
+
 TCRβhigh SP8 were at equal levels within both the WT and Relb-/- grafts (Figure 
4.4 B and C). Interestingly, however, both the percentages and absolute numbers of the total 
SP8 population was reduced within the Relb
-/- 
grafts, in comparison to the SP8 population 
recovered from WT grafts. This significant reduction to total SP8 numbers consequently 
resulted in a significant reduction to the absolute numbers of both the immature CD69
+ 
Qa2
-
 
TCRβhigh SP8 and mature CD69- Qa2+ TCRβhigh SP8 fractions, in comparison to WT control 
grafts, even though the percentages of these two cohorts were comparable between the two 
conditions (Figure 4.4C). Collectively, Figure 4.4 suggests that conventional SP8 thymocytes 
can progress to the mature CD69
- 
Qa2
+
 TCRβhigh stage of development within an mTEC 
deficient thymus microenvironment. However, these results also imply the maintenance, or 
perhaps efficacy of development, of thymocytes restricted to SP8 lineage is influenced by 
mTEC, as deficiency in RelB-dependent mTEC results in overall reductions to the numbers of 
MHC class I restricted thymocytes.     
Importantly, we wanted to confirm those mature CD69
- 
Qa2
+
 SP4 and SP8 cells recovered 
from the Relb
-/- 
grafts were intrathymically generated from within the grafted 
microenvironment and did not represent host peripheral CD4 or CD8 T cells circulating into 
the mTEC deficient thymic compartments. We therefore explored the surface expression 
patterns of CD44, Qa2 and HSA, as the reported phenotype of peripheral T cells homing back  
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Figure 4. 4 Grafting Of An mTEC Deficient Thymic Microenvironment Into An 
WT Host Restores Conventional SP8 T Cell Development 
(A) Thymocytes from adult Relb
-/-
 (bottom) or WT C57BL/6 (top), 5 weeks in age 
were isolated and stained for flow cytometry analysis. The Qa2 and CD69 expression 
was explored within the TCRβhigh SP8 fraction of cells and represented as contour 
FACS plots. (B) The same expression patterns for Qa2 and CD69 were explored 
within the TCRβhigh SP8 fraction of thymocytes recovered from WT (top) and Relb-/- 
(bottom) TEC grafts into WT hosts. 
(C) The percentages (top) and AN (bottom) of three thymocyte subsets: total SP8 
thymocytes, CD69
+
 Qa2
-
 TCRβhigh SP8 and CD69- Qa2+ TCRβhigh SP8, were 
calculated and displayed as bar graphs. Each bar graph represents the mean percentage 
or AN of thymocyte subsets recovered from either WT TEC grafts (white bars) or 
Relb
-/-
 TEC grafts (gray bars) into WT hosts, from a minimum of 5 individual grafts 
per condition. The standard error bars display the SEM, and an student’s two tailed 
unpaired T test was performed on all results, where ns denoted a non-significant 
difference as P > 0.05 and * or ** indicate a significant difference (* = P < 0.05 and 
** = P < 0.01). 
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to thymus has been shown to be HSA
-
 Qa2
hi
 CD44
+
 SP cells (Hale and Fink, 2009). In 
contrast to this recirculating T cell phenotype, the vast majority of both the TCRβhigh SP4 and 
SP8 subsets obtained from both WT and TEC Relb
-/-
 grafts were CD44
low 
(Figure 4.5 A, B 
and 4.6 A, B). In fact, Relb
-/-
 TEC grafts contained fewer Qa2
hi
 CD44
+
 and HSA
-
 CD44
+
 
thymocytes, compared to WT grafts. This reduction was significant between both the 
percentage and absolute number of SP4 and SP8 resident populations of the Relb
-/-
 grafts 
compared to WT controls (Figure 4.5 B and 4.6 B). Therefore this data would imply those 
mature CD69
- 
Qa2
+
 TCRβhigh SP4 and SP8 thymocytes detected within the RelB-dependent 
mTEC deficient grafts are intrathymically generated within the grafted thymic 
microenvironment and have not migrated in from the hosts periphery.  
To obtain further support for this conclusion, we also grafted Relb
-/-
 and WT 2-dGuo FTOC 
under the kidney capsule of RAG-2 GFP reporter mice and explored the GFP levels of SP4 
and SP8 present within the grafted thymic microenvironment. Although it is yet to be 
confirmed if the RAG-2 GFP
-
 proportions of SP thymocytes detected within the thymus of 
these report mice represent recirculating peripheral T cells or thymocytes retained with the 
thymus for long periods (Hale and Fink, 2009; McCaughtry et al., 2007), we were interested 
to explored the GFP
-/low 
populations of SP cells detected within the WT and Relb
-/-
 TEC grafts. 
Most of the SP4 (Figure 4.5C) and SP8 (Figure 4.6C) thymocyte cohorts recovered from the 
Relb
-/- 
TEC grafts were RAG-2 GFP
+
 and displayed close to equal levels of GFP expression in 
comparison to those SP thymocytes obtained from WT grafts, providing further evidence that 
these cells are intrathymically produced and not recirculating RAG-2 GFP
-
 peripheral T cells. 
Within the SP4 population, the fraction of GFP
+
 cells within the Relb
-/- 
grafts were actually 
higher than those observed within WT grafts. The mean fluorescence intensities (MFI) of Qa2  
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Figure 4. 5 Mature CD69
- 
Qa2
+
 SP4 Thymocytes Present Within mTEC Deficient 
Grafts Are Not Recirculating Host Peripheral T Lymphocytes 
(A) Thymocytes recovered from WT (top) and Relb
-/-
 (bottom) TEC grafts into WT 
hosts were isolated and stained for flow cytometric analysis. CD44 expression against 
HSA (left) or Qa2 (right) was determined within the TCRβhigh SP4 fraction of cells 
and represented as contour FACS plots. 
(B) The percentages and AN of both TCRβhigh SP4 populations: CD44+ HSA- and 
Qa2
+
 CD44
+
 subsets, were calculated from WT TEC grafts (white bars) and Relb
-/-
 
TEC grafts (gray bars) into WT hosts and displayed as mean bar graphs, representing 
at least 5 separate grafts per condition. The standard error bars indicate the SEM, and a 
student’s two tailed unpaired T test was performed on all results, where *** denoted a 
highly significant difference, as P < 0.001. 
(C) The RAG-2 GFP levels of expression was analyzed within the TCRβhigh SP4 
subset of thymocytes obtained from either WT TEC grafts (top) and Relb
-/-
 TEC grafts 
(bottom), transplanted into RAG-2 GFP adult hosts. CD4 versus CD8 profiles are 
displayed as contour plots whilst RAG-2 GFP expression levels are represented as a 
histogram. The data is typical of two independent experiments repeats per condition.  
(D) The mean fluorescence intensity (MFI) of Qa2 expression in CD69
- TCRβhigh SP4 
thymocyte population recovered from WT TEC grafts (white bars) or Relb
-/- 
TEC 
grafts (grey bars) into WT hosts are presented along side WT CD4
+
 splenocytes 
(striped bars). Data is displayed as mean bars graphs, representative of at least 5 
individual grafts per condition. The standard error bars denote the SEM and a 
student’s two tailed unpaired T test was performed on the results, where ns denoted a 
non-significant difference (P > 0.05) and *** denoted a highly significant difference 
(P < 0.001). 
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Figure 4. 6 Mature CD69
- 
Qa2
+
 SP8 Thymocytes Present Within mTEC Deficient 
Grafts Are Not Recirculating Host Peripheral T Lymphocytes 
(A) Thymocytes recovered from WT (top) and Relb
-/-
 (bottom) TEC grafts into WT 
hosts were isolated and stained for flow cytometry analysis. CD44 expression against 
HSA (left) or Qa2 (right) was explored within the TCRβhigh SP8 fraction of cells and 
represented as contour FACS plots. 
(B) The percentages and AN of both TCRβhigh SP8 populations: CD44+ HSA- and 
Qa2
+
 CD44
+
 subsets, were calculated from WT TEC grafts (white bars) and Relb
-/-
 
TEC grafts (gray bars) into WT hosts and displayed as a mean bar graph, representing 
at least 5 individual grafts per condition. The standard error bars indicate the SEM, 
and a student’s two tailed unpaired T test was performed on all results, where * or ** 
indicate a significant difference (* = P < 0.05 and ** = P < 0.01). 
(C) GFP levels of expression was explored within the TCRβhigh SP8 subsets of 
thymocytes obtained from WT TEC grafts (top) and Relb
-/-
 TEC grafts (bottom), 
transplanted into RAG-2 GFP adult hosts. CD4 versus CD8 profiles are displayed as 
contour plots whilst RAG-2 GFP expression levels are represented as a histogram. The 
data is typical of two independent experiments repeats per condition.  
(D) The mean fluorescence intensity (MFI) of Qa2 expression within the CD69
-
TCRβhigh SP8 thymocyte population recovered from WT TEC grafts (white bars) or 
Relb
-/- 
TEC grafts (grey bars) into WT hosts are presented alongside WT CD8
+
 
splenocytes (striped bars). Data is displayed as mean bars graphs, representative of at 
least 5 individual grafts per condition. The standard error bars denote the SEM and a 
student’s two tailed unpaired T test was performed on the results, where ns denoted a 
non-significant difference (P > 0.05) and ** denotes a significant difference (P < 0.01). 
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within the CD69
-
 fraction of TCRβhigh SP4 (Figure 4.5 D) and TCRβhigh SP8 subsets (Figure 
4.6 D) obtained from WT and Relb
-/-
 grafts were also investigated, as peripheral T cells 
demonstrate increased Qa2 levels in comparison to mature CD69
- 
Qa2
+
 TCRβhigh SP 
thymocytes (Boursalian et al., 2004). Consistent with the data described above, the CD69
-
 
TCRβhigh SP4 and SP8 thymocytes recovered from the Relb-/- grafts displayed equal Qa2 MFI 
levels to the equivalent thymocyte population obtained from WT grafts, whilst mature CD69
-
 
TCRβhigh SP4 and SP8 thymocytes from both WT and Relb-/- TEC grafts had significantly 
lower Qa2 MFI levels in comparison to peripheral CD4 and CD8 T cells.        
Collectively, Figures 4.5 and 4.6 summaries three independent experimental approaches to 
demonstrate that the mature SP4 and SP8 populations detected within the RelB-dependent 
mTEC deficient microenvironment have been generated intrathymically within the grafted 
microenvironment and do not represent a cohort of recirculating T cells migrating in from the 
periphery of the host. 
4.2.3 Conventional CD4 SP Thymocytes Can Develop Extrathymically, 
From The Time They First Emerge As Immature CCR9
+
CCR7
-
CD69
+
 Cells 
To further explore the dependence of newly selected SP4 cells on medullary support for their 
continued maturation we investigated the ability of these cells to survive and mature 
extrathymically. Whilst recent thymic emigrants (RTE) have been shown to complete their 
maturation extrathymically (Boursalian et al., 2004) it is not known how far back in 
development this window of thymic independence extends, particularly in relation to the post-
positive selection stages of SP differentiation.  To investigate this, we explored the 
extrathymic development of the least mature CD4 SP thymocytes, based on the criteria 
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defined in Chapter 3, ie. cells of a CCR7
-
CCR9
+
CD69
+
 immature TCRβhigh SP4 surface 
phenotype. Using the experimental approach described in Figure 4.7 A, CCR9
+
CCR7
-
CD69
+
 
SP4 thymocytes, which also express a HSA
high
CD62L
low
Qa2
-
CD69
+
 phenotype (Figure 4.8 B 
‘input population’) were isolated from adult CD45.2+ C57BL/6 mice and intravenously 
injected into congenic CD45.1
+ 
C57BL/6 hosts. Analysis of lymph node and splenic 
lymphocyte preparations from mice sacrificed 7 days later showed that injected donor 
CD45.2
+ 
cells had remained as SP4 cells within the host peripheral lymphoid tissue (Figure 
4.8 A). Closer examination of the maturational status of this persisting SP4 thymocyte 
population recovered from the host LN and spleen revealed the input population had 
undergone extrathymic maturation (Figure 4.8 B). Thus, when compared to the surface 
phenotype of CD45.1
+ 
host peripheral CD4 T cells (black line), the donor CD45.2
+ 
populations (red line) had acquired a corresponding HSA
low
CD62L
high
Qa2
high 
CD69L
low
 
phenotype.  Thus, the data obtained confirms conventional CD4 SP development can occur 
independently of thymic support from the time these cells first emerge as CCR9
+
CCR7
-
CD69
+
 TCRβhigh SP4 thymocytes. Therefore, these results identify a window of thymic 
independence within the T cell developmental process, which extends as far back as the 
earliest stages of SP4 thymocyte development following positive selection.  
Additionally, we were interested in providing a comparative analysis of extrathymic 
maturation of CCR9
+
CCR7
-
CD69
+TCRβhigh SP4 thymocytes in relation to other thymocyte 
subsets; either the less mature CD4
+
 CD8
+
 DP cell fraction or the more mature CCR9
-
CCR7
+
CD69
-TCRβhigh SP4 fraction. By using the experimental techniques described in 
Figure 4.7 B and C, immature CCR9
+
CCR7
-
CD69
+TCRβhigh SP4 cells were isolated from 
CD45.1
+
 WT donors and co-injected into CD45.1
+
 x CD45.2
+
 WT hosts at a 1:1 ratio with  
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Figure 4. 7 Experimental Approaches To Explore Extrathymic Maturation Of 
Conventional SP4 Thymoyctes 
(A) CCR7
-
CCR9
+
CD69
+TCRβhigh SP4 thymocytes were isolated via high speed cell 
sorting from a CD45.2
+
 WT adult donor and intravenously (IV) transferred into a 
CD45.1
+
 WT adult host. Purity checks were performed on isolated cell populations 
and are displayed as FACS contour plots (left), displaying the CD4 versus CD8 profile 
then the CD4 SP population for the expression of CCR9 versus CD69. 7 days post IV 
transfer, CD45.1
+ 
hosts were sacrificed and total LN or spleen analyzed separately by 
flow cytometry for the presence and maturation status of CD45.2
+
 donor cells. 
 
(B and C) An identical CCR7
-
CCR9
+
CD69
+
TCRβhigh SP4 thymocyte subset was 
isolated via high speed cell sorting from a CD45.1
+
 donor and mixed at a one to one 
ratio with either CCR7
+
CCR9
-
CD69
-TCRβhigh SP4 cells (B) or DP thymocytes (C) 
isolated from a WT adult CD45.2
+
 donor. The cells were then co-injected IV into a 
CD45.1
+
 x CD45.2
+
 host. The sort purities of each input population per cell cocktail 
are displayed on the left of each box. 7 days post IV the CD45.1
+
 x CD45.2
+
 hosts 
were sacrificed and the total LN or spleen analyzed separately by flow cytometry for 
the presence of both CD45.1
+
CD45.2
-
 and the CD45.2
+
CD45.1
-
 donor cells.  
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Figure 4. 8 Extrathymic Maturation Of Conventional SP4 Thymocytes Within 
The Periphery Of A WT Host  
Using the experimental approach described in Figure 4.8 A CCR7
-
CCR9
+
CD69
+TCRβhigh SP4 thymocytes from a WT adult CD45.2+ donor were IV 
transferred into a WT adult CD45.1
+
 host. 7 days post IV CD45.1
+
 hosts were 
sacrificed and total LN analyzed by flow cytometry for the presence and maturational 
status of CD45.2
+ 
donor cells. 
(A) The output populations of CD45.1 versus CD45.2 cells from the LN of a 
CD45.1
+
CD45.2
- 
host are displayed as dot plot.  Both the CD45.1
+
 and CD45.2
+
 
populations were then gated for their CD4 versus CD8 profiles. 
(B) The left histograms display the expression levels for HSA, CD62L, Qa2 and CD69 
of the input CCR7
-
 CCR9
+
 CD69
+
 TCRβhigh SP4 CD45.2+ donor population. The 
histograms on the right display overlays of the expression levels of HSA, CD62L, Qa2 
and CD69 within either the detected donor CD45.2
+
 TCRβhigh SP4 output cell 
populations (red line) or TCRβhigh CD4 T cells obtained from the CD45.1+ host LN 
(black line). 
All data in this figure is representative of at least 3 independent experiments.  
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either DP or mature CCR9
-
CCR7
+
CD69
-TCRβhigh SP4 thymocyte subsets, obtained from 
CD45.2
+
 WT adult donor mice. This co-injection system enabled the development and 
survival of thymocytes at different stages of their maturation program to be compared directly, 
within the same host peripheral environment. The survival rates of each input thymocyte 
population recovered from the CD45.1
+
 x CD45.2
+ 
WT hosts 7 days post IV transfer revealed 
a ratio of 10:1 after co-injection of CCR9
+
CCR7
-
CD69
+TCRβhigh SP4 and less mature DP 
thymocytes (Figure 4.9 D), whilst a 0.2:1 ratio was obtained after co-injection of 
CCR9
+
CCR7
-
CD69
+TCRβhigh SP4 and more mature CCR9-CCR7+CD69-TCRβhigh SP4 
thymocytes (Figure 4.9 B). Both the immature and mature SP4 fractions of cells maintained a 
CD4
+
CD8
-
 phenotype (Figure 4.9 A), whilst the small DP population that persisted within 
host peripheral tissues differentiated into cells of both CD4 and CD8 lineages (Figure 4.9 C).  
Collectively, the data obtained via this co-injection experimental technique indicate that 
immature, newly selected CCR9
+
CCR7
-
CD69
+TCRβhigh SP4 thymocytes display a reduced 
capacity for extrathymic development compared to their mature CCR9
-
CCR7
+
CD69
-TCRβhigh 
SP4 counterparts, whilst demonstrating a greater rate of extrathymic development compared 
to their more immature DP thymocyte populations.  
4.2.4 Differentiation of Foxp3
+
CD25
+
 nTreg Precursors is dependent on 
medullary epithelial cell support  
The medullary thymic microenvironment has an essential role, not just in the harboring of 
conventional SP4 and SP8 thymocyte subsets, but also in the generation of thymocytes of non 
conventional lineages, such as nTreg within the SP4 cohort, defined by their expression of the 
transcription factor Foxp3. Differentiation down this specialized SP4 thymocyte fate is  
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Figure 4. 9 Comparison Of The Persistence Of Immature Conventional CCR7
-
CCR9
+
CD69
+
 SP4 Thymocytes Within The Periphery Of A WT Host 
Using the experimental approaches described in Figure 4.8 B and C, CCR7
-
CCR9
+
CD69
+
 TCRβhigh SP4 from a CD45.1+ donor were co-injected with either 
CCR7
+
CCR9
-
CD69
-
 SP4 CD45.2
+
 donor cells (A) or DP CD45.2
+
 donor cells (C) at a 
one to one ratio and IV transferred into a CD45.1
+
 x CD45.2
+
 host. 7 days post IV the 
CD45.1
+
 x CD45.2
+
 hosts were sacrificed and total LN analyzed by flow cytometry for 
the presence of both the CD45.2
+ 
CD45.1
- 
and CD45.1
+ 
CD45.2
- 
donor populations. 
The output populations from each subset are displayed as a FACS dot plot with the 
numbers displayed denoting the percentages of each cohort detected. The CD4 versus 
CD8 profile of each population is also displayed as contour plots (A and C).  
The ratios of the percentages recovered from the CCR7
-
CCR9
+
CD69
+
 and 
CCR7
+
CCR9
-
CD69
-
 SP4 co-injection (B) or the CCR7
-
 CCR9
+
 CD69
+
 and DP (D) co-
injection from the total host LN cell population are displayed as bar graphs, with the 
error bars representing the SEM. Data displayed is typical of four individual grafts per 
condition. 
 
  
 189 
  
 190 
  
  
 191 
thought to involve a series of developmental stages, including the initial generation of a 
Foxp3
-
CD25
+
 nTreg precursor population, which undergo differentiation into Foxp3
+
CD25
+ 
nTreg progeny (Lio and Hsieh, 2008). The transition from Foxp3
-
CD25
+
nTreg precursor to 
Foxp3
+
CD25
+ 
nTreg is believed to be independent of TCR-mediated interactions (Burchill et 
al., 2008; Lio and Hsieh, 2008). However, we were interested to explore this further using our 
RelB-dependent mTEC deficient model and investigate the requirement of mTEC in the 
generation of Foxp3
-
CD25
+
 nTreg precursors, which to date remains unknown. 
 
The analysis of WT and Relb
-/-
 TEC grafts for the presence of Foxp3
+
CD25
+
 nTreg and their 
Foxp3
-
CD25
+
 precursors revealed reduced percentages and numbers of both populations in 
Relb
-/-
 TEC grafts, in comparison to their WT counterparts (Figure 4.10A and B). Thus, 
indicating the generation of Foxp3
-
CD25
+
 nTreg precursors, previously identified to occur at 
the intermediate CCR7
+
CCR9
-
CD69
+
 stage of SP4 development (Chapter 3, Figure 3.9), is a 
process dependent on a normal medullary compartment. Therefore, the selective absence of a 
normal mTEC compartment impacts heavily upon intrathymic Foxp3
+ 
CD25
+
 nTreg 
development at an early stage, through their control of the generation of Foxp3
-
CD25
+
 nTreg 
precursors.  
To further define the stages of nTreg development in relation to dependency upon thymic 
medullary support we investigated nTreg generation following intravenous transfer of defined 
populations. In agreement with an earlier study (Lio and Hsieh, 2008), we found that Foxp3
-
CD25
+ 
nTreg precursors, predominantly within the intermediate CCR9
-
CCR7
+
CD69
+ 
TCRβhigh SP4 population (Figure 3.9), differentiated into Foxp3+CD25+ nTreg following 
intravenous transfer into the periphery of a WT host, 7 days post transfer (Figure 4.11A  
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Figure 4. 10 The Generation Of Foxp3
+ 
CD25
+ 
nTreg And CD25
+
 Foxp3
-
 nTreg 
Precursors Is An mTEC Dependent Process 
(A) Thymocytes recovered from WT (top) and Relb
-/-
 (bottom) TEC grafts into WT 
hosts were isolated and analyzed for intracellular staining of Foxp3 within the 
TCRβhigh SP4 population. The Foxp3- fraction of the TCRβhigh SP4 thymocytes was 
also explored for their surface expression levels of CD25.  
(B) The percentages (top) and AN (bottom) of the Foxp3
+
 TCRβhigh SP4 nTreg subset 
(left) and Foxp3
-
 CD25
+
 TCRβhigh SP4 nTreg precursors (right) were calculated from 
WT TEC grafts (white bars) and Relb
-/-
 TEC grafts (gray bars) into WT hosts and 
displayed as a mean bar graph, representing at least 5 individual grafts per condition. 
The standard error bars indicate the SEM, and a student’s two tailed unpaired T test 
was performed on all results, where *** denoted a significant difference (P < 0.001) 
and ** denotes a significant difference (P < 0.01). 
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middle panel). This isolated Foxp3
-
CD25
+ 
nTreg precursor population also generated nTreg in 
vitro, within the RTOC system (Figure 4.11 A bottom panel). Collectively Figure 4.11A 
indicates that Foxp3
-
CD25
+ 
nTreg precursors can undergo the transition into Foxp3
+
CD25
+
 
nTreg, with or without the presence of mTEC. In marked contrast, we found the less mature 
CD69
+
CCR7
-
CCR9
+
 TCRβhigh SP4 thymocyte cohort was unable to give rise to 
Foxp3
+
CD25
+
 nTreg extrathymically, (Figure 4.11B top panel), in marked contrast to this 
cohort’s capacity to generate conventional CD4 T cells within the periphery (Figure 4.8). This 
isolated immature SP4 population demonstrated the capability to differentiate into both 
Foxp3
-
CD25
+ 
nTreg precursors and their Foxp3
+
CD25
+
 nTreg progeny in vitro, within the 
RTOC system (Figure 4.11 B bottom panel), suggesting that mTEC interactions alone may be 
sufficient to drive the differentiation of Foxp3
+
CD25
+
 nTreg from the CCD9
+
CCR7
-
CD69
+
SP4 stage.   
4.2.5 The Generation And Homing Of Distinct DC Subsets Within The 
Thymic Microenvironment Is Dependent On Medullary Epithelial Cell 
Support 
The ability of immature SP4 thymocytes to continue their maturation into conventional 
mature cells, independent of mTEC interaction, caused us to consider other cell types that 
may be present within both the Relb
-/- 
grafts and the peripheral lymphoid tissue of WT hosts 
that may facilitate this continued differentiation program. DC are a strong candidate, as this 
cell type would be present with the peripheral lymphoid tissue of a WT host to assist 
extrathymic conventional SP4 development, whilst this population may also be within the 
Relb
-/-
 grafts. Analysis of the presence of total CD11c
+
 DC populations, via confocal  
  
 196 
 
Figure 4. 11 CCR7
-
CCR9
+
CD69
+TCRβhigh SP4 Thymocytes Do Not Generate 
Foxp3
+
 nTreg Extrathymically 
Using the experimental approach described in Figure 4.8 CCR7
-
CCR9
+
CD69
+TCRβhigh SP4 (B) or CD25+Foxp3- TCRβhigh SP4 nTreg precursors (A) 
from a CD45.2
+
 host were isolated using a high speed cell sorter and either: IV 
injected into a CD45.1
+
 host, or reaggregated with TEC preparations from E15 
C57BL/6 WT 2-dGuo FTOCs within the RTOC system.  
(A) The cell purity of the isolated CD25
+
Foxp3
-
CD69
+
 SP4 input population is 
displayed in the top panel. The output populations were then analyzed by flow 
cytometry, 7 days post IV injection (middle), or 7 days after RTOC culture (bottom). 
The recovered CD45.2
+
 thymocytes were identified and stained CD4 versus CD8 
expression. The TCRβhigh SP4 population was explored for surface expression of 
CD25 against the intracellular staining of Foxp3.  
(B) The CCR7
-
CCR9
+
CD69
+
 TCRβhigh SP4 input population was analysed by flow 
cytometry 7 days post IV injection (top) or 7 days after RTOC culture (bottom). The 
recovered CD45.2
+
 thymocytes were identified and stained for CD4 versus CD8 
expression and the TCRβhigh SP4 population was analyzed for surface expression of 
CD25 against the intracellular staining of Foxp3.  
All data within this figure is representative of at least 2 experimental repeats.  
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microscopy analysis, revealed CD11c
+
 DC within both WT and Relb
-/- 
TEC grafts (Figure 
4.12 A). Within the WT grafts these CD11c
+ 
cells were localized to ERTR5
+
 medullary areas. 
However, as described earlier (Figure 4.2 A), all ERTR5
+
 medullary regions were absent 
within the Relb
-/- 
grafts, yet clustering of CD11c
+ 
DC was still observed. Thus, this simple 
confocal analysis confirms the presence of DC within the RelB-dependent mTEC deficient 
thymic environments and offers support to our proposal that this cell type may be driving 
conventional SP4 development within this grafting environment. In addition, this data also 
suggests that the defect in nTreg production observed within the Relb
-/-
 grafts is not due to the 
absence of DC.  
To investigate further the potential role of DC in supporting conventional SP4 development, 
we explored the presence of different DC subsets within the Relb
-/-
 thymic microenvironments 
(Figure 4.12 B and C). Thymic DC can be divided into two distinct subsets CD11c
+
B220
+
 
plasmacytoid DC (pDC) and CD11c
+
 B220
-
 conventional DC (cDC). cDC can be further 
subdivided into two subsets: CD11b
-
 CD8
+
 Sirpα- DC and CD11b+ CD8- Sirpα+ DC (Wu and 
Shortman, 2005). The CD11b
-
 CD8
+
 Sirpα- cDC subset is thought to be intrathymic generated 
(Wu and Shortman, 2005; Yui et al., 2010), while the additional CD11b
+
CD8
-Sirpα+ cDC and 
pDC populations migrate into thymus from periphery (Li et al., 2009).  
The proportions of the different DC subsets recovered from WT grafts closely resembled 
those obtained for WT adult thymus samples (Figure 4.12 B), with similar percentages of 
pDC and cDC subsets and approximately the same fractions of CD11b
-
CD8
+Sirpα- versus 
CD11b
+
CD8
-Sirpα+ cDC subsets. In contrast, however, the Relb-/- grafts displayed striking 
differences to the proportions of these three distinct DC subsets (Figure 4.12B and C). In  
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Figure 4. 12 Homing Of Distinct Dendritic Cells Subsets To mTEC Deficient 
Thymic Microenvironments Within A WT Host 
(A) WT (top panel) or Relb
-/-
 (bottom panel) TEC grafts into WT hosts were harvest 6-
12 weeks post transplantation and frozen for confocal analysis. 7μm sections were cut 
and stained for CD11c and ERTR5. Bars represent 100 μm. 
(B) WT (middle) or Relb
-/- 
TEC (bottom) grafts into WT host were analyzed by FACS 
analysis, along side adult WT C57BL/6 thymocytes (top), for the presence of different 
DC subsets. Thymocytes were stained for CD11c versus B220 (left) and both the 
CD11c
+
B220
- 
conventional DC and B220
+
CD11c
+
 plasmacytoid DC subsets identified. 
The  
CD11c
+
B220
-
 cDC population was then gated and analyzed for Sirpα and CD8 
expression (right). The numbers displayed within each FACS plot gate represent the 
percentages of each distinct DC subset. 
(C) The percentages (top) and AN (bottom) of pDC versus cDC subsets (left) and 
Sirpα+CD8- versus Sirpα-CD8+ cDC subsets (right) obtained from WT TEC grafts 
(white bars) or Relb
-/- 
TEC grafts (grey bars) are displayed as mean bar graphs, 
representative of at least 5 individual grafts per condition. The error bars represent the 
SEM and a student’s two tailed unpaired T test was performed on all results, where ns 
denoted a non-significant difference (P > 0.05), and *, ** or *** indicates a significant 
difference (* = P < 0.05, ** = P < 0. 01, ***= P <0.001). 
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comparison to WT grafts, Relb
-/- 
grafts exhibited significant reductions in both the 
percentages and absolute numbers of the pDC subset, extrathymically generated and home to 
thymus from the periphery. In contrast, no differences in the overall percentages and absolute 
numbers of cDC were seen between WT and Relb
-/- 
grafts (Figure 4.12C), however, 
disruptions to the proptions of CD11b
-
 CD8
+
 Sirpα- DC versus CD11b+ CD8- Sirpα+ cDC 
were observed within the Relb
-/-
 grafts. Unlike the approximate proportions of 60% 
CD8
+Sirpα- to 40% CD8-Sirpα+ cDC subsets displayed within the WT grafts, Relb-/- grafts 
displayed 20% CD8
+Sirpα- to 80% CD8-Sirpα+ cDC. This change in the cDC distribution 
resulted in a highly significant reduction in the absolute numbers of CD8
+Sirpα- cDC 
recovered from the Relb
-/-
 grafts compared to the WT controls. In contrast, the percentage 
increase in the CD8
-Sirpα+ cDC population from Relb-/- grafts did not translate into a 
significant difference in terms of absolute numbers. 
Overall, exploration into the different DC subsets within the Relb
-/-
 TEC grafts suggests the 
absence of a structured mTEC compartment results in a reduction to both the intrathymically 
generated CD8
+Sirpα- cDC subset and the extrathymically generated pDC populations that 
migrate into the thymus from the periphery. Therefore, this data suggests a possible 
requirement for the thymic medulla in both the homing of pDC to the thymic 
microenvironment and perhaps in the intrathymic generation of CD8
+
 Sirpα- cDC. 
Additionally, the results identified peripherally induced CD8
-Sirpα+ cDC as a potential 
candidate in the involvement of conventional SP4 generation within the Relb
-/-
 grafts, due to 
their presence been unaffected by the absence of RelB-dependent mTEC compartments. This 
data also does not rule out the possibility that the defect in nTreg production observed within 
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the RelB-dependent mTEC deficient thymic microenvironment is not a consequence, at least 
in part, of the reduction in both the pDC and the CD8
-Sirpα+ cDC subsets.  
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4.3 DISCUSSION  
Following positive selection in the cortex, SP4 and SP8 thymocytes migrate into specialized 
medullary thymic microenvironments, where they reside between 5 to 14 days, although the 
precise medullary dwell time remains controversial(McCaughtry et al., 2007; Scollay and 
Godfrey, 1995). During this residency, developing SP thymocytes interact with medullary 
thymic epithelial cells and DC, which is known to be essential for establishing T cell 
tolerance, via the deletion of thymocytes displaying αβTCRs with potential specificity to self 
(Anderson and Takahama, 2012). However, the involvement of the thymus medulla in other 
aspects of αβT cell development remains unclear, including its role in the generation and 
selection of Foxp3
+
 nTreg and the continued maturation of the multistep conventional SP 
developmental program. Investigations into the effect of medullary defects on conventional 
SP development have suggested intact mTEC compartments are critical in the differentiation 
program of SP4 development (Li et al., 2007), while additional studies have proposed a 
specific role for mTEC in the intrathymic generation of Foxp3
+
 nTreg (Aschenbrenner et al., 
2007; Hinterberger et al., 2010).  
The data obtained through exploring T cell development in vivo within either the RelB-
dependent mTEC deficient grafting models or extrathymically, is in both accordance and 
disagreement with these proposed roles of the mTEC population. Our findings do not support 
the suggestion mTEC provide essential support for SP4 differentiation, but rather that 
conventional CD4 SP thymocyte development can occur independently of the thymic medulla. 
Data showed that SP4 thymocytes are capable of undergoing their maturation program 
extrathymically, with complete thymic independence occurring from the newly selected 
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CCR7
-
CCR9
+
CD69
+
 stages of development, immediately following positive selection. In 
marked contrast, however, experiments showed that mTEC are crucial for the intrathymic 
generation of Foxp3
+
 nTreg. Investigations suggest Foxp3
+
 nTreg development is dependent 
upon an intact thymic medulla, with a specific requirement for mTEC mapping to early stages 
in nTreg development to foster the generation of Foxp3
-
CD25
+ 
nTreg precursors. Collectively, 
these results demonstrate a differential requirement for the thymus medulla in relation to 
Foxp3
+
nTreg versus conventional SP4 thymocyte development. 
Given that the generation of Foxp3
-
CD25
+ 
nTreg precursors is thought to be dependent upon 
CD28-CD80/CD86 interactions (Hinterberger et al., 2011; Lio et al., 2010; Vang et al., 2010), 
as well as TCR-MHC binding (Lio and Hsieh, 2008), our findings fit well with the expression 
of both these co-stimulatory molecules and MHC class I and class ll by the mTEC population 
(Derbinski et al., 2005; Gray et al., 2007). Thus, the ability of mTEC to provide these 
fundamental molecules may be the basis of why Foxp3
-
CD25
+ 
nTreg precursors generation is 
dependent upon an intact medulla. This suggestion that mTEC provide peptide/MHC ligands 
for nTreg development fits well with reports documenting the generation of antigen-specific 
TCR transgenic nTreg following the targeting of model antigens to mTEC (Aschenbrenner et 
al., 2007; Hinterberger et al., 2010) and the normal numbers of Treg are generated in bone 
marrow chimaeras, where the haemopoietic compartment is MHC class II deficient 
(Aschenbrenner et al., 2007; Liston et al., 2008).  Although these experimental models 
revealed an essential role of mTEC in Foxp3
-
CD25
+ 
nTreg precursors development, they did 
not identify the cell types responsible for driving continued SP4 T cell development down this 
nonconventional lineage. Additional investigations are needed to confirm the precise 
interactions between mTEC and developing SP4 thymocytes, essential to drive nTreg 
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precursor development, be it cell-cell mediated interactions, or perhaps indirect mTEC effects 
of nTreg selection through their manipulation of the thymic microenvironment and the 
behavior of other cell types. It has been demonstrated mTEC can influence DC mediated 
selection of nTreg via their cytokine production (Hanabuchi et al., 2010), whilst XCL1-
mediated medullary accumulation of thymic DC, produced by Aire
+
 mTEC, is thought to 
critically contribute to the development of nTreg (Lei et al., 2011). Thus, further investigation 
of the dual role of mTEC and DC in nTreg development is required. 
A further limitation to our investigation is whether mTEC interactions alone are sufficient to 
direct the generation of Foxp3
-
CD25
+
 nTreg precursors, or if interactions with additional cell 
types, particularly thymic DC, are required to drive differentiation of nTreg. Although 
preliminary data acquired from the reaggregation of immature CCR9
+
CCR7
-
CD69
+
SP4 
thymocytes with WT TEC populations in vitro demonstrated that both Foxp3
-
CD25
+
 nTreg 
precursors and their Foxp3
+
CD25
+
 nTreg progeny can develop in the presence of mTEC, 
additional studies are needed to explore the potential impact of other cell types in the 
development of this specialized SP4 lineage. Extensive studies have suggested that DC 
mediate central tolerance via their ability to select nTreg, (Proietto et al., 2008b; Spence and 
Green, 2008; Watanabe et al., 2005a; Wirnsberger et al., 2009). However, how DC are 
involved in the process of nTreg differentiation, be it exclusively, or in cooperation with 
mTEC (Watanabe et al., 2005b), still remains relatively unclear.  
The examination of DC within the RelB-dependent medullary deficient thymic 
microenvironments identified dramatic alterations to both the anatomical positioning of this 
cell type and the proportions of their distinct cohorts. DC predominantly accumulate within 
the medullary region of the thymus (Barclay, 1981), which was confirmed within the WT 
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TEC grafting environments, where CD11c
+
 DC clustering was detected within the ERTR5
+
 
medullary areas. Interestingly, however, even though ERTR5
+ 
regions were absent within the 
RelB-dependent mTEC deficient grafts, CD11c
+
 DC still clustered within particular
 
areas. 
The nature of these areas is currently unclear and we are presently investigating whether they 
represent cortical regions, or areas rich in vasculature that could represent sites of cell entry in 
the graft. On closer inspection of the DC populations within this environment, significant 
reductions were detected within both the intrathymic generated Sirpα-CD8+ cDC population 
and the pDC subset, that is extrathymically generated and homed to the thymus. These 
striking results highlight a potential role for mTEC in DC recruitment and/or generation and 
extend previous observations that mTEC mediated chemokine production controls the 
intrathymic positioning of DC (Lei et al., 2011). These results also raise the possibility that 
the considerable reduction in the numbers of these two specific DC populations within the 
Relb
-/-
 thymic microenvironment is consequently causing the decrease in the nTreg precursors 
and thus, their nTreg progeny. Clearly, further, more extensive investigations are required to 
dissect the division of labor between mTEC and DC populations in the generation of this 
specialized non-conventional SP4 lineage.    
Furthermore, in addition to the role the DC population may be playing in nTreg generation, 
our experimental approaches do not address whether thymic DC are involved in continued 
conventional SP4 and SP8 development. The finding that conventional CD4 SP thymocyte 
development can occur independently of the thymus medulla from the earliest CD69
+
CCR7
-
CCR9
+
 stages in their differentiation program raises the possibility that thymic DC may be 
involved in this developmental process. It is possible that the mislocalized DC clusters present 
within the RelB-dependent mTEC deficient microenvironment may support the continued 
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maturation of the SP4 and SP8 thymocytes observed within these grafts. This proposal is 
aided by the strong assumption DC populations would also be present within the secondary 
lymphoid tissue of WT hosts, to drive conventional SP4 extrathymic maturation. As the Relb
-
/-
 grafts display significant reduction to both their pDC and SirpαCD8+ cDC populations, 
perhaps the unaltered Sirpα+CD8- subset is exclusively capable of driving this conventional 
maturational program. 
The further effects of mTEC deficiency observed within the Relb
-/-
 grafted microenvironment 
on thymocyte development suggest possible supplementary roles for this specialized stromal 
population in the later stages of intrathymic T cell development. Although RelB-dependent 
mTEC deficiency displayed no effect on the ability of conventional SP8 thymocytes to mature 
to the Qa2
+
CD69
-
 stage in differentiation, the overall reduction to the number of SP8 cells 
within Relb
-/-
 grafts imply that maintenance, or perhaps efficacy of development, of MHC 
class I restricted thymocytes is influenced by mTEC. It has been reported that SP8 
thymocytes have higher rates of proliferation in comparison to their SP4 counterparts 
(Boursalian et al., 2004; McCaughtry et al., 2007). The mTEC deficient microenvironment 
may, therefore, limit their proliferation ability and thus, result in the overall reduction to the 
cell numbers of this population. However, the significant reduction to the 
CD44
high
Qa2
+
HSA
low
 recirculating, or perhaps long term thymic residents, within the SP8 
populations  may be accountable, in part, for this reduction in total SP8 cell numbers.  
This decrease in recirculating SP4 and SP8 populations may also suggest an involvement of 
mTEC in homing of peripheral T cells back to the medulla. It has been reported peripheral T 
cells that return to the thymus enter at the corticomedullary junction and persist in the medulla. 
It has also been reported that the thymic architecture is affected by the presence of this 
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recirculating population, with the mature T cells causing mTEC regeneration (Hale and Fink, 
2009; Surh et al., 1992). Therefore intact mTEC environments may be essential for 
recruitment of peripheral T cells back to the thymus. Interestingly, with the use of RAG-2 
GFP reporter mice, it has been suggested up to 50% of GFP
-
 thymic residents are Treg 
(McCaughtry et al., 2007; Weinreich and Hogquist, 2008). Therefore, regardless of whether 
this population represents immigrating mature peripheral T cells or long term thymic residents, 
the reduction in the CD44
high
Qa2
+
HSA
low
 SP4 subsets, along with the reduced GFP
- 
SP4 cells 
obtained from Relb
-/- 
grafts into a RAG-2 GFP host may contribute to the reduced numbers of 
nTreg observed within the same environment. 
In conclusion these results not only highlight differences in the maturational requirements for 
conventional SP thymocytes and nTreg, they warrant a rethinking of the role of the thymus 
medulla in T cell development. Thus, rather than representing a specialised microenvironment 
that is required to foster the completion of late stage αβT cell development per se, the primary 
role of the thymic medulla appears to be the generation of self tolerance via both negative 
selection and the generation of Foxp3
-
CD25
+ 
nTreg precursors and their Foxp3
+
CD25
+
 T cells 
progeny.  
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CHAPTER  5: THE ROLE OF CCR4 IN T CELL 
DEVELOPMENT AND CORTEX TO MEDULLA MIGRATION 
OF POSITIVELY SELECTED THYMOCYTES. 
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5.1 INTRODUCTION  
One of the dramatic migratory changes in intrathymic T cell development is the re-
localisation of positively selected CD4 or CD8 SP thymocytes from the cortex into the 
medulla. An early study using Pertussis Toxin treatment to inhibit G-protein coupled 
chemokine receptors resulted in a profound block in cortex to medulla migration of SP 
thymocytes, implicating chemokines in this migratory process (Ehrlich et al., 2009; Suzuki et 
al., 1999). Of the large family of chemokine receptors, CCR7 has been identified to play a key 
role in driving the cortex to medulla migration of newly generated CD4 and CD8 SP 
thymocytes (Kwan and Killeen, 2004; Ueno et al., 2004). CCR7 ligands, CCL21 and CCL19, 
are predominantly produced by mTEC and are distributed within the medulla (Ueno et al., 
2002), whilst a fraction of cortical DP thymocytes receive TCR-mediated positive selection 
survival signals upregulate CCR7 on their cell surface (Davalos-Misslitz et al., 2007).  
Interestingly, it has also been reported that MHC Class I mediated positive selection leads to 
an enhanced upregulation of CCR7 expression on DP thymocytes compared to selection via 
MHC class II. In line with this, the enforced over expression of CCR7 has been demonstrated 
to increase CD8 SP development (Yin et al., 2007), suggesting that CCR7 may be more 
important in the specific migration of CD8 SP thymocytes into medullary regions and that 
other unidentified chemokine receptors may be involved in the migration of CD4 SP cells. 
Data in Chapter 3 showing that CCR4 is rapidly upregulated on the initiation of positive 
selection at the DP stage of development identifies this chemokine receptor as possible 
additional regulator of thymocyte entry to the medulla. In addition, CCR4 ligands, CCL17 
and CCL21, are highly expressed within the medullary microenvironment, produced primarily 
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by mTEC (Griffith et al., 2009) and thymic DC (Lieberam and Forster, 1999). It has been 
demonstrated that on initiation of positive selection CD69
+ 
DP thymocytes become responsive 
to CCL22, which is maintained with the most immature CD4 SP population (Campbell et al., 
1999). Complementary to this data, Ccr4 mRNA levels have also been shown to be 
upregulated within the same CCL22 responsive CD69
+
 DP and immature CD4 SP thymocytes 
subsets (Campbell et al., 1999; Suzuki et al., 1999), suggesting a potential role for CCL22 in 
migration of positively selected thymocytes from the cortex to the medulla. However, the 
possible role of CCR4 in the thymus is not well understood.  Using Ccr4
-/- 
mice (Chvatchko et 
al., 2000), the aim of this chapter was to explore the potential involvement of CCR4 in cortex 
to medulla thymocyte migration and post-positive selection maturation of both conventional 
and Foxp3
+
 T regulatory lineages.  
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5.2 RESULTS 
5.2.1 CCR7 Mediates Medullary Accumulation Of SP4 And SP8 
Thymocytes, But Is Dispensable For Their Development 
In initial experiments aimed at defing the role of chemokine receptors on medullary migration, 
we analysed the thymus of Ccr7
-/- 
mice, known to have defective cortex-to-medulla transition 
(Ueno et al., 2004), in order to provide comparison with subsequent analysis of Ccr4
-/-
 mice. 
The analysis of thymocyte development in adult Ccr7
-/- 
mice revealed no gross abnormalities 
to T cell development (Figure 5.1). No significant alterations to thymocyte cellularity were 
observed as a consequence of CCR7 deficiency (Figure 5.1 A). The absolute numbers of cells 
at all four main stages of thymocytes development; DN, DP, SP4 and SP8, also displayed no 
difference in CCR7 deficient mice compared to their WT controls (Figure 5.1 A and C). In 
addition, DP thymocytes from adult Ccr7
-/- 
mice revealed no disruption to the frequencies of 
pre-positive selection CD69
-
DP cells compared to CD69
+
 DP cells undergoing the selection 
process (Figure 5.1 D). The percentages and absolute numbers of the immature CD69
+
 Qa2
-
 
fraction of thymocytes versus the mature CD69
-
 Qa2
+
 cell population within both the SP4 
(Figure 5.2 A and B) and SP8 (Figure 5.2 C and D) subsets showed no alterations between the 
Ccr7
-/- 
mice and their WT counterparts. Collectively, this data suggest the absence of CCR7 
does not perturb conventional T cell development. In contrast, while analysis of the CD25+ 
FoxP3
+
 nTreg lineage revealed an increase to both the percentage and absolute number in 
Ccr7
-/-
 mice compared to their WT controls (Figure 5.3), no detectable differences were 
observed in the percentage or absolute number of CD25
+ 
FoxP3
-
 nTreg precursors. 
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Figure 5. 1 Grossly Normal T Cell Development In CCR7 Deficient Mice 
Adult Ccr7
-/-
 or WT thymocyte cell suspensions were isolated and cell numbers 
obtained, before staining for flow cytometry analysis.  
 
The absolute numbers (AN) of each distinct population was calculated per mouse from 
the total thymocte cell count and the percentage of each population acquired via flow 
cytometry analysis. The AN of each distinct population was displayed as a mean bar 
graph from WT (white bars) or Ccr7
-/-
(grey bars) samples, with data representing x5 
independent mice per condition and the error bars denoting the SEM. A student’s two 
tailed unpaired T test was performed on all results, where ns denoted a non-significant 
difference, as P > 0.05.  
 
(A) The absolute cell count of total WT or Ccr7
-/-  
thymus samples. 
(B) WT (top) and Ccr7
-/- 
(bottom) total cell samples were explored for CD4 versus 
CD8 surface expression, displayed as a contour plot, or TCRβ and CD69 expression 
levels, displayed as histograms. The numbers depict the frequency of cells within each 
gate.  
(C) The AN of CD4
-
CD8
-
 DN, CD4
+
 CD8
+
 DP, TCRβhigh CD4+CD8- SP and TCRβhigh 
CD8
+
CD4
-
 SP thymocyte cohorts from WT or Ccr7
-/-
 samples. 
(D) The CD4
+
 CD8
+
 DP population was separated on the basis of their CD69 
expression and the AN of CD69
- 
versus CD69
+ 
DP subsets calculated and displayed 
from WT or Ccr7
-/-
cell suspensions. 
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Figure 5. 2 Conventional SP4 and SP8 T Cell Development Is Not Disrupted In 
CCR7 Deficient Mice 
Thymocytes from adult WT (top) or Ccr7
-/-
 (bottom) mice were isolated and stained 
for flow cytometry analysis. The Qa2 and CD69 expression was explored within the 
(A) TCRβhigh SP4 population or (C) TCRβhigh SP8 subset and represented as contour 
FACS plots.  
The percentages (top) and AN (bottom) of (B) SP4 populations: CD69
+
 Qa2
-
 TCRβhigh 
SP4 (left) and CD69
- 
Qa2
+
 TCRβhigh SP4 (right), or (D) SP8 populations: CD69+ Qa2- 
TCRβhigh SP8 (left) and CD69- Qa2+ TCRβhigh SP8 (right), were calculated per mouse 
and displayed as bar graphs. Each bar graph represents the mean percentages or AN of 
thymocyte subsets recovered from x5 individual WT (white bars) or Ccr7
-/-
 (gray bars) 
mice. The standard error bars display the SEM, and a student’s two tailed unpaired T 
test was performed on all results, where ns denoted a non-significant difference, as P > 
0.05.  
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Figure 5. 3 CCR7 Deficient Mice Have Increased Frequencies Of Foxp3
+ 
CD25
+ 
Treg Whilst The Generation Of CD25
+
 Foxp3
-
 Treg Precursors Is Unaffected 
(A) Thymocytes recovered from adult WT (top) or Ccr7
-/-
 (bottom) mice were isolated 
and analysed for intracellular staining of Foxp3 within the TCRβhigh SP4 population. 
The Foxp3
-
 fraction of the TCRβhigh SP4 thymocytes was also explored for their 
surface expression levels of CD25.  
 
(B) The percentages (top) and AN (bottom) of the Foxp3
+
 TCRβhigh SP4 Treg subset 
(left) and Foxp3
-
 CD25
+
 TCRβhigh SP4 Treg precursors (right) were calculated from 
WT (white bars) and Ccr7
-/-
 (gray bars) hosts and displayed as mean bar graphs, 
representing x5 individual mice per condition. The standard error bars indicate the 
SEM, and a student’s two tailed unpaired T test was performed on all results, where ns 
denoted a non-significant difference (P > 0.05), and ** or *** indicate a significant 
difference (** = P < 0.01 and ***= P < 0.001). 
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Low resolution (Figure 5.4) images of whole thymic sections confirmed previously published 
findings that Ccr7
-/- 
adult thymic environments display abnormal medullary structures 
compared to WT controls (Figure 5.4A) (Ueno et al., 2004). Ccr7
-/-
 mice had small, sparsely 
distributed medullas, in comparison to the larger WT medullary areas. Higher resolution 
images of thymic medullary areas of adult Ccr7
-/-
 or WT mice were taken to assess the 
distribution of SP4 and SP8 thymocytes as described in the Section 5.2, which confirmed the 
previously reported findings that absence of CCR7 results in a reduction in SP4 and SP8 
thymocyte numbers in the thymic medulla (Figure 5.4 C) (Nitta et al., 2009; Ueno et al., 
2004). In line with earlier reports (Davalos-Misslitz et al., 2007; Nitta et al., 2009), the 
greatest reduction in medullary accumulation was observed within the SP8 population (5 fold 
reduction). However, the reduction in medullary SP4 numbers (2 fold reduction in Ccr7
-/-
 
compared to WT), contrast with reports that have disputed the effects of CCR7 deficiency on 
SP4 medullary accumulation (Davalos-Misslitz et al., 2007). Overall, this data supports the 
idea that absence of CCR7 reduces medullary retention of both SP4 and SP8 thymocytes in 
the adult thymus.  
5.2.2 CCR4 Is Not Essential For Normal T Cell Development Or Medullary 
Positioning Of Post-Positive Selection SP Thymocytes 
To study the involvement of CCR4 in thymocyte development and cortex to medulla 
reclocalisation, we first explored thymic expression of CCL22 and CCL17 via quantitative 
PCR (Figure 5.5). TEC and DC populations were isolated from digested thymus samples 
acquired from either E15 WT FTOC or adult WT mice and the mRNA levels of CCL17 and 
CCL22 determined within each individual subset. Examination of CCL21 and CCL17 mRNA  
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Figure 5. 4 CCR7 Deficiency Results In Reduced Numbers Of SP4 And SP8 
Thymocytes Within Thymic Medullary Regions  
WT and Ccr7
-/- adult thymi were frozen for confocal analysis. 7μm thymus sections 
were cut and stained for immunofluorescence confocal analysis. 
(A) Tile scans of a series of low resolution images are shown for whole thymus 
sections from WT (left) and Ccr7
-/- (right) hosts, stained for ERTR5 and β5T. Bars 
represent a scale of 1mm  
(B) Higher resolution images of smaller thymic areas stained for CD4 and CD8. The 
white dashed line denotes the corticomedullary junction, C=cortex and M=medulla. 
Bars represent a scale of 100 μm 
(C) The number of SP4 (left graph) or SP8 (right graph) cells within a 100μm x 
100μm square medullary area were counted within x3 regions per section, on x4 serial 
section images per host. The numbers acquired from x3 WT (white bars) and x3 Ccr7
-
/- 
(grey bars) hosts are displayed as mean bar graphs. The standard error bars indicate 
the SEM and a student’s two tailed unpaired T test was performed on all results, where 
*** denotes highly significant difference, as P < 0.001. 
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Figure 5. 5 Gene Expression Patterns Of CCR4 Ligands CCL22 and CCL17 In 
Distinct TEC And DC Populations 
Quantitative real time PCR was performed for gene expression analysis of CCL17 
(left) or CCL22 (right) on the indicated populations:  
 
(A) TEC populations were isolated from WT BALB/c E15 FTOC samples, cultured 5 
to 7 days, via high speed cell sorting:  
 CD45-EpCAM+CD40+DEC205+Mature cTEC (white bars)  
 CD45-EpCAM+CD40+DEC205-CD80-Immature mTEC (right horizontal strip bars)  
 CD45-EpCAM+CD40+DEC205-CD80+Mature mTEC (large square lined bars) 
 Total FTOC (grey bars) 
 Total 2-dGuo treated FTOC (checkered bars) 
Or isolated from fresh WT BALB/c E15 thymic lobes: 
 CD45- EpCAM+CD40-DEC205+Immature cTEC (left horizontal strips bars)  
 
(B) DC populations were isolated from BALB/c WT adult thymus samples via high 
speed cell sorting: 
 B220+ CD11c+plasmacytoid DC (pDC) (right horizontal strip bars)  
 B220- CD11c+ Sirpα+ conventional DC (cDC) (grey bars) 
 B220- CD11c+Sirpα- cDC (right horizontal strip bars)  
Mature mTEC (white bars) were isolated as described in (A) 
 
Error bars indicate the standard error of the mean (SEM) and mRNA levels were 
normalized to house keeping gene β-actin. Data is from at least two independently 
sorted biological samples, with each gene analyzed a minimum of two times, with 
each PCR ran in triplicates to obtain a SEM. 
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levels within the four distinct TEC populations revealed that both ligands were higher in 
mature mTEC (Figure 5.5 A). Although CCL22 mRNA was not detectable within any of the 
additional three TEC subsets, CCL17 mRNA was present in all TEC subsets, although at a 
considerably lower level than that of the mature mTEC fraction. Examination of CCL17 and 
CCL22 expression within the three distinct thymic DC subsets: pDC, Sirpα+ cDC and Sirpα- 
cDC, identified striking differences. Both CCL17 and CCL22 mRNA levels were greater in 
Sirpα+ cDC compared to the other two DC populations. In addition, CCL17 and CCL22 
mRNA levels were significantly greater within Sirpα+ cDC compared to mature mTEC. 
Collectively this data suggests that while mature mTEC displayed the highest levels of 
CCL17 and CCL22 mRNA expression amongst TEC populations, Sirpα+ cDC expressed the 
highest CCL17 and CCL22 mRNA levels compared to all thymic populations tested. 
To explore the effects of the absence of CCR4 expression on both thymocyte development 
and the intrathymic distribution of SP4 and SP8 lineages, we analysed Ccr4
-/- 
mice 
(Chvatchko et al., 2000), using an identical experimental strategy to that used for Ccr7
-/- 
  
mice. Collectively, Figures 5.6 to 5.9 display detailed analysis of T cell development and 
intrathymic thymocyte positioning in the thymus of adult Ccr4
-/- 
mice, compared to their WT 
counterparts. No discernable differences were seen between WT and Ccr4
-/-
 mice, including 
the generation of mature CD69
-
 Qa2
+
 SP4 and SP8 cohorts (Figure 5.7), along with the 
differentiation of CD25
+
 FoxP3
- 
nTreg precursors and their CD25
+
 FoxP3
+ 
nTreg progeny  
(Figure 5.8), indicating that CCR4 is not essential during intrathymic T cell development.  In 
addition, no significant reductions to medullary size or perturbed SP4 or SP8 thymocyte 
positioning were observed within Ccr4
-/-
 mice (Figure 5.9), ruling out an essential role for this 
chemokine receptor in cortex-to-medulla migration.  
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Figure 5. 6 Grossly Normal T cell Development In CCR4 Deficient Mice 
Adult Ccr4
-/-
 or WT thymocyte cell suspensions were isolated and absolute cell 
numbers obtained, before staining for flow cytometry analysis.  
 
The absolute numbers (AN) of each distinct population was calculated per mouse from 
the total thymocte cell count and the percentage of each population acquired via flow 
cytometry analysis. The AN of each distinct population was displayed as a mean bar 
graph from WT (white bars) or Ccr4
-/-
(grey bars) samples, with data representing x6 
independent mice per condition and the error bars denoting the SEM. A student’s two 
tailed unpaired T test was performed on all results, where ns denoted a non-significant 
difference, as P > 0.05.  
 
(A) The absolute cell count of total WT or Ccr4
-/- 
total thymus samples. 
(B) WT (top) and Ccr4
-/- 
(bottom) total cell samples were explored for CD4 versus 
CD8 surface expression, displayed as a contour plot, or TCRβ and CD69 expression 
levels, displayed as histograms. The numbers depict the frequency of cells within each 
gate.  
(C) The AN of CD4
-
CD8
-
 DN, CD4
+
 CD8
+
 DP, TCRβhigh CD4+CD8- SP and TCRβhigh 
CD8
+
CD4
-
 SP thymocyte cohorts from WT or Ccr4
-/-
samples. 
(D) The CD4
+
 CD8
+
 DP population was separated on the basis of their CD69 
expression and the AN of CD69
- 
versus CD69
+ 
DP subsets calculated and displayed 
from WT or Ccr4
-/-
 cell suspensions. 
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Figure 5. 7 Conventional SP4 and SP8 T Cell Development Is Not Disrupted In 
CCR4 Deficient Mice 
Thymocytes from adult WT (top) or Ccr4
-/-
 (bottom) mice were isolated and stained 
for flow cytometry analysis. The Qa2 and CD69 expression was explored within: (A) 
TCRβhigh SP4 population, or (C) TCRβhigh SP8 subset, and represented as contour 
FACS plots.  
The percentages (top) and AN (bottom) of (B) SP4 populations: CD69
+
 Qa2
-
 TCRβhigh 
SP4 (left) and CD69
- 
Qa2
+
 TCRβhigh SP4 (right), or (D) SP8 populations: CD69+ Qa2- 
TCRβhigh SP8 (left) and CD69- Qa2+ TCRβhigh SP8 (right), were calculated per mouse 
and displayed as bar graphs. Each bar graph represents the mean percentage or ANof 
thymocyte subsets recovered from x6 individual WT (white bars) or Ccr4
-/-
 (gray bars) 
mice. The standard error bars display the SEM, and a student’s two tailed unpaired T 
test was performed on all results, where ns denoted a non-significant difference, as P > 
0.05.  
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Figure 5. 8 The Frequency Of Foxp3
+ 
CD25
+ 
Treg Or CD25
+
 Foxp3
-
 Treg 
Precursors Is Not Disrupted In CCR4 Deficient Mice 
(A) Thymocytes recovered from adult WT (top) or Ccr4
-/-
 (bottom) mice were isolated 
and analyzed for intracellular staining of Foxp3 within the TCRβhigh SP4 population. 
The Foxp3
-
 fraction of TCRβhigh SP4 thymocytes was also explored for their surface 
expression levels of CD25.  
 
(B) The percentages (top) and AN (bottom) of the Foxp3
+
 TCRβhigh SP4 Treg subset 
(left) and Foxp3
-
 CD25
+
 TCRβhigh SP4 Treg precursors (right) were calculated from 
WT (white bars) and Ccr4
-/-
 (gray bars) hosts and displayed as mean bar graphs, 
representing x6 individual mice per condition. The standard error bars indicate the 
SEM, and a student’s two tailed unpaired T test was performed on all results, where ns 
denoted a non-significant difference, where P > 0.05. 
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Figure 5. 9 Normal Accumulation Of SP4 And SP8 Thymocytes Within 
Medullary Regions In CCR4 Deficient Mice  
WT and Ccr4
-/- adult thymi were frozen for confocal analysis. 7μm whole thymus 
sections were cut and stained for immunofluorescence confocal analysis. 
 
(A) Tile scans of a series of low resolution images are shown for whole thymus 
sections from WT (left) and Ccr4
-/- (right) host, staining for ERTR5 and β5T. Bars 
represent a scale of 1mm  
 
(B) Higher resolution images of smaller thymic areas for the analysis of CD4 and CD8 
staining. The white dashed line denotes the corticomedullary junction, C=cortex and 
M=medulla. Bars represent a scale of 100 μm 
 
(C) The number of SP4 (left graph) or SP8 (right graph) cells within a 100μm x 
100μm square medullary area were counted within x3 regions per section, on x4 serial 
section images per host. The numbers acquired from x3 WT (white bars) and x3 Ccr4
-
/- 
(grey bars) hosts are displayed as mean bar graphs. The standard error bars indicate 
the SEM, and a student’s two tailed unpaired T test was performed on all results, 
where * denoted a significant difference (P= < 0.05). 
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To further investigate a potential subtle role for CCR4 in adult intrathymic T cell 
development, we established mixed bone marrow chimaeras with WT or Ccr4
-/- 
bone marrow 
samples. Lethally irradiated CD45.1
+
 hosts were reconstituted with an intra-venous transfer 
mixture of BM cells from WT CD45.1
+
 donors and either CD45.2
+
 WT or CD45.2
+
 Ccr4
-/- 
donors, at a 1:1 input ratio. Initially hosts received total BM cells from WT or Ccr4
-/- 
donors, 
but on repeat, BM samples were T cell depleted prior to transfer. Results are displayed from 
both total and T cell depleted BM chimera mice. Chimera hosts were sacrificed 5 weeks post 
BM reconstitution and thymocyte development and intrathymic position of CD45.1
+
 WT or 
CD45.2
+ 
Ccr4
-/-
 donor cellswas explored.  
Initial analysis of thymocyte development between the WT and Ccr4
-/-
 donors in competitive 
environments revealed CD45.2
+
 Ccr4
-/- 
thymocytes displayed no disruption to their 
development program compared to their CD45.1
+
 WT counterparts (Figure 5.10-12), 
including successful generation of the most mature CD69
-
 Qa2
+
 SP4 and SP8 cohorts (Figure 
5.11), along with the differentiation of CD25
+
 FoxP3
- 
nTreg precursors and their CD25
+
 
FoxP3
+ 
nTreg progeny  (Figure 5.12). Both T cell depleted and total BM reconstitutions 
displayed comparable unaffected phenotypical effects on the T cell development program. 
Due to small sample sizes no statistical analysis was performed and more extensive analysis is 
needed to draw any firm conclusions from this experimental model. The study of thymocyte 
localization within this competitive microenvironment also revealed no disruption to the 
positioning of Ccr4
-/- 
SP4 and SP8 cells compared to WT counterparts (Figure 5.13).  
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Figure 5. 10 Ccr4
-/- 
Thymocyte Maturation Within A Competitive 
Microenvironment With Their WT Counterparts 
(A) Lethally irradiated WT CD45.1
+
 hosts were intravenously (IV) injected with a 
mixture of adult bone marrow cells (total BM or T cell depleted BM) from a WT 
CD45.1
+
 donor combined with either Ccr4
-/- 
CD45.2
+
 or control WT CD45.2
+
 donor 
cells (littermate controls), at a 1:1 ratio. In this experimental setting Ccr4
-/- 
thymocytes 
develop within a WT thymic microenvironment within competition with WT 
developing thymocytes. 5 weeks post bone marrow reconstitution mice were sacrificed 
and the thymus analysed to explore developmental differences between the WT 
CD45.2
+ 
and Ccr4
-/- 
CD45.2
+
donor populations. Thymocytes were analysed for their 
developmental status by flow cytometry analysis and their intrathymic localization 
determined via immunofluorescence confocal analysis  
 
(B) Thymocytes were isolated from non-T cell depleted WT bone marrow 
reconstituted hosts. The CD45.2
+ 
WT (top) or CD45.2
+ 
Ccr4
-/- 
(bottom) donor 
thymocytes were identified from a histogram and their CD4 versus CD8 surface 
expression was explored and displayed as a contour plot. The TCRβ expression and 
CD69 expression levels of total CD45.2
+ 
thymocytes was also investigated and 
displayed as histograms. The numbers depict the percentages of cells within each gate. 
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Figure 5. 11 CCR4
 
Deficient Thymocytes Do Not Present With Altered 
Conventional SP4 And SP8 T Cell Development In The Presence Of WT 
Competition 
CD45.2
+ 
WT donor thymocytes (left) or CD45.2
+ 
Ccr4
-/-
 donor thymocytes (right) 
from non-T cell depleted bone marrow reconstituted WT hosts were identified and 
their Qa2 and CD69 expression was explored within: (A) TCRβhigh CD4+ SP subsets 
or (D) TCRβhigh CD8+ SP subsets, represented as contour FACS plots.  
 
The percentages of CD45.2
+ 
WT (white bars) or CD45.2
+ 
Ccr4
-/-
 (grey bars) 
populations: 
CD69
+
 Qa2
-
 TCRβhigh SP4 (left) and CD69- Qa2+ TCRβhigh SP4 (right) from (B) total 
BM reconstitution or (C) T cell depleted BM reconstitution. 
CD69
+
 Qa2
-
 TCRβhigh SP8 (left) and CD69- Qa2+ TCRβhigh SP8 (right) from (E) total 
BM reconstituted hosts or (F) T cell depleted BM reconstituted hosts. 
 
Percentages are displayed as mean bars graphs, representing x3 individual hosts per 
non-T cell depleted BM condition, and x 2 hosts per T cell depleted BM condition. 
The standard error bars display the SEM. 
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Figure 5. 12 CCR4 Deficient Thymocytes Do Not Display Reduced Frequencies 
Of Foxp3
+ 
CD25
+ 
Treg Or CD25
+
 Foxp3
-
 Treg Precursors In The Presence Of 
WT Competition  
(A) CD45.2
+ 
WT donor thymocytes (top) or CD45.2
+ 
Ccr4
-/-
 donor thymocytes 
(bottom) from non-T cell depleted bone marrow reconstituted WT hosts were 
identified by flow cytometry and analyzed for intracellular staining of Foxp3 within 
the TCRβhigh SP4 population. The Foxp3- fraction of TCRβhigh SP4 thymocytes was 
also explored for their surface expression levels of CD25. All data is represented as 
contour FACS plots. 
  
The percentages of CD45.2
+ 
WT (white bars) or CD45.2
+ 
Ccr4
-/-
 (grey bars) donor 
cells within the Foxp3
+
 TCRβhigh SP4 Treg subset (left) or Foxp3- CD25+ TCRβhigh 
SP4 nTreg precursor population (right), recovered from (B) total BM reconstituted 
hosts or (C) T cell depleted BM reconstituted hosts. 
 
Results are displayed as mean bar graphs, representing x3 individual hosts per non-T 
cell depleted BM condition, and x 2 hosts per T cell depleted BM condition. The 
standard error bars display the SEM. 
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Figure 5. 13 Grossly Normal Intrathymic Accumulation Of CCR4 Deficient 
Thymocytes in The Presence Of WT Competition 
WT host thymi receiving either: CD45.1
+
 WT + CD45.2
+
 WT T cell depleted bone 
marrow or CD45.1
+
 WT + CD45.2
+
 Ccr4
-/- 
T cell depleted bone marrow (see model 
5.10) were frozen for confocal analysis. 7μm thymus sections were cut and stained for 
CD45.1, CD45.2 and the medullary marker ERTR5. 
(A) High resolution images of the cortex (right) or medulla (right) from CD45.1
+
 WT 
+ CD45.2
+
 WT hosts (top) or CD45.1
+
 WT + CD45.2
+
 Ccr4
-/- 
host (bottom). C=cortex 
and M=medulla. Bars represent a scale of 100 μm 
(B) The number of CD45.2
+
 WT donor thymocytes (white bars) or CD45.2
+
 Ccr4
-/- 
donor thymocytes (grey bars) within a 100μm x 100μm area of either cortical (left) or 
medullary regions (right) were counted within x3 regions per section, on x4 serial 
section images per host. A total of x3 hosts per condition were analysed and cell 
counts are displayed as mean bar graphs. The standard error bars indicate the SEM and 
a student’s two tailed unpaired T test was performed on all results, where ns denoted a 
non-significant difference, (P > 0.05) and * denoted a significant difference (P= < 
0.05). 
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5.2.3 CCR4 x CCR7 Double Deficient Mice Display Disrupted T Cell 
Development And Intrathymic Localisation of SP4/SP8 Thymocytes 
Although establishing competitive bone marrow chimeras was aimed at eliminating possible 
compensatory chemokine receptors that may facilitate unperturbed thymocyte development 
and cortex to medulla migration in Ccr4
-/-
 mice, we were interested to explore this further. As 
both previously published data (Kwan and Killeen, 2004; Ueno et al., 2004) and our own 
analysis (Figure 5.1 to 5.4) shows CCR7 drives cortex to medulla migration of SP4 and SP8 
thymocytes, we speculated that the lack of CCR4 may be partially compensated by the 
presence of CCR7. We therefore generated Ccr4
-/- 
x Ccr7
-/-
 double deficient mice and in 
preliminary experiments explored thymocyte development and intrathymic localization of 
SP4 and SP8 lineages. Analysis of thymocyte development within Ccr4
-/- 
x Ccr7
-/-
 double 
deficient mice revealed striking differences in comparison to their WT counterparts (Figure 
5.14), including significantly reduced thymocyte cellularity, with an approximate one-third 
decline to the total cell count compared to their WT controls (Figure 5.14 A). Despite this, no 
major disruption of CD4 or CD8 thymocyte subsets was found (Figure 5.14 B and D), 
although Ccr4
-/- 
x Ccr7
-/-
 mice perhaps showed an increase in the percentage of the TCRβhigh 
SP4 fraction (Figure 5.14 B and C- top graph).  
Analysis of the generation of immature CD69
+
 Qa2
- 
versus mature CD69
-
 Qa2
+
 fractions of 
convention SP4 cells in Ccr4
-/- 
x Ccr7
-/-
 mice revealed differences in the proportions of 
thymocytes at these two maturational stages, compared to the WT controls (Figure 5.15), with 
Ccr4
-/- 
x Ccr7
-/-
 mice showing an increase in the percentages of CD69
+
 Qa2
- 
cells and a 
percentage decrease in CD69
-
 Qa2
+ 
SP4 thymocytes (Figure 5.15 B). This preliminarily  
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Figure 5. 14 Absence of CCR4 And CCR7 Results In Decreased Thymocyte Cell 
Numbers And An Increase In The Frequency Of The TCRβhigh SP4 Cohort 
Adult Ccr4
-/- 
x
 
Ccr7
-/-
 or WT thymocyte cell suspensions were isolated and absolute 
cell numbers obtained before staining for flow cytometry analysis.  
 
The AN of each distinct population was calculated per mouse from the total thymocte 
cell count and the percentage of each population acquired via flow cytometry analysis. 
The AN of each distinct population was displayed as a mean bar graph from WT 
(white bars) or Ccr4
-/- 
x
 
Ccr7
-/-
 (grey bars) samples, with data representing x6 
independent mice per condition and the error bars denoting the SEM. A student’s two 
tailed unpaired T test was performed on all results, where ns denoted a non-significant 
difference (P > 0.05) and *, ** or *** indicate a significant difference (* = P < 0.05, 
** = P < 0.01 and ***= P < 0.001). 
 
(A) The absolute cell count of total WT or Ccr4
-/- 
x
 
Ccr7
-/-
 thymus samples. 
(B) The CD4 versus CD8 surface expression on total thymocytes was explored in WT 
(top) and Ccr4
-/- 
x
 
Ccr7
-/-
 (bottom) cell samples and displayed as contour plots. The 
TCRβ expression and CD69 expression levels of total thymocytes was also 
investigated and displayed as histograms. The numbers depict the frequency of cells 
within each gate.  
(C) The percentages (top) and AN (bottom) of CD4
-
CD8
-
 DN, CD4
+
 CD8
+
 DP, 
TCRβhigh CD4+CD8- SP and TCRβhigh CD8+CD4- SP thymocyte subsets from WT or 
Ccr4
-/- 
x
 
Ccr7
-/-
 samples. 
(D) The CD4
+
 CD8
+
 DP population was separated on the basis of their CD69 
expression and the percentages (top) or AN (bottom) of CD69
- 
versus CD69
+ 
DP 
displayed from WT or Ccr4
-/- 
x
 
Ccr7
-/-
cell suspensions. 
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Figure 5. 15 Conventional SP4 T Cell Development Is Disrupted In A CCR4 x 
CCR7 Double Deficient Mice 
(A) Thymocytes from adult WT (top) or Ccr4
-/- 
x
 
Ccr7
-/-
 (bottom) mice were isolated 
and stained for flow cytometry analysis. The Qa2 and CD69 expression was explored 
within the TCRβhigh SP4 population and represented as contour FACS plots.  
 
(B) The percentages (top) and AN (bottom) of SP4 populations: total TCRβhigh SP4 
thymocytes (left), CD69
+
 Qa2
-
 TCRβhigh SP4 (middle) and CD69- Qa2+ TCRβhigh SP4 
(right), were calculated per mouse and displayed as bar graphs. Each bar graph 
represents the mean percentages or AN of thymocyte subsets recovered from x6 
individual WT (white bars) or Ccr4
-/- 
x
 
Ccr7
-/- 
(gray bars) mice. The standard error 
bars denote the SEM, and a student’s two tailed unpaired T test was performed on all 
results, where ns denoted a non-significant difference (P > 0.05) and * or ** indicates 
a significant difference (*= P < 0.05 and **= P < 0.01). 
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analysis of TCRβhigh SP4 population, therefore, suggests the absence of both CCR4 and 
CCR7 disrupts the developmental program of this SP lineage, with the immature versus 
mature status of this subset skewed toward a CD69
+
 Qa2
- 
phenotype. 
Analysis of the equivalent populations within the TCRβhigh SP8 thymocyte subset exposed 
additional variation within Ccr4
-/- 
x Ccr7
-/-
 mice (Figure 5.16). FACS plots displaying CD69 
and Qa2 expression within the Ccr4
-/- 
x Ccr7
-/-
 TCRβhigh SP8 population differed to those 
obtained from the WT controls (Figure 5.16 A). Overall Qa2 levels appeared higher within 
the total Ccr4
-/- 
x Ccr7
-/-
 TCRβhigh SP8 population compared to their WT counterparts, with a 
detectable subset of cells co-expressing very high levels of Qa2 and CD69, not evident within 
the WT TCRβhigh SP8 cohort. The average percentage analysis of the immature versus mature 
TCRβhigh SP8 subsets identified an overall reduction to the percentage of Ccr4-/- x Ccr7-/- 
mature CD69
-
 Qa2
+ TCRβhigh SP8 cells, compared to their WT counterparts (Figure 5.16 B). 
The decline of this mature SP8 fraction was complimentary to the decrease observed in the 
equivalent population of TCRβhigh SP4 thymocytes. In contrast, no alterations were observed 
to the percentage of immature CD69
+
 Qa2
-/intermediate  TCRβhigh SP8 cells from Ccr4-/- x Ccr7-/- 
hosts compared to WT. Collectively, preliminary investigations into SP4 and SP8 thymocyte 
development within a Ccr4
-/- 
x Ccr7
-/-
 thymic microenvironment suggest both receptors are 
essential for successful maturation of both SP conventional lineages.   
Analysis of the development of the CD25
+
 FoxP3
+
 nTreg SP4 lineage within the Ccr4
-/- 
x 
Ccr7
-/-
 microenvironment also displayed disruptions in the absence of these two receptors. 
The percentages of Ccr4
-/- 
x Ccr7
-/-
 CD25
+
 FoxP3
+
 nTreg was significantly increased and the 
frequency of CD25
+
 FoxP3
-
 nTreg precursors reduced, compared to their WT counterparts  
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Figure 5. 16 Conventional SP8 T Cell Development Is Disrupted In CCR4 x 
CCR7 Double Deficient Mice 
(A) Thymocytes from adult WT (top) or Ccr4
-/- 
x
 
Ccr7
-/-
 (bottom) mice were isolated 
and stained for flow cytometry analysis. The Qa2 and CD69 expression was explored 
within the TCRβhigh SP8 population and represented as contour FACS plots.  
 
(B) The percentages (top) and AN (bottom) of SP8 populations: total TCRβhigh SP8 
thymocytes (left), CD69
+
 Qa2
-
 TCRβhigh SP8 (middle) and CD69- Qa2+ TCRβhigh SP8 
(right), were calculated per mouse and displayed as bar graphs. Each bar graph 
represents the mean percentages or AN of thymocyte subsets recovered from x6 
individual WT (white bars) or Ccr4
-/- 
x
 
Ccr7
-/- 
(gray bars) mice. The standard error 
bars denote the SEM, and a student’s two tailed unaired T test was performed on all 
results, where ns denoted a non-significant difference (P > 0.05) and * or *** indicate 
a significant difference (* = P < 0.05 and ***= P < 0.001). 
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(Figure 5.17 A and B). The percentage increase in FoxP3
+
 nTreg was comparable to the 
increase observed within Ccr7
-/- 
mice (Figure 5.3). In contrast, however, the decreased 
frequency of CD25
+
 FoxP3
-
 nTreg precursors was a unique characteristic of Ccr4
-/- 
x Ccr7
-/-
 
mice, not shared by Ccr4
-/- 
(Figure 5.8) or Ccr7
-/-
 (Figure 5.3) strains. This data, therefore, 
suggests the absence of CCR4 and CCR7 results in the decreased generation of CD25
+
 FoxP3
-
 
nTreg precursors, but conflictingly, evokes an increase to their CD25
+
 FoxP3
+
 nTreg progeny.   
Exploration of the thymic architecture and intrathymic distribution of SP thymocytes within 
the adult Ccr4
-/- 
x Ccr7
-/-
 microenvironment displayed severe disruptions in comparison to 
their WT counterparts and additionally the Ccr7
-/-
 strain (Figure 5.18). In comparison to Ccr7
-
/-  
thymic structure (Figure 5.4), the Ccr4
-/- 
x Ccr7
-/-
 thymus grossly appeared to contain 
smaller medullary structures. From the data displayed we cannot confirm if the medullary 
volume is significantly less and additional analysis is required.  The numbers of SP4 and SP8 
thymocytes within these small Ccr4
-/- 
x Ccr7
-/-
 medullary areas were significantly reduced 
compared to their WT counterparts (Figure 5.18 C). Quantification revealed a two fold 
decreased to the numbers of both SP4 and SP8 lineages as a consequence of the absence of 
both CCR4 and CCR7. The two fold decrease in the SP4 thymocyte population was at a 
comparable level to the reduction observed within the Ccr7
-/-
 adult thymus, however, 
surprisingly, a greater reduction was observed within the SP8 population of the Ccr7
-/-
 
microenvironment, in comparison to Ccr4
-/- 
x Ccr7
-/-
 mice. Therefore, confocal analysis of the 
Ccr4
-/- 
x Ccr7
-/-
 thymic microenvironment suggested the absence of both CCR4 and CCR7 
increases the severity of the reduced medullary size observed within the Ccr7
-/-
 adult strain. 
The number of SP thymocytes within a given area of the reduced Ccr4
-/- 
x Ccr7
-/-
 medullary 
region, however, is not further reduced compared to Ccr7
-/-
condition.   
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Figure 5. 17 CCR7 x CCR4 Double Deficiency Disturbs The Frequencies Of Both 
Foxp3
+ 
CD25
+ 
Treg And CD25
+
 Foxp3
-
 Treg Precursors 
(A) Thymocytes recovered from adult WT (top) or Ccr4
-/- 
x
 
Ccr7
-/-
  (bottom) mice 
were isolated and analysed for intracellular staining of Foxp3 within the TCRβhigh SP4 
population. The Foxp3
-
 fraction of the TCRβhigh SP4 thymocytes were also explored 
for their surface expression levels of CD25.  
 
(B) The percentages (top) and AN (bottom) of the Foxp3
+
 TCRβhigh SP4 Treg subset 
(left) and Foxp3
-
 CD25
+
 TCRβhigh SP4 Treg precursors (right) were calculated from 
WT (white bars) and Ccr4
-/- 
x
 
Ccr7
-/-
 (gray bars) hosts and displayed as mean bar 
graphs, representing x6 individual mice per condition. The standard error bars indicate 
the SEM, and a student’s two tailed unpaired T test was performed on all results, 
where ns denoted a non-significant difference (P > 0.05) and *or *** indicate a 
significant difference (* = P < 0.05 and ***= P < 0.001). 
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Figure 5. 18 Absence of Both CCR4 and CCR7 Results In Reduced Numbers Of 
SP4 And SP8 Thymocytes Within Medullary Regions  
WT and Ccr4
-/- 
x
 
Ccr7
-/-
 adult thymi were frozen for confocal analysis. 7μm thymus 
sections were cut and stained for immunofluorescence confocal analysis. 
 
(A) Tile scans of a series of low resolution images are shown for whole thymus 
sections from WT (left) and Ccr4
-/- 
x
 
Ccr7
-/-
 (right) hosts, stained for ERTR5 and β5T. 
Bars represent a scale of 1mm  
(B) Higher resolution images of smaller thymic areas stained for CD4 and CD8. The 
white dashed line denotes the corticomedullary junction, C=cortex and M=medulla. 
Bars represent a scale of 100 μm 
(C) The number of SP4 (left graph) or SP8 (right graph) cells within a 100μm x 
100μm medullary area were counted within x3 regions per section, on x4 serial section 
images per host. The numbers acquired from x3 WT (white bars) and x3 Ccr4
-/- 
x
 
Ccr7
-/-
 (grey bars) hosts are displayed as mean bar graphs. The standard error bars 
indicate the SEM and a student’s two tailed unpaired T test was performed on all 
results, where *** and ** denotes a significant difference (** = P < 0.01 and ***= P < 
0.001). 
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5.3 DISCUSSION  
Relocation of positively selected thymocytes to the medulla is essential for tolerance 
induction and is controlled, at least in part, by CCR7 (Kurobe et al., 2006). The level of 
involvement of CCR7 however, remains under some dispute (Davalos-Misslitz et al., 2007). 
As absence of CCR7 does not result in a total absence of SP4 and SP8 cohorts within adult 
thymic medullary regions, we were interested to explore the role of additional chemokine 
receptors in cortex to medulla migration of thymocytes, on the initiation of positive selection. 
From work in Chapter 3, CCR4 was identified as an attractive candidate to be involved in this 
process. The receptor displayed rapid upregulation upon the initiation of positive selection 
within a large fraction of CD69
+
 DP thymocytes and was maintained on the cell surface of 
SP4 subsets at their early stages in development. In addition, we confirmed CCL17 and 
CCL21 are highly expressed within medullary areas, predominately by Sirpα+ DC, but also by 
mature mTEC. However, in both the steady state and within a competitive setting, Ccr4
-/- 
thymocytes displayed no disruption to their intrathymic T cell development program. 
Therefore, if CCR4 is indeed involved in post-selection maturation, its role must be 
dispensable and compensated for by redundancy within the chemokine receptor system.   
We hypothesized that CCR7 may have compensatory effects over the absence of CCR4 and to 
address this, towards the end of my PhD studies we generated a novel Ccr4
-/- 
x Ccr7
-/- 
double 
deficient compound mutant mouse strain. Preliminary analysis of Ccr4
-/- 
x Ccr7
-/- 
mice 
suggested perturbed post-positive selection maturation and thymic localization at a greater 
severity than that observed in Ccr7
-/- 
adults. Absence of both CCR4 and CCR7 resulted in 
reductions to overall thymic cellularity and perturbed differentiation of conventional SP4 and 
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SP8 development.  Ccr4
-/- 
x Ccr7
-/-
 presented with increased percentages of total TCRβhigh 
SP4, but attenuated development of the most mature CD69
-
 Qa2
+
 fractions within both 
lineages. In addition, medullary areas of adult Ccr4
-/- 
x Ccr7
-/-
 mice appeared smaller than 
those of Ccr7
-/- 
mice. Further experiments are required to analyze directly the medullary 
volume of these mice. Importantly, while reductions were observed in the thymic cellularity 
of Ccr4
-/- 
x Ccr7
-/-
 mice, absolute cell numbers obtained from WT mice used as controls for 
this condition were higher compared to the counts acquired from the controls of the Ccr4
-/- 
and Ccr7
-/-
 single mutants. This difference could be due to variability in sourcing of C57BL/6 
WT mice, due to limitations with availability in our animal facility. Further experiments are 
required to study the potential impact on T cell development caused by combined absence of 
CCR4 and CCR7.  
As absence of CCR7 has been linked to defective negative selection (Davalos-Misslitz et al., 
2007; Kurobe et al., 2006), it would be of interest to address the possible involvement of both 
CCR4 and CCR7 in the process of negative selection of the T cell repertoire. To address this, 
additional analysis is essential, along with analysis of any potential breakdown in central 
tolerance. This could be examined by analyzing the deletion of particular αβTCRs to 
endogenous mouse mammary tumor viruses, or by crossing our mutant mice onto TCR 
transgenic backgrounds. Interestingly, within this chapter we demonstrated that the Sirpα+ 
CD8
-
 DC population is the predominate producer of CCR4 ligands CCL17 and CCL21 within 
the thymic environment. Collectively this could suggest that absence of CCR4 may disrupt SP 
thymocyte interactions with DC, which manifest as alterations in negative selection.  
In addition to conventional SP thymocytes, differentiation of CD25
+
 FoxP3
- 
nTreg precursors 
and their CD25
+
 FoxP3
+ 
nTreg progeny was also examined in Ccr4
-/- 
x Ccr7
-/-
 adult mice and 
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a possible reduction in the SP4 CD25
+
 FoxP3
- 
nTreg precursor population was observed. 
However, given that an increase in their CD25
+
 FoxP3
+ 
nTreg progeny was also detected, 
these findings clearly identify the need for additional analysis, to include not only analysis of 
intrathymic development, but also disturbed localization, perhaps hindering thymic exit 
resulting in thymic accumulation. Regardless of the detailed impact of combined CCR4 and 
CCR7 deficiency and in contrast to the effects observed following Pertussis Toxin treatment 
(Ehrlich et al., 2009; Suzuki et al., 1999), double deficient mice still have medullary areas that 
contain both SP4 and SP8 thymocytes. Hence, cortex to medulla migration must still occur in 
the combined absence of both CCR4 and CCR7. This implies that other unknown chemokine 
receptors are facilitating this migratory pathway and may compensate for CCR4 and CCR7 
removal. CCR8 is an attractive candidate to be involved at this specific stage in intrathymic 
development, as it has been identified to display very similar expression patterns to that of 
CCR4.  TCR activation during positive selection results in the upregulation of this receptor 
and its surface expression is increased further within the immature CD4 SP faction (CD69
+
 
HSA
+
 CD62L
-
). Its expression, like that of CCR4, is limited to SP4 cells, with undetectable 
levels on CD8 SP thymocytes (Kremer et al., 2001). However, to date no investigations have 
explored the potential involvement of CCR8 in cortex to medulla migration. CCR9 is an 
additional receptor that could possibly compensate for the removal of CCR4 and CCR7, based 
upon its surface expression patterns on DP thymocytes and immature SP4 and SP8 subsets 
(Chapter 3). Although CCR9 is important for DP cortical retention (Choi et al., 2008), CCL25 
is expressed in both the corticex and medulla (Uehara et al., 2002) so it may also be involved 
in medullary migration.  Additional CCR4/CCR9 compound mutants could explore this 
possibility in more depth. 
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In conclusion our investigations into the role of CCR4 in cortex to medulla migration and the 
continued differentiation of positively selected thymocytes support a model in which this 
receptor is not essential for either T cell development nor appropriate intrathymic thymocyte 
localization. Further analysis of mice lacking both CCR4 and CCR7 will reveal whether 
compensatory mechanisms by CCR7, at least partly, explains these observations, or if CCR4 
has no involvement in the chemokine receptor- mediated migration of SP thymocytes and 
their continued maturation.  
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CHAPTER 6: GENERAL DISCUSSION 
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6.1 BACKGROUND AND OVERALL AIMS 
The differentiation of a diverse and self-tolerant T cell repertoire is dependent on the unique 
thymic microenvironment and stringent selection processes. Positive selection is a 
fundamental checkpoint in T cell development and thymocytes that successfully rearrange 
their TCRα and TCRβ genes are screened for their ability to recognize self-MHC in the cortex. 
The αβTCR must interact at low avidity with self peptide-MHC complex presented on the cell 
surface of cTEC and such engagements stimulate the transition from DP to SP thymocytes. At 
this stage in development, cells commit to either a CD4
+
 CD8
- 
or CD4
- 
CD8
+
 SP lineage fate 
and undergo the transition from cortical regions, across the corticomedullary junction, into 
medullary areas, a migratory pathway facilitated by chemotatic signals (Ehrlich et al., 2009; 
Suzuki et al., 1999). Those thymocytes that fail to be positively selected undergo death by 
neglect. Following entry to the medulla, high avidity TCR interactions with peptide-MHC 
complexes induce death signals and negative selection, contributing to the deletion of self-
reactive thymocytes, which is essential for the establishment of central tolerance.  
Thymocyte residency within the medulla is indispensible for the establishment of tolerance. 
Positively selected SP cells are thought to reside within the medulla between 5 to 14 days, 
although the precise medullary dwell time remains unclear (McCaughtry et al., 2007; Scollay 
and Godfrey, 1995). During this medullary residency SP thymocytes interact with medullary 
thymic epithelial cells (mTEC) and DC and any residual thymocytes displaying αβTCRs with 
potential specificity to self, that have escaped negative selection within the cortex are deleted 
(Anderson and Takahama, 2012). A proportion of these self reactive thymocytes have an 
alternative fate and upon high avidity bind of their TCR to self-peptide-MHC complexes 
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undergo maturing into Foxp3
+
 nTreg (Moran et al., 2011; Stritesky et al., 2012) This Foxp3
+
 
SP4 nTreg population is vital in the regulation of immune homeostasis and immunological 
tolerance (Sakaguchi et al., 1995). In addition, while residing within the medulla conventional 
SP4 and SP8 lineages complete their multistep maturation program of late stage αβT cell 
development, before their export into the periphery to become naive T cells. Disruptions in 
either thymocyte homing to the medulla, or normal development of its structure, have been 
suggested to result in a breakdown of tolerance, which can manifest as autoimmunity (Burkly 
et al., 1995; Kurobe et al., 2006; Naspetti et al., 1997).  
The general aim of this study was to explore the importance of specialized medullary 
microenvironments in T cell development and selection. The main emphasis of our 
investigations was to address the following questions: 
a) What is the role of the thymic medulla in the post-positive selection maturation processes 
of conventional and Foxp3
+
 regulatory SP thymocytes? 
b) What are the signals that control cortical-to-medullary transition of developing 
thymocytes?  
6.2 REDEFINING THE ROLE OF THE THYMIC MEDULLA IN αβT 
CELL DEVELOPMENT 
The role of thymic medulla in the establishment of central tolerance is well established. 
However, the function of the thymic medulla in supporting the late stages of conventional 
CD4 and CD8 SP development, along with the generation of the specialized non-conventional 
nTreg lineage, is less well known. Literature suggests mTEC interactions are essential in the 
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differentiation program of SP4 thymocytes (Li et al., 2007), in addition to the intrathymic 
generation of Foxp3
+
 nTreg (Aschenbrenner et al., 2007; Hinterberger et al., 2010). Thus, we 
explored the effects of mTEC deficiency on development of these diverse thymocyte lineages, 
post-positive selection.  
Amid the exploration of the role of the thymic medulla we established a new classification 
system to map the phenotypic changes of thymocytes during the process of positive selection. 
We utilized chemokine receptor surface expression patterns to defined distinct stage of SP4 
and SP8 intrathymic T cell development. This approach facilitated the identification of a new 
cohort of the most immature SP4 thymocytes, based upon their CCR9
+
CCR4
+
CCR7
- 
CD69
+
 
phenotype. We predicted this immature fraction of thymocytes is the most recent population 
to have undergone the positive selection process and we demonstrated at this stage in maturity 
SP4 cells have yet to commit to the SP4 lineage, maintaining their ability to differentiate into 
SP8 thymocytes. This chemokine receptor classification system also provides an alternative to 
commonly used “developmental stage defining markers” such as CD62L HSA and Qa2, with 
markers of potential functional importance within the intrathymic T cell development process 
(Chapter 3).  
We designed an experimental model to directly explore intrathymic T cell development 
within an mTEC deficient microenvironment, in the presence of an otherwise normal immune 
system.  Experiments using this mTEC deficient grafting model challenged the suggestion 
that mTEC provide essential support for SP4 differentiation, but instead implies conventional 
SP thymocyte development can occur independently of the thymus medulla. Furthermore 
analysis of extrathymic maturation offered additional confirmation to the notion that mTEC 
do not provide vital support for SP4 differentiation. In marked contrast, our experiments 
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support the proposal that the generation of Foxp3
+
 nTreg is critically dependent upon an intact 
thymus medulla, as we demonstrated the requirement of mTEC for the differentiation of the 
Foxp3
-
CD25
+ 
nTreg precursor population and their progeny (described in Figure 6.1).  
Collectively, the results of Chapter 4 warrant reconsideration of the role of the medullary 
microenvironment during T cell development. These findings demonstrate a disparity in 
the requirement of the thymic medulla with regards to the FoxP3
+
 nTreg versus conventional 
SP lineages, suggesting the principle role of the medulla is in the establishment of tolerance, 
via both negative selection and nTreg generation, as opposed to an essential site that nurtures 
later stages of conventional αβT cell development. Such findings raise a complexity of 
questions into the essential signals that drive both developmental pathways. For example, 
while differentiation into the most mature stages in conventional SP development can occur 
independently of mTEC, based upon their CD69
-
 Qa2
+
 surface phenotype, the transplantation 
of mTEC deficient grafts into an athymic host demonstrated that those mature CD4 and CD8 
T cells raised in the absence of an intact medulla induce autoimmunity, in the absence of 
protection by peripheral tolerance. Thus, whilst we suggest conventional SP thymocytes can 
complete their full differentiation program in the absence of mTEC on the basis of their 
surface expression patterns of age defining markers, we demonstrate such thymocytes are not 
likely to be tolerant to self. Moreover, we established that WT hosts provide sufficient 
peripheral tolerance to control autoreactive T cells raised in an mTEC deficient environment, 
preventing autoimmunity. Overall, the data indicates an intact medulla may not be 
fundamental in the generation of a mature conventional CD4 or CD8 T cell pool, although it 
is essential for the development of a self-tolerant repertoire. In addition, this study calls for a 
rethink of the length of medullary residency and emigration in regards to differentiation of  
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Figure 6. 1 A Requirement For mTEC The Generation Of Foxp3
+
 nTreg But Not 
Conventional SP Thymocytes 
The figure demonstrates a proposed model of the requirement for medullary thymic 
epithelial cell (mTEC) during SP thymocyte development.  
 
Initially, CD4
+
CD8
+
 DP cells that successfully undergo positive selection differentiate 
into the most immature CCR7
-
CCR9
+
CD69
+
 SP4 thymocyte subset. In the absence of 
mTEC these newly selected SP4 cells can continue their development into 
conventional CD69
-
Qa2
+
 mature SP4 and SP8 thymocytes. In contrast, differentiation 
into Foxp3
+
 CD25
+
 T-regulatory SP4 cells is blocked in the absence of mTEC, 
indicating an essential role for these cells to support the development of newly 
generated SP4 thymocytes into Foxp3
+
 CD25
+
 T-regulatory cells. 
 
The surface expression profiles of each thymocyte subset at different maturational 
stages are highlighted.  
 
Red crosses indicate the absence of a cell type. 
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various T cell lineages. The diverse mTEC requirements of conventional versus FoxP3
+
 
nTreg lineages may influence their specific medullary dwell time. The exact time thymocytes 
are believed to reside in the medulla remains under dispute (McCaughtry et al., 2007; Scollay 
and Godfrey, 1995), however, there are two well-established yet conflicting models of how 
thymic residency and egress is regulated. The ‘conveyor belt’ mechanism suggests the oldest 
thymocytes leave first and all immature T cell share the same maturational phenotype as they 
exit the thymus as recent thymic emigrants (RTE) (McCaughtry et al., 2007). In contrast the 
‘lucky dip’ model suggests thymocytes can leave the medullary pool randomly at any stage in 
their maturation program and hence the RTE cell pool represents cells at various stages of 
their maturity (Egerton et al., 1990; Kelly and Scollay, 1990; Scollay and Godfrey, 1995).  
The most recent investigations into medulla dwell time using the RAG-2 GFP model suggests 
conventional SP4 and SP8 lineages emigrate via the conveyor belt method into the periphery 
4 to 5 days after medullary entry. These studies propose non-conventional thymocytes have 
extended medullary dwell times in comparison to conventional lineages. This assumption is 
based specifically on NKT and nTreg lineages, due to a large proportion of the two 
populations displaying an intrathymic RAG-2 GFP
-
 phenotype. The decay of GFP expression 
within these specialized subsets would imply they represent either long term thymic residents 
or recirculating cells (McCaughtry et al., 2007). It has been demonstrated the most mature 
NK1.1
+ 
fraction of NKT cells undergo longer term retention in the thymus (Berzins et al., 
2006), whilst investigations ongoing within our own laboratory suggest the sufficient 
generation of this distinct mature NK1.1
+
 subsets is dependent on an intact medullary 
environment (unpublished). In contrast, to date there is no research in to the possible long 
term residency of nTreg within medullary regions, however the re-entry of Treg back to the 
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thymus has been reported (Bosco et al., 2006). Further experiments are planned to investigate 
whether the absence of an intact mTEC compartment alters the medullary dwell time of 
positively selected T cells. As we have revealed the initial development of the nTreg 
lineage occurs at the intermediate CCR9
- 
CCR7
+
 CD69
+ 
SP4 stage of maturation and this 
processes is dependent upon mTEC signals, this may suggest a need for additional medullary 
dwell time. The reduced RAG-2 GFP
-
 populations recovered from our mTEC deficient 
microenvironments grafted into a RAG-2 GFP host supports such a theory, if we make the 
assumption at least a fraction of the RAG-2 GFP
– 
population represents the nTreg population. 
Currently while we have been unsuccessful in our attempts to successfully intracellular stain 
for Foxp3 without disrupting GFP expression and thus, we aim to modify the technique to 
simultaneously detect the two molecules. This would aid the identification of the RAG-2 
GFP
-
 thymic residents, offering confirmation if they are indeed the nTreg population. In 
addition, we have recently generated new mouse colonies in which RAG-2 GFP mice have 
been crossed with either LTR-deficient or Aire-deficient, both of which display medullary 
abnormalities. These mice should prove to be useful in investigating how altered medullary 
microenvironments might impact upon thymic medullary dwell time and the frequency of 
recent thymus emigrants. 
The thymic medulla is not exclusively comprised of developing thymocytes and mTEC. This 
unique specialized microenvironment is comprised of additional cell types including thymic 
DC (Barclay, 1981; Lei et al., 2011). Intrathymic DC subsets, via antigen presentation, are 
capable of regulating negative selection (Gallegos and Bevan, 2004), or inducing the 
generation of nTreg (Proietto et al., 2008b; Spence and Green, 2008; Watanabe et al., 2005a; 
Wirnsberger et al., 2009). Our investigations into DC subsets within mTEC deficient thymus 
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grafts demonstrated that in the absence of this epithelial cell population the Sirpα+ CD8- cDC 
cohort, which homes to the thymus from the periphery (Li et al., 2009), was present at normal 
frequencies. In contrast, in the absence of an intact medullary environment the thymically 
generated Sirpα- CD8+ cDC and the peripherally derived pDC populations were both 
significantly reduced (Li et al., 2009; Wu and Shortman, 2005). While the importance of 
mTEC for the other DC subsets is not fully understood, this finding may suggest that the 
Sirpα+ CD8- cDC division may stimulate conventional SP4 and SP8 development, yet its 
presence must be insufficient to drive the generation of nTreg. Surprisingly, this DC subset 
specifically has been identified as having superior capacity to generate Foxp3
+ 
nTreg (Proietto 
et al., 2008b), however the additional Sirpα- CD8+ cDC and pDC populations have also 
demonstrated the ability to induce this specific T cell lineage intrathymically (Guerri et al., 
2013; Martin-Gayo et al., 2010; Proietto et al., 2008b). Collectively, the involvement of 
mTEC in nTreg induction identified within our own studies, together with the well-
documented role of distinct DC subsets, supports the idea that the generation of this 
specialized population is unlikely to require the interactions of a dedicated antigen presenting 
cells type, but rather it is dependent on either or perhaps a collective of these two cohorts 
(Wirnsberger et al., 2009).  We are currently performing in vitro RTOC experiments 
involving defined combinations of distinct DC subsets, together with the presence or absence 
of mTEC to gain a better understanding of the importance of these cells in conventional and 
Foxp3
+
 nTreg T cell development. Furthermore it has been suggested that diverse DC subsets 
induce nTreg population with distinct functions, on the basis of their cytokines production 
profile (Martin-Gayo et al., 2010). Therefore this experimental approach could also be 
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utilized to explore the possibility of distinct nTreg subpopulations, on the basis of the APC 
upon which they were selected. 
Overall, more detailed analysis is essential to confirm mTEC are essential for DC mediated 
nTreg selection and reveal what critical signals this specialized epithelial cell type is 
providing. The generation of Foxp3
-
CD25
+ 
nTreg precursors is thought to be dependent upon 
CD28-CD80/CD86 interactions (Hinterberger et al., 2011; Lio et al., 2010; Vang et al., 2010), 
in addition to TCR-MHC binding (Lio and Hsieh, 2008). Thus, it is possible the absence of 
the mTEC population results in the failure of TRA production and self-antigen cross-
presentation to DC, consequentially leading to their inability to induce the differentiation of 
this nTreg SP4 lineage.  The expression of endogenous self-antigen is considered a distinct 
function of the Aire
+
 mTEC population (Derbinski et al., 2001). Interestingly, however, Aire 
protein has also been found in the thymically induced Sirpα- CD8+ cDC population, although 
this population is significantly reduced in the mTEC deficient microenvironment (Heino et al., 
2000). It has also been found that thymic homing DC subsets, particularly the pDC cohort, 
but to a lesser extent the Sirpα+CD8- cDC fraction, have been shown to transport antigens 
from the periphery for presentation to the developing thymocytes (Hadeiba et al., 2012). The 
inability of the DC resident within our mTEC deficient environments to induce nTreg 
generation, would suggest any DC bound antigen, perhaps peripherally derived, present 
within the grafts must be insufficient at driving the development of this non-conventional SP4 
lineage and thus, mTEC derived self-antigen specifically must be crucial. One possible 
explanation for this is that peripheral derived antigen is not able to induce sufficient TCR 
affinity and signal strength to drive the differentiation of this specific SP4 subset.  In contrast 
any peripheral antigen presented to developing T cells by DC subsets present within our 
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mTEC deficient environment may be sufficient to complete conventional SP4 and SP8 
development, in addition to the interactions they undergo with the cTEC population. From 
this data, however, we are unable to confirm if conventional SP4 and SP8 development is 
TCR mediated via DC interaction, or if indeed DC are even involved, as additional survival 
signals could be facilitating this continued maturational process.   
Thus, we hypothesize the mTEC production of TRA is vital for the development of the 
CD25
+
 FoxP3
-
 nTreg precursor population and their CD25
+
 FoxP3
-
 nTreg progeny. The 
synthesis of self-antigen and their direct presentation by mTEC, or cross-presentation by DC, 
to developing thymocytes facilitates the generation of this specialized regulatory T cell subset 
via high avidity TCR- self -peptide MHC complex interactions. In additional we speculate 
homed DC populations within our mTEC deficient microenvironment may present peripheral 
antigen to developing thymocytes, which may support their continued development to the 
later stage of conventional αβT cell development, or perhaps provide the correct survival 
signals in a TCR-peptide MHC independent manner to foster their development (Described in 
Figure 6.2).  
6.3 HOW DO POSITIVELY SELECTED THYMOCYTES ENTER THE 
MEDULLA? 
An additional aim of this thesis was to explore how thymocytes undergo ordered migration 
into the specialized medullary thymic microenvironment. Pertussis Toxin treatment results in 
the complete absence of SP thymocytes entering the thymic medulla (Ehrlich et al., 2009; 
Suzuki et al., 1999), whilst the absence of CCR7 alone results in small medullary areas that 
still contain SP4 and SP8 thymocytes (Ueno et al., 2004). Thus, we hypothesized that  
  
 289 
 
Figure 6. 2 Proposed Interactions of Antigen Presenting Cells With Immature SP 
Thymocytes During CD4 SP Conventional And Foxp3
+
 nTreg Development  
Conventional T cell development (upper panel): 
In this model, dendritic cells (DC) can interact with newly generated CCR7
-
CCR9
+
CD69
+
 SP4 thymocytes, via either T cell receptor (TCR)- MHC cell mediated 
interactions, or other survival signals, to mediate the continued development of 
conventional SP4 and SP8 thymocytes that can occur in the absence of mTEC. 
 
Foxp3
+
 T regulatory development (lower panel): 
Here, the direct presentation of self-peptides by Aire
+
 medullary thymic epithelial cell 
(mTEC) to newly generated CCR7
-
CCR9
+
CD69
+
 SP4 thymocytes induces the 
generation of Foxp3
-
 CD25
+
 nTreg precursors and their Foxp3
+
 CD25
+
 nTreg progeny. 
This model also suggests that the cross-presentation of self-peptides from Aire
+
 mTEC 
to DC facilitates their ability to also drive Foxp3
+
 CD25
+
 nTreg differentiation, 
supporting the idea of a dual requirement for both mTEC and DC in nTreg 
development.  
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additional chemokine receptors are involved in this process. Analysis of the chemokine 
receptor surface expression patterns of developing thymocytes, along with the gene 
expression patterns of chemokines within distinct TEC populations, identified CCR4 as a 
promising additional candidate for intrathymic cortex to medulla migration. Most published 
data on expression of CCR4 and its ligands in the thymus is limited to either PCR analysis or 
functional chemokine migration assays (Campbell et al., 1999) and thus, per cell analysis of 
expression of CCR4 during T cell development remained unexplored. Our own results clearly 
show CCR4 is expressed on the cell surface of thymocytes undergoing the positive selection 
process, which are likely to be undertaking corticomedullary relocalization. However, 
detailed analysis of mice lacking CCR4 expression suggested that this chemokine receptor is 
not essential for intrathymic positioning of developing thymocytes.  
As a consequence of the known redundancy that occurs within the chemokine receptor system 
it is very difficult to explore the effects of the removal of individual chemokine receptors, as 
additional receptors may conceal their true involvement. Thus, in an attempt to overcome this 
problem we generated a novel compound mutant mouse strain with a double deficiency in 
CCR4 and CCR7, as CCR7 has been identified to be pivotal in cortex to medulla migration 
(Kwan and Killeen, 2004; Ueno et al., 2004). Initial preliminary analysis of these mice was 
performed and such experiments suggested that all major SP4 and SP8 thymocyte subsets 
were present, including CD4
+
 cells expressing Foxp3, indicating that a normal program of T 
cell development can occur in the combined absence of these receptors. In addition, confocal 
analysis of thymus sections showed very small medullary areas containing SP4 and SP8 
thymocytes. It is important to note such findings are at their preliminary stage and require 
further detailed analysis, to confirm if these mice display with further reductions to their 
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medullary size in comparison to Ccr7
-/- 
mice. To obtain a more definitive idea of the effects of 
the combined absence of CCR4 and CCR7 has on medullary size we hope to explore the 
architecture of different chemokine receptor deficient thymic microenvironments using 
advanced imaging techniques, with the aid of collaborations with Dr Magali Irla, at the Center 
of Immunology in Marseille. Due to limitations of two-dimensional thymic sections, we hope 
to instead image a series of immunolabelled thymic sections to create a full three-dimensional 
(3D) organ reconstruction of intact thymus samples, to enable the visualization of the whole 
tissue. The establishment of this method has already facilitated insight into the organization, 
development and function of the thymic medulla (Irla et al., 2013) and we hope by utilizing 
this technique we can explore the alteration to thymic structure in the absence  of CCR4, 
CCR7, or within the compound mutant. Therefore we should be able to directly address the 
effects of CCR4 deficiency, either exclusively or in conjunction with CCR7, on thymic 
architecture. We will particularly focus on the medullary volume and the quantification of 
medullary islet within the different chemokine receptor deficient mouse strains, to offer more 
clarity to the role of CCR4 in cortex to medulla migration of positively selected SP 
thymocytes.  
If indeed the hints within our preliminary data are correct and the medullary volumes are 
significantly reduced as a consequence of absence of CCR4 and CCR7, this raises the 
question as to where the increased percentages of both the total TCRβhigh SP4 population and 
the raised CD25
+
 FoxP3
+
 nTreg subset detected within these mouse strains reside within the 
thymic microenvironment. A reduction to medullary size and an increase to the two SP4 
subsets would suggest the thymocytes must be mislocalised within cortical regions. Thus, 
more detailed imaging of the thymic microenvironment will be extremely beneficial to offer 
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more clarity on thymocyte positioning as a consequence of the removal of specific 
chemokine-receptor mediated migration.  One experimental approach could be the use of live 
cell imaging and two-photon microscopy, which has been used in the past to track the 
migratory pathway of CCR7 deficient mice (Ehrlich et al., 2009). Such experimental analysis 
of the migratory pattern of CCR4 deficient and CCR4 x CCR7 double deficient thymocytes 
may identify any existing subtle alterations to SP intrathymic migration pathways. In 
experiments involving standard confocal microscopy, the visualization of mislocalized SP 
thymocytes can be difficult due to the overwhelming numbers of DP residents tightly packed 
within the cortical regions of a steady state adult mouse. To overcome this problem 
competitive bone marrow chimeras of WT hosts can be used for more successful 
identification of the intrathymic localization of SP thymocyte. This technique was adopted in 
the identification of misloclaised Ccr7
-/- 
SP thymocytes within cortical regions (Ueno et al., 
2004) and thus the reconstitution of Ccr4
-/- 
x Ccr7
-/- 
bone marrow in competition with WT 
cells may aid the detection of the Ccr4
-/- 
x Ccr7
-/- 
SP positioning. This experimental approach 
may provide more detailed analysis of the migratory potential of the Ccr4
-/- 
x Ccr7
-/-
 
thymocytes when place under the selective pressures of a competitive environment, although 
this technique revealed no alterations to the positioning of Ccr4
-/-
 thymocytes.     
6.4 CONCLUDING REMARKS 
In summary, the experiments in this thesis have helped in our understanding of the 
importance of the thymic medulla in late stage T cell development. The observation 
conventional T cell development occurs in the absence of an intact mTEC compartment, 
while Treg development is mTEC dependent, raising the possibility that the primary role of 
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the medulla is not to act as a site of general SP thymocyte differentiation, but as a 
microenvironment specialized for tolerance induction. In addition, our investigations into the 
role of CCR4 in cortex to medulla migration identified this chemokine receptor is not 
essential in the cortex to medulla reclocalizaion of positively selected thymocytes, or their 
subsequent intrathymic developmental program. Therefore, if CCR4 is involved in post-
selection maturation, its contribution must be both dispensable and compensated for by 
redundancy within the chemokine receptor system. Nevertheless, although CCR4 may not 
have a vital role in intrathymic T cell development, due to its tight window of expression, the 
receptor acts as a good marker of newly generated SP4 thymocytes. To expose possible 
redundancy by CCR7, concealing the involvement of CCR4 in cortex to medulla migration, 
more advance imaging techniques are need to visualize thymocyte migratory pathways and 
the medulla architecture of Ccr4
-/- 
x Ccr7
-/- 
steady state microenvironments. Collectively, we 
aim to confirm if the removal of CCR4 and CCR7 simultaneously increases the severity of the 
phenotype observed upon CCR7 removal exclusively.    
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